Special Thanks To My Beloved Father
“Syed Ashfaq Ali”
For your guidance, strength, and endless inspiration.
“The Family Medicine Casebook: Practical Clinical Scenarios for Everyday Practice”
By
Dr. Syed Aamir Ali Naqvi
Family Physician (Gold Medalist)
Credentialed (PM&DC, MMC)
Member – Pakistan Academy of Family Physicians (PAFP)
M.D. (SSMU, KZ)
ECFMG Regd. (USA)
MCC Certified (Canada)
PGD-FM (SCM, STMU, PK)
PGCert-MHR (GIHD, STMU, PK)
© 2026 Dr. Syed Aamir Ali Naqvi – All Rights Reserved
Table of Contents
⚕️ Scope of Practice — Family Physician
I. General & Administrative
Patient registration, record keeping, confidentiality, consent, documentation
Health screening, preventive check-ups, vaccination
Chronic disease follow-up, medication reconciliation
Fitness, medical and vaccination certificates
Referral documentation, emergency stabilization, medico-legal notes
II. General Medicine (Adult)
1. Acute illnesses
Fever, flu, sore throat, tonsillitis, bronchitis, pneumonia (mild–moderate)
Gastroenteritis, food poisoning, dyspepsia, GERD
Migraine, tension headache, vertigo
UTI, cystitis, prostatitis (initial management)
Allergies, urticaria, anaphylaxis (stabilize, refer if severe)
Poisoning (first aid, antidote, referral)
2. Chronic conditions
Hypertension, Diabetes, Dyslipidemia
Thyroid disorders
Asthma, COPD (stable cases, exacerbations initial care)
Chronic kidney disease (stages 1–3)
Benign prostatic hyperplasia
Arthritis, gout, chronic pain
Obesity, metabolic syndrome
3. Geriatric medicine
Polypharmacy review
Falls, confusion, dementia, frailty
Pressure ulcers, chronic wounds
III. Pediatrics (Children & Infants)
Growth & development monitoring, nutrition counseling
Immunizations (national & travel-related)
Fever, respiratory, ear, throat, skin, GI infections
Worm infestation, dehydration, anemia
Asthma, allergies, eczema
Developmental delays (screening & referral)
Neonatal jaundice (identify, initial management, refer if severe)
Febrile seizures, breath-holding spells
School health, behavioral issues (ADHD screening, learning problems)
IV. Women’s Health / Obstetrics & Gynecology
Antenatal check-up (normal pregnancy) & referral when high-risk
Postnatal follow-up, breastfeeding advice
Menstrual disorders: dysmenorrhea, menorrhagia, amenorrhea
Vaginal discharge, pelvic pain, UTI
Contraception advice & prescriptions
Menopause management
Breast examination, Pap smear (screening & referral for abnormal findings)
Pregnancy testing, counseling, referral for complications
V. Men’s Health
Erectile dysfunction, premature ejaculation
Infertility (basic work-up, referral)
Prostatitis, BPH, LUTS (assessment, initial management)
Hypogonadism screening, testosterone deficiency awareness
VI. Dermatology
Acne, eczema, psoriasis, fungal, bacterial, viral skin infections
Urticaria, drug rash, contact dermatitis
Alopecia, dandruff, pigmentation disorders
Scabies, lice, nail infections
Skin tag/wart removal (if trained & equipped)
Suspicious lesions — biopsy or referral for malignancy
VII. ENT / Eye
ENT:
Otitis media/externa, wax, sinusitis, allergic rhinitis
Sore throat, tonsillitis, pharyngitis
Epistaxis (initial control, referral if uncontrolled)
Vertigo (BPPV, vestibular neuritis)
Eye:
Conjunctivitis, stye, blepharitis
Foreign body removal
Refractive errors screening
Red eye — initial treatment or referral if suspect glaucoma or ulcer
VIII. Cardiology
Hypertension (all grades, referral if resistant or crisis)
Ischemic heart disease (angina, post-MI follow-up)
Palpitations, arrhythmias (ECG interpretation, referral if unstable)
Heart failure (stabilize, manage mild cases, refer severe)
Peripheral vascular disease
IX. Respiratory
Asthma, COPD, bronchitis, pneumonia, tuberculosis (screening, initial therapy)
COVID-19, influenza management
Occupational lung disease screening
Smoking cessation counseling
X. Gastroenterology
GERD, peptic ulcer, IBS, constipation, diarrhea, hemorrhoids
Hepatitis screening & follow-up (A, B, C)
Cholelithiasis, pancreatitis — diagnose, stabilize, refer
Malabsorption, fatty liver, obesity counseling
XI. Nephrology / Urology
UTI, renal colic, stones (pain relief, hydration, referral if obstructed)
CKD screening (urinalysis, eGFR)
Proteinuria, hematuria — work-up, referral
BPH, prostatitis
Catheterization (if trained and indicated)
XII. Endocrinology
Diabetes (type 1, type 2, gestational)
Thyroid disorders (hypo/hyperthyroidism)
Adrenal and pituitary disorders (screening, refer specialized)
Obesity, metabolic syndrome, PCOS
XIII. Neurology
Headache, migraine, tension, cluster
Seizures (stabilize, initiate treatment, refer)
Stroke (recognize, stabilize, urgent referral)
Neuropathy (diabetic, B12 deficiency)
Parkinsonism, tremor, weakness evaluation
XIV. Psychiatry & Behavioral Health
Anxiety, depression, stress, insomnia
Substance abuse screening, counseling, referral
Grief, trauma, marital, family counseling
Suicide risk identification & immediate referral
ADHD, learning disorders (pediatric screening)
XV. Orthopedics / Musculoskeletal
Sprains, strains, tendinitis, back pain
Fracture first aid, immobilization, referral
Osteoarthritis, rheumatoid arthritis follow-up
Sports injuries
Gout, bursitis
XVI. Surgical / Emergency Care
Minor cuts, burns, lacerations, abscess drainage
Wound suturing & dressing
Foreign body removal (skin, eye, ear, nose)
Epistaxis, tooth extraction (if trained)
Shock, dehydration, hypoglycemia management
Anaphylaxis, asthma attack stabilization
CPR, basic life support
Snake bite, dog bite (first aid, antiserum, referral)
XVII. Infectious Diseases
Fever of unknown origin (FUO)
Dengue, malaria, typhoid, hepatitis, influenza, COVID-19
STDs (screening, counseling, initial management)
HIV counseling, testing, post-exposure prophylaxis (PEP)
Traveler’s health: vaccination, malaria prophylaxis
XVIII. Preventive & Community Health
Screening: BP, diabetes, cholesterol, BMI, cancer, anemia
Immunization (child, adult, travel, occupational)
Health education, smoking cessation, weight management
Occupational health, ergonomic counseling
Environmental & vector-borne disease awareness
XIX. Rehabilitation & Chronic Care
Post-stroke, post-MI, post-fracture rehabilitation
Lifestyle modification plans
Pain management (non-opioid, non-invasive)
Home care advice, caregiver training
XX. Legal & Ethical Responsibilities
Documentation and record retention
Informed consent & confidentiality
MLCs (injury, assault, poisoning) — document and refer
Disability & fitness certification (as permitted)
Professional boundaries, referral ethics
Prescribing legally registered medicines only
⚖️ Summary of Role
Diagnose and manage >80% of all primary care conditions
Stabilize and refer serious, surgical, or tertiary-level cases
Maintain preventive and community health standards
Act ethically, document properly, and ensure continuity of care
I. GENERAL & ADMINISTRATIVE
1. Patient Registration & History Taking
Purpose: Create accurate medical records for continuity of care
Steps:
Collect demographics: name, age, gender, contact, ID
Chief complaint, history of presenting illness
Past medical history, surgical history, medications, allergies
Family history, social history (smoking, alcohol, occupation)
Review of systems relevant to presenting complaint
Documentation: Ensure legible, complete, and timely entries
2. Consent & Documentation
Informed Consent:
Explain diagnosis, procedure, benefits, risks, alternatives
Obtain signature or verbal consent documented in the chart
Confidentiality:
Maintain patient privacy per ethical and legal standards
Limit access to authorized personnel only
3. Maintenance of Medical Records
Keep records updated, organized, and secure
Use electronic medical records (EMR) or structured paper charts
Include lab results, prescriptions, imaging reports, and follow-ups
4. Preventive Health Checkups & Annual Screenings
Adults: BP, BMI, blood glucose, lipid profile, cancer screening (breast, cervical, colon)
Children: Growth monitoring, developmental milestones, anemia screening
Document results, provide counseling, and schedule follow-ups
5. Vaccination Services & Travel Medicine Advice
Routine immunizations per national schedule
Travel vaccines based on destination risk (e.g., yellow fever, hepatitis A/B, typhoid)
Counsel on vaccine side effects and timing
6. Chronic Disease Follow-Up & Medication Review
Regular review of patients with hypertension, diabetes, asthma, etc.
Check adherence, efficacy, and side effects of medications
Adjust therapy based on labs, symptoms, and guidelines
7. Health Certificates
Fitness certificates: for employment, sports, school
Medical certificates: for sick leave, chronic conditions, or immunization status
Ensure documentation matches clinical assessment
8. Referral Letters & Medico-Legal Documentation
Provide structured referral letters with diagnosis, current therapy, and reason for referral
Maintain medico-legal records for injury, assault, or occupational health
9. Emergency Stabilization Before Referral
Provide first aid, CPR, oxygen, or stabilization as required
Document interventions, vital signs, and patient response
Ensure safe transport with clear instructions to receiving facility
Patient Instructions / Ethical Notes:
Explain procedures and follow-up clearly to patients
Maintain confidentiality, document care thoroughly
Encourage preventive health and adherence to chronic disease management
II. GENERAL MEDICINE (ADULT)
1. Acute Illnesses / Presentations:
Sudden onset fever, malaise, or systemic symptoms
Rapid assessment to differentiate self-limiting vs potentially serious conditions
Case 2a – Fever & Viral Infection
Diagnosis:
Acute viral infection presenting with fever, malaise, myalgia, and mild respiratory or gastrointestinal symptoms
Patient Presentation / Wordings:
“I have a fever, body aches, and feel very tired.”
“My throat is sore, and I have a runny nose and mild cough.”
“I’ve had diarrhea and mild vomiting for a day or two.”
Examination / Assessment:
Vital signs: temperature, pulse, BP, respiratory rate, oxygen saturation
General assessment: hydration, consciousness, signs of systemic infection
ENT: throat, tonsils, nasal mucosa
Lung auscultation for crackles, wheezing, or signs of pneumonia
Abdominal examination if gastrointestinal symptoms present
Investigations (if indicated):
CBC for persistent high fever
Rapid antigen tests if influenza or COVID-19 suspected
Stool or other labs only if severe or persistent symptoms
Treatment / Prescription / Management:
A. Supportive Care:
Hydration: oral fluids, ORS if vomiting/diarrhea present
Rest and avoidance of strenuous activity
B. Symptomatic Relief:
Antipyretics: Paracetamol 500–1000 mg PO every 6 hours PRN (max 4 g/day)
NSAIDs for pain or myalgia: Ibuprofen 400 mg PO every 8 hours with food (if no contraindications)
Saline nasal drops or steam inhalation for congestion
Throat lozenges for sore throat
C. Antibiotics:
Not indicated unless bacterial infection suspected (persistent high fever, purulent discharge, localized signs)
Expected Side Effects / Precautions:
Paracetamol: hepatotoxicity if overdosed
NSAIDs: GI irritation, renal impairment, caution in hypertensive or renal patients
Monitoring / Follow-Up:
Watch for warning signs: persistent high fever >3 days, difficulty breathing, chest pain, altered consciousness
Daily self-monitoring of temperature and symptoms
Follow-up in clinic if symptoms worsen or persist
Referral Criteria:
Respiratory distress, hypoxia, or pneumonia
Severe dehydration due to vomiting/diarrhea
Signs of sepsis or systemic deterioration
Patient Instructions:
Maintain adequate fluid intake and rest
Take medications as prescribed, do not exceed recommended doses
Monitor for warning signs and seek immediate care if they occur
Avoid close contact with others if contagious (cough, sneezing)
Legal / Ethical Justification:
Family physicians provide evidence-based symptomatic management for viral illnesses
Avoid unnecessary antibiotics to prevent antimicrobial resistance
Proper documentation of assessment and counseling ensures medicolegal protection
Case 2b – Pharyngitis, Tonsillitis & Mild Respiratory Infections
Diagnosis:
Acute bacterial or viral pharyngitis/tonsillitis or mild lower respiratory tract infection (bronchitis, mild pneumonia)
Patient Presentation / Wordings:
“My throat is sore and it hurts to swallow.”
“I have fever, headache, and swollen glands in my neck.”
“I have a cough with mild fever and fatigue.”
Examination / Assessment:
Vital signs: temperature, pulse, BP, respiratory rate
Throat and oral cavity: redness, exudates, tonsillar enlargement
Cervical lymph nodes: tenderness, enlargement
Lung auscultation: check for crackles, wheezing, or consolidation
Assess hydration, general condition, and oxygen saturation
Investigations (if indicated):
Rapid antigen detection test for Group A Streptococcus
Throat swab culture if persistent or severe
Chest X-ray if pneumonia suspected
CBC if high fever or systemic signs
Treatment / Prescription / Management:
A. Symptomatic Relief:
Analgesics / antipyretics: Paracetamol 500–1000 mg PO every 6 hours PRN
NSAIDs: Ibuprofen 400 mg PO every 8 hours with food if inflammation present
Saltwater gargle, warm fluids, throat lozenges
B. Antibiotic Therapy (if bacterial infection suspected or confirmed):
First-line: Amoxicillin 500 mg PO TID × 10 days
Penicillin allergy: Azithromycin 500 mg PO day 1, then 250 mg PO daily × 4 days
C. Supportive Measures:
Adequate hydration, rest, and avoidance of irritants (smoke, dust)
Monitor for worsening symptoms or complications (peritonsillar abscess, pneumonia)
Expected Side Effects / Precautions:
Antibiotics: diarrhea, rash, hypersensitivity reactions
NSAIDs: GI upset, renal effects
Paracetamol: hepatotoxicity if overdosed
Monitoring / Follow-Up:
Reassess if symptoms persist beyond 7 days or worsen
Watch for respiratory distress, high fever, or signs of systemic infection
Ensure completion of full antibiotic course if prescribed
Referral Criteria:
Severe pain, trismus, peritonsillar abscess
Respiratory distress or hypoxia
Persistent high fever, sepsis, or immunocompromised patients
Patient Instructions:
Take medications exactly as prescribed
Rest and maintain hydration
Avoid close contact with others if contagious
Return to clinic for worsening symptoms or complications
Legal / Ethical Justification:
Family physicians provide primary care for acute pharyngitis and mild respiratory infections
Judicious antibiotic use prevents resistance
Proper documentation of diagnosis, treatment, and follow-up protects against legal liability
Case 2c – Gastroenteritis, Dyspepsia & Food Poisoning
Diagnosis:
Acute gastrointestinal illness due to infection (viral, bacterial, or parasitic) or food-related causes
Presenting with diarrhea, vomiting, abdominal pain, or dyspepsia
Patient Presentation / Wordings:
“I have diarrhea and vomiting after eating outside food.”
“I feel nauseated, bloated, and have stomach cramps.”
“I vomited several times and my stomach hurts.”
Examination / Assessment:
Vital signs: temperature, pulse, BP, respiratory rate
Hydration status: mucous membranes, skin turgor, capillary refill
Abdominal examination: tenderness, distension, bowel sounds
Signs of systemic infection or sepsis
Investigations (if indicated):
Stool microscopy, culture if bloody diarrhea or severe infection suspected
CBC if high fever or systemic symptoms
Electrolytes if significant dehydration or persistent vomiting
Treatment / Prescription / Management:
A. Hydration & Supportive Care:
Oral rehydration solution (ORS) for mild to moderate dehydration
IV fluids (Ringer’s lactate or normal saline) if severe dehydration
Encourage small, frequent meals once vomiting subsides
B. Symptomatic Relief:
Antiemetics: Ondansetron 4 mg PO/ODT every 8 hours PRN
Antidiarrheals (if non-bloody and mild): Loperamide 4 mg initial, then 2 mg after each loose stool; max 16 mg/day
Antacids or proton pump inhibitors for dyspepsia
C. Antibiotics (if indicated):
Only for suspected bacterial infections (severe, bloody diarrhea, high-risk patients)
Ciprofloxacin 500 mg PO BID × 5 days (adult, adjust per local guidelines)
Expected Side Effects / Precautions:
Antiemetics: mild constipation or headache
Antidiarrheals: abdominal cramps, constipation; avoid in bloody diarrhea
Antibiotics: diarrhea, rash, hypersensitivity
Monitoring / Follow-Up:
Monitor hydration status and symptom improvement
Daily follow-up for persistent vomiting or diarrhea
Hospital referral if worsening dehydration, systemic infection, or inability to tolerate oral intake
Referral Criteria:
Severe dehydration, hypotension, or shock
Bloody diarrhea, high-grade fever, or persistent vomiting
Signs of sepsis or severe systemic involvement
Patient Instructions:
Maintain adequate oral fluids and rest
Eat light, bland diet once tolerated
Avoid self-medication with unnecessary antibiotics
Return to clinic if symptoms worsen or persist beyond 48–72 hours
Legal / Ethical Justification:
Family physicians provide timely, evidence-based care for acute gastroenteritis
Proper documentation and patient counseling protect against legal claims
Judicious use of antibiotics prevents resistance and ensures patient safety
Case 2d – Migraine, Tension Headache, Vertigo
A. Migraine (Acute / Recurrent)
Diagnosis: Migraine without aura / with aura
Patient Presentation / Wordings:
“I have a severe throbbing headache, often on one side.”
“Light and sound make it worse.”
“Sometimes I see flashes or visual disturbances before a headache.”
“Nausea or vomiting accompanies the headache.”
Examination / Red Flags:
Normal neuro exam in typical cases
Red flags for referral: sudden severe headache (“worst ever”), neurological deficits, vision loss, fever, neck stiffness, trauma
Treatment / Prescription:
Acute attack:
Paracetamol 500–1000 mg orally every 6–8 hours as needed (max 4 g/day)
NSAID (Ibuprofen 400–600 mg orally every 8 hours as needed) – take with food to reduce GI irritation
Sumatriptan 50–100 mg orally at onset if moderate–severe attack, may repeat after 2 hours if no relief (max 200 mg/day)
Preventive therapy (if >4 attacks/month):
Propranolol 20–40 mg orally twice daily
OR Amitriptyline 10–25 mg orally at bedtime
Expected Side Effects:
Paracetamol: rare liver toxicity (avoid >4 g/day)
Ibuprofen: GI irritation, heartburn, rare kidney effects
Sumatriptan: flushing, chest tightness, dizziness
Propranolol: fatigue, bradycardia, hypotension
Amitriptyline: drowsiness, dry mouth, weight gain
Monitoring: Symptom diary, headache frequency, BP if on beta-blocker
Referral Criteria: Neurological deficits, sudden severe headache, unresponsive migraine, medication overuse headache
Patient Instructions: Take acute medications at onset, maintain headache diary, avoid triggers, rest in quiet/dark room
Legal/Ethical Justification: Management of typical migraine attacks and preventive therapy is within Family Medicine scope; referral criteria ensure patient safety
B. Tension Headache
Diagnosis: Tension-Type Headache
Patient Presentation / Wordings:
“I feel a tight band-like pressure around my head.”
“Pain is mild to moderate, lasts hours to days.”
“No nausea or visual disturbances.”
Treatment / Prescription:
Paracetamol 500–1000 mg orally every 6–8 hours as needed
NSAID (Ibuprofen 200–400 mg orally every 6–8 hours as needed)
Non-pharmacologic: stress management, physiotherapy, sleep hygiene
Expected Side Effects: Same as above for paracetamol and NSAIDs
Monitoring: Frequency, severity, impact on daily life
Referral Criteria: Change in headache pattern, neurological signs, refractory headaches
Patient Instructions: Take medication as needed, maintain stress management, ergonomic adjustments, adequate sleep
Legal/Ethical Justification: Symptomatic management of tension headaches is within Family Medicine scope; red flags warrant referral
C. Vertigo (Peripheral / Benign Positional Vertigo)
Diagnosis: Benign Paroxysmal Positional Vertigo (BPPV) / Vestibular Vertigo
Patient Presentation / Wordings:
“I feel like the room is spinning when I move my head.”
“Symptoms last seconds to minutes, triggered by head movement.”
“Sometimes nausea accompanies it.”
Examination / Red Flags:
Dix-Hallpike maneuver positive for BPPV
Normal neurological exam if peripheral
Red flags: new neurological deficit, sudden hearing loss, severe headache → urgent referral
Treatment / Prescription:
Epley maneuver / vestibular repositioning exercises (first-line)
Meclizine 25 mg orally 1–2 times daily for short-term symptom relief if severe
Anti-emetics (Ondansetron 4 mg orally every 8 hours) if persistent nausea
Expected Side Effects:
Meclizine: drowsiness, dry mouth
Ondansetron: headache, constipation
Monitoring: Symptom resolution, recurrence, ability to perform daily activities
Referral Criteria: Persistent vertigo >2 weeks, neurological deficits, hearing loss, unsteady gait, suspected central cause
Patient Instructions: Perform repositioning exercises as instructed, avoid sudden head movements, take medications if needed for nausea/dizziness
Legal/Ethical Justification: Diagnosis and initial management of BPPV and vestibular vertigo are within Family Medicine scope; referral criteria defined for central or complicated vertigo
Case 2e – Urinary Tract Infection, Cystitis & Prostatitis (Initial Management)
Diagnosis:
Acute uncomplicated urinary tract infection (UTI)
Cystitis in adults
Suspected bacterial prostatitis (initial management)
Patient Presentation / Wordings:
“I have a burning sensation when urinating.”
“I feel the urge to urinate frequently, but only pass small amounts.”
“I have lower abdominal discomfort or mild fever.”
“I have lower back or perineal pain with urinary symptoms (possible prostatitis).”
Examination / Assessment:
Vital signs: temperature, pulse, BP
Abdominal exam: suprapubic tenderness
Flank pain: costovertebral angle tenderness
Genitourinary exam: prostate palpation in suspected prostatitis
Assess hydration, systemic involvement, and comorbidities
Investigations (if indicated):
Urine dipstick: leukocytes, nitrites, hematuria
Urine microscopy / culture and sensitivity if recurrent or complicated
CBC if systemic infection suspected
PSA and renal function if prostatitis suspected
Treatment / Prescription / Management:
A. Uncomplicated UTI / Cystitis:
First-line: Nitrofurantoin 100 mg PO BID × 5 days
Alternative: Trimethoprim-sulfamethoxazole 160/800 mg PO BID × 3 days (if no resistance risk)
Symptomatic relief: Paracetamol 500–1000 mg PO q6h PRN for dysuria
B. Suspected Acute Bacterial Prostatitis:
Empiric oral antibiotics: Ciprofloxacin 500 mg PO BID × 10–14 days
Pain management: NSAIDs (Ibuprofen 400 mg PO q8h with food)
Supportive measures: hydration, warm sitz baths
Expected Side Effects / Precautions:
Nitrofurantoin: GI upset, pulmonary reactions (rare)
Ciprofloxacin: GI upset, tendonitis risk, photosensitivity
NSAIDs: GI irritation, renal caution
Monitoring / Follow-Up:
Symptom improvement within 48–72 hours
Reassess if persistent fever, worsening pain, or urinary obstruction
Urine culture follow-up in recurrent or complicated cases
Referral Criteria:
Severe infection with high fever, systemic symptoms, or sepsis
Recurrent UTIs or resistant organisms
Suspected complicated prostatitis, obstruction, or abscess
Patient Instructions:
Complete full antibiotic course
Drink adequate fluids
Avoid irritants (caffeine, alcohol) during treatment
Return to clinic if symptoms persist or worsen
Legal / Ethical Justification:
Family physicians provide initial evaluation and management of UTIs and prostatitis
Proper documentation and patient counseling ensure medicolegal protection
Timely treatment reduces risk of complications, hospitalization, and antibiotic resistance
Case 2f – Allergic Reactions, Urticaria & Anaphylaxis
Diagnosis:
Acute allergic reaction ranging from mild urticaria to life-threatening anaphylaxis
Patient Presentation / Wordings:
“I have red, itchy hives all over my body.”
“My lips and face are swelling, and I feel short of breath.”
“I have a sudden rash with difficulty breathing after eating or taking medication.”
Examination / Assessment:
Vital signs: BP, pulse, respiratory rate, oxygen saturation
Airway assessment: check for stridor, hoarseness, or swelling of tongue/throat
Skin: urticaria, angioedema, redness
Respiratory: wheezing, accessory muscle use
Cardiovascular: hypotension, tachycardia
Assess severity: mild, moderate, severe (anaphylaxis)
Investigations (if indicated):
Usually clinical diagnosis; labs only if systemic involvement or for follow-up
Consider CBC, serum tryptase (post-anaphylaxis)
Treatment / Prescription / Management:
A. Mild Allergic Reaction / Urticaria:
Antihistamines: Cetirizine 10 mg PO OD or Loratadine 10 mg PO OD
Symptomatic care: topical calamine, avoid triggers
B. Moderate to Severe / Anaphylaxis:
Immediate: Epinephrine 0.3–0.5 mg IM (adult) into mid-outer thigh; may repeat every 5–15 min if needed
Oxygen therapy 5–10 L/min via face mask
IV fluids: 0.9% normal saline, 1–2 L rapidly for hypotension
Adjunct: corticosteroids (Hydrocortisone 100–200 mg IV) and antihistamines (Diphenhydramine 25–50 mg IV/IM)
Monitor airway, BP, and pulse continuously
C. Referral / Escalation:
All cases of anaphylaxis require immediate transfer to emergency care
Patients with respiratory distress, hypotension, or systemic involvement
Expected Side Effects / Precautions:
Epinephrine: transient palpitations, anxiety, tremor
Antihistamines: drowsiness, dry mouth
Corticosteroids: hyperglycemia, fluid retention
Monitoring / Follow-Up:
Observe patient for biphasic reactions for at least 4–6 hours after severe reactions
Educate patient on avoidance of triggers and emergency epinephrine use
Prescribe epinephrine auto-injector if recurrent anaphylaxis risk
Patient Instructions:
Avoid known allergens
Carry epinephrine auto-injector if indicated
Seek immediate medical care for future severe reactions
Take antihistamines as prescribed for mild reactions
Legal / Ethical Justification:
Family physicians must stabilize allergic reactions promptly
Timely management and proper documentation protect patient safety and physician liability
Educating patients on triggers and emergency measures ensures ethical, patient-centered care
Case 2g – Poisoning or Drug Overdose (First Aid & Referral)
Diagnosis:
Acute poisoning or drug overdose from accidental or intentional ingestion
Common Patient Presentations / Wordings
“I accidentally took too many pills.”
“I feel dizzy, nauseous, and weak.”
“I have stomach pain and vomiting.”
“I feel short of breath or my heart is racing.”
“I don’t know exactly what substance I ingested.”
“I took something intentionally to harm myself.”
“My skin feels clammy or I am sweating a lot.”
“I feel confused or drowsy.
Objective Findings / Red Flags
Vitals: Hypotension, tachycardia, bradycardia, hypoxia
General Exam: Altered consciousness, drowsiness, agitation, cyanosis
Red Flags (refer immediately / emergency):
Respiratory distress
Seizures
Coma or severe altered mental status
Hypotension or shock
Cardiac arrhythmias
Ingestion of life-threatening substances (e.g., organophosphates, opioids, paracetamol in toxic dose, cyanide)
Initial Diagnostic Approach in Clinic
History: Substance ingested, dose, time of ingestion, co-ingestants, comorbidities
Examination: Vitals, airway, breathing, circulation, neurological status
Basic Tests (if available and safe):
Blood glucose (rule out hypoglycemia)
ECG if cardiotoxic drug suspected
Serum electrolytes, renal, liver function if ingestion >24 hrs or suspected toxic drug
Blood paracetamol / salicylate level if suspected overdose
5. Management / Treatment in Primary Care (Prescription-Ready / First Aid)
A. Immediate Stabilization
Airway, Breathing, Circulation (ABC): Ensure airway is patent, oxygen if needed
IV access if hypotensive, for fluids: Normal Saline 500–1000 ml bolus if hypotensive
Activated Charcoal: 50 g orally or via NG tube if within 1–2 hours of ingestion (except corrosives, hydrocarbons)
B. Symptomatic / Specific Antidotes (if available)
Paracetamol overdose: N-acetylcysteine (NAC) protocol
Opioid overdose: Naloxone 0.4–2 mg IV/IM/SC repeat as needed
Benzodiazepine overdose: Usually supportive; flumazenil only if severe and no chronic use
Others: Treat as per standard toxicology protocols
C. Monitoring Instructions
Continuous monitoring of vitals, oxygen saturation, mental status
Record fluid balance and urine output
Monitor for arrhythmias or seizures
6. Referral Criteria / When to Escalate
All suspected poisoning or overdose cases require immediate hospital referral
Any hemodynamic instability, respiratory compromise, altered consciousness, or seizures → emergency care
Corrosive ingestion, multi-drug overdose, or unknown substance → hospital referral
Long-term monitoring for chronic toxicity or psychiatric evaluation if intentional ingestion
Expected Side Effects / Precautions:
Activated charcoal: constipation, black stools, vomiting
IV fluids: monitor for overload in patients with renal/cardiac disease
Antidotes: follow dosing strictly to avoid toxicity
Monitoring / Follow-Up:
Serial vital signs and neurological assessment
Laboratory monitoring: electrolytes, renal/liver function
Psychological evaluation if intentional overdose
Patient Instructions:
Avoid repeat exposure to toxic substances
Take medications only as prescribed
Follow-up for any delayed effects or complications
Seek immediate care if symptoms worsen
Legal / Ethical Justification:
Family physicians must provide prompt first aid for poisoning and initiate referral
Accurate documentation is essential for patient safety and medicolegal protection
Early intervention reduces morbidity, mortality, and long-term complications
2. Chronic Conditions
Case 2h – Hypertension (Chronic Management)
Diagnosis:
Primary (essential) hypertension
Secondary hypertension if underlying cause suspected
Patient Presentation / Wordings:
“My blood pressure readings are high at home.”
“I feel dizzy and have occasional headaches.”
“I am being followed up for high blood pressure.”
Examination / Assessment:
Vital signs: multiple BP readings in both arms, pulse, weight, BMI
Cardiovascular exam: heart sounds, murmurs, peripheral pulses
Fundoscopy: hypertensive retinopathy
Check for signs of target organ damage: ECG, renal function, echocardiography if indicated
Investigations:
Routine: CBC, electrolytes, renal function, fasting glucose, lipid profile
ECG for left ventricular hypertrophy or ischemic changes
Urinalysis for proteinuria
Optional: echocardiography if cardiovascular disease suspected
Treatment / Prescription / Management:
A. Lifestyle Modifications:
Reduce salt intake (<5 g/day), DASH diet
Weight management and regular physical activity
Limit alcohol, avoid smoking
Stress management techniques
B. Pharmacological Therapy (Individualized):
First-line:
ACE inhibitors (e.g., Lisinopril 10–20 mg PO OD)
ARBs (e.g., Losartan 50–100 mg PO OD)
Calcium channel blockers (e.g., Amlodipine 5–10 mg PO OD)
Thiazide diuretics (e.g., Hydrochlorothiazide 12.5–25 mg PO OD)
Combination therapy if BP not controlled with monotherapy
Monitoring: adjust doses based on BP response and tolerability
C. Expected Side Effects / Precautions:
ACE inhibitors: dry cough, hyperkalemia, angioedema
ARBs: hyperkalemia, dizziness
CCBs: peripheral edema, flushing
Diuretics: hypokalemia, dehydration, electrolyte imbalance
Monitoring / Follow-Up:
Home BP monitoring: 1–2 times daily, record readings
Clinic BP every 4–6 weeks initially until controlled, then every 3–6 months
Monitor renal function and electrolytes if on ACE inhibitors, ARBs, or diuretics
Screen for target organ damage periodically
Referral Criteria:
Resistant hypertension (BP not controlled on ≥3 medications)
Secondary hypertension suspected (renal artery stenosis, endocrine disorders)
Target organ damage or complications (heart failure, CKD, stroke)
Patient Instructions:
Take medications at the same time every day
Maintain lifestyle modifications strictly
Monitor BP at home and keep a log
Report symptoms: dizziness, fainting, swelling, persistent cough
Do not stop medications abruptly
Legal / Ethical Justification:
Family physicians manage chronic hypertension to reduce cardiovascular risk
Documenting BP readings, treatment decisions, and counseling protects against legal claims
Following evidence-based guidelines ensures ethical, safe care
Case 2i – Diabetes Mellitus (Chronic Management)
Diagnosis:
Type 2 Diabetes Mellitus (T2DM)
Poorly controlled or newly diagnosed adult diabetes
Patient Presentation / Wordings:
“I feel very thirsty and urinate frequently.”
“My sugar readings are high at home.”
“I am here for routine diabetes follow-up.”
Examination / Assessment:
Vital signs: BP, pulse, BMI, waist circumference
General assessment: signs of dehydration, infection
Foot examination: ulcers, neuropathy
Ophthalmic: refer for retinopathy screening
Neurological: peripheral neuropathy signs (vibration, monofilament test)
Investigations:
Fasting blood glucose, postprandial glucose
HbA1c every 3–6 months
Lipid profile, renal function tests (creatinine, eGFR), urinalysis for microalbuminuria
ECG if cardiovascular risk present
Treatment / Prescription / Management:
A. Lifestyle Modifications:
Balanced diet with carbohydrate control
Weight management and regular exercise
Smoking cessation, limit alcohol
Educate on hypoglycemia recognition and management
B. Pharmacological Therapy:
First-line: Metformin 500–1000 mg PO BID (titrate to tolerance)
Second-line / add-on therapy:
Sulfonylureas (e.g., Glimepiride 1–4 mg PO OD)
DPP-4 inhibitors, SGLT2 inhibitors, or GLP-1 agonists per guidelines and patient comorbidities
Insulin therapy if inadequate control on oral agents or in acute complications
C. Expected Side Effects / Precautions:
Metformin: GI upset, lactic acidosis (rare, avoid in CKD stage ≥3)
Sulfonylureas: hypoglycemia
SGLT2 inhibitors: urinary infections, dehydration
Insulin: hypoglycemia, weight gain
Monitoring / Follow-Up:
Self-monitoring of blood glucose (SMBG) as instructed
HbA1c every 3–6 months
Annual screening for retinopathy, nephropathy, neuropathy, cardiovascular disease
Monitor for complications: foot care, infection prevention
Referral Criteria:
Poorly controlled diabetes despite optimal therapy
Complications: diabetic foot, retinopathy, nephropathy, neuropathy
Pregnancy, planned surgery, or acute metabolic complications
Patient Instructions:
Take medications as prescribed and do not skip doses
Follow dietary and exercise plan strictly
Monitor blood sugar at home and record readings
Report symptoms: hypoglycemia, infections, vision changes, foot ulcers
Legal / Ethical Justification:
Family physicians provide comprehensive chronic diabetes care
Documentation of glycemic control, counseling, and complications protects against medicolegal issues
Evidence-based management reduces morbidity, hospitalization, and long-term complications
Case 2j – Dyslipidemia (Chronic Management)
Diagnosis:
Primary or secondary dyslipidemia
Elevated cholesterol, LDL, triglycerides, or low HDL
Patient Presentation / Wordings:
“My cholesterol is high on lab tests.”
“I have a family history of heart disease.”
“I am here for routine lipid management.”
Examination / Assessment:
Vital signs: BP, heart rate
BMI, waist circumference, signs of metabolic syndrome
Cardiovascular exam: heart sounds, peripheral pulses
Assess for xanthomas, corneal arcus
Labs: fasting lipid profile, fasting glucose, renal and liver function tests
Investigations:
Baseline: Total cholesterol, LDL, HDL, triglycerides
Cardiac risk assessment: Framingham score or ASCVD risk
Repeat lipid profile every 3–12 months depending on therapy
Treatment / Prescription / Management:
A. Lifestyle Modifications:
Diet: reduce saturated fat, trans fat, cholesterol; increase fiber
Weight management and regular aerobic exercise
Smoking cessation and limit alcohol
Educate patient about cardiovascular risk reduction
B. Pharmacological Therapy:
First-line: Statins (e.g., Atorvastatin 10–40 mg PO OD; dose titrated per LDL target)
Alternatives / add-ons: Ezetimibe, fibrates, or PCSK9 inhibitors for refractory cases
Monitor adherence and tolerance
C. Expected Side Effects / Precautions:
Statins: myalgia, mild liver enzyme elevation, rarely rhabdomyolysis
Fibrates: GI upset, gallstones, myopathy (especially with statins)
Monitor liver function tests before starting and periodically
Monitoring / Follow-Up:
Lipid profile 6–12 weeks after initiating or adjusting therapy
Monitor for side effects (muscle pain, liver enzymes)
Cardiovascular risk reassessment annually
Reinforce lifestyle modifications at every visit
Referral Criteria:
Severe or refractory dyslipidemia
Familial hypercholesterolemia
Patients with premature or multiple cardiovascular events despite therapy
Patient Instructions:
Take statins at the same time daily, preferably at night
Maintain healthy diet and regular exercise
Report muscle pain, dark urine, or persistent fatigue
Keep scheduled follow-up visits and labs
Legal / Ethical Justification:
Family physicians provide primary care for dyslipidemia to prevent cardiovascular events
Documentation of therapy, counseling, and monitoring ensures medicolegal safety
Evidence-based treatment aligns with ethical standards for chronic disease management
Case 2k – Thyroid Disorders (Chronic Management)
Diagnosis:
Hypothyroidism (primary or secondary)
Hyperthyroidism (Graves’ disease, toxic nodular goiter, or other causes)
Patient Presentation / Wordings:
Hypothyroidism: “I feel tired, gain weight, and feel cold all the time.”
Hyperthyroidism: “I feel anxious, my heart races, and I have lost weight.”
“I am here for routine thyroid follow-up or lab review.”
Examination / Assessment:
Vital signs: BP, pulse (tachycardia in hyperthyroidism)
General: BMI, weight changes, signs of anemia or edema
Thyroid: palpation for size, nodules, tenderness, asymmetry
Eyes: exophthalmos in Graves’ disease
Reflexes: delayed in hypothyroidism, brisk in hyperthyroidism
Skin: dry and coarse (hypothyroid), warm and moist (hyperthyroid)
Investigations:
TSH, free T4, free T3
Anti-TPO antibodies if autoimmune thyroid disease suspected
ECG if arrhythmia or tachycardia present
Ultrasound if nodules detected
Treatment / Prescription / Management:
A. Hypothyroidism:
Levothyroxine 50–150 µg PO daily (start low and titrate based on TSH)
Take on empty stomach, 30–60 minutes before breakfast
Monitor TSH every 6–8 weeks initially, then every 6–12 months once stable
B. Hyperthyroidism (Initial Management / Chronic Care):
Beta-blockers (e.g., Propranolol 10–40 mg PO TID) for symptom control
Antithyroid drugs (e.g., Methimazole 5–20 mg PO daily)
Monitor TSH, free T4, free T3 every 4–6 weeks initially
Referral to endocrinology for definitive therapy (radioiodine or surgery) if indicated
Expected Side Effects / Precautions:
Levothyroxine: palpitations, insomnia if overdosed
Methimazole: rash, agranulocytosis (monitor CBC), hepatotoxicity
Beta-blockers: bradycardia, fatigue, hypotension
Monitoring / Follow-Up:
TSH, free T4 every 6–12 weeks until euthyroid
Symptom review: energy, weight, palpitations, tremors
ECG if arrhythmias or prolonged tachycardia present
Adjust doses based on labs and clinical response
Referral Criteria:
Large goiter causing compressive symptoms
Nodules suspicious for malignancy
Poorly controlled hyperthyroidism or severe hypothyroidism
Pregnancy or planning conception
Patient Instructions:
Take medications consistently and at the same time each day
Monitor for symptoms of hypo- or hyperthyroidism
Attend all follow-up lab tests
Avoid sudden discontinuation of therapy
Educate on recognizing agranulocytosis (fever, sore throat) with antithyroid drugs
Legal / Ethical Justification:
Family physicians manage chronic thyroid disorders to prevent complications (cardiac, metabolic, growth issues)
Proper documentation and patient education ensure medicolegal protection
Evidence-based therapy ensures safe, ethical chronic care
Case 2l – Asthma & COPD (Chronic Management)
Diagnosis:
Chronic asthma (mild, moderate, or severe persistent)
Chronic obstructive pulmonary disease (COPD) – GOLD stages 1–3
Patient Presentation / Wordings:
“I have a cough, wheezing, and shortness of breath, especially at night.” (Asthma)
“I get short of breath on exertion and have a chronic cough with sputum.” (COPD)
“I want advice on managing my inhalers and flare-ups.”
Examination / Assessment:
Vital signs: BP, pulse, respiratory rate, oxygen saturation
Lung auscultation: wheezes, crackles, reduced breath sounds
Assess inhaler technique
General assessment: BMI, signs of right heart strain in advanced COPD
Peak expiratory flow rate (PEFR) in asthma
Investigations:
Spirometry: FEV1, FVC, FEV1/FVC ratio
Chest X-ray if suspicion of infection, COPD complications, or comorbidities
Pulse oximetry at rest and exertion
Treatment / Prescription / Management:
A. Asthma (Chronic Management):
Controller medication: Inhaled corticosteroids (ICS) ± long-acting beta-agonists (LABA)
Example: Budesonide 200–400 µg BID
Reliever: Short-acting beta-agonist (SABA) PRN
Example: Salbutamol 100–200 µg 2 puffs PRN
Adjuncts: Leukotriene receptor antagonists (Montelukast 10 mg PO OD) for allergic asthma
B. COPD (Stable Management):
Tiotropium 18 µg via inhaler once daily
Salbutamol 100 µg inhaler 1–2 puffs as needed
Influenza and pneumococcal vaccination advice
C. COPD – Mild Exacerbation
Short course oral corticosteroids: Prednisolone 30–40 mg once daily for 5 days
Increase SABA inhaler use
Antibiotics only if purulent sputum or infection suspected: Amoxicillin 500 mg orally three times daily for 5–7 days
Expected Side Effects / Precautions:
ICS: oral thrush, dysphonia; rinse mouth after use
Beta-agonists: palpitations, tremor
Systemic corticosteroids: hyperglycemia, fluid retention, mood changes
Monitoring / Follow-Up:
PEFR monitoring for asthma
Symptom diary, exacerbation frequency
Annual spirometry for COPD progression
Oxygen saturation and exercise tolerance
Adherence and correct inhaler technique
Referral Criteria:
Frequent exacerbations despite optimal therapy
Severe airflow limitation (FEV1 <50% predicted)
Respiratory failure or persistent hypoxia
Consider pulmonology referral for advanced COPD or difficult-to-control asthma
Patient Instructions:
Use inhalers correctly, follow stepwise asthma/COPD action plan
Avoid triggers: allergens, smoke, pollution
Adhere to vaccination schedule
Seek urgent care for severe breathlessness, cyanosis, or wheezing unrelieved by inhalers
Legal / Ethical Justification:
Family physicians provide long-term management of chronic respiratory diseases to prevent morbidity and hospitalization
Documentation of exacerbations, treatment adjustments, and patient education protects medicolegal safety
Evidence-based care aligns with ethical standards for chronic disease management
Case 2m – Chronic Kidney Disease (CKD, Stages 1–3, Chronic Management)
Diagnosis:
CKD stage 1–3 (eGFR 30–90 mL/min/1.73 m²)
Early CKD due to diabetes, hypertension, or other chronic conditions
Patient Presentation / Wordings:
“My kidney tests show mildly reduced function.”
“I have swelling in my legs and feel tired.”
“I am following up for chronic kidney disease.”
Examination / Assessment:
Vital signs: BP, pulse, BMI
General: edema, pallor
Cardiovascular: heart sounds, peripheral pulses
Abdominal: kidney palpation (if palpable), bladder
Labs: serum creatinine, eGFR, electrolytes, urinalysis, albumin/creatinine ratio
Screen for anemia, mineral bone disease, and proteinuria
Investigations:
Baseline: CBC, serum creatinine, eGFR, electrolytes
Urinalysis: proteinuria, hematuria
Blood pressure monitoring
Optional: renal ultrasound if structural abnormalities suspected
Treatment / Prescription / Management:
A. Blood Pressure Control:
Target: <130/80 mmHg (if tolerated)
ACE inhibitors or ARBs preferred for proteinuria
Example: Lisinopril 10–20 mg PO OD, titrate to effect
B. Glycemic Control (if diabetic):
Target HbA1c 7% (individualized)
Prefer Metformin if eGFR ≥45; reduce dose or stop if eGFR <30
C. Lifestyle & Supportive Measures:
Low-salt diet, moderate protein intake if indicated
Maintain hydration, avoid nephrotoxic drugs (NSAIDs, contrast without precautions)
Smoking cessation, weight management, exercise
D. Management of Complications:
Anemia: Iron supplementation ± erythropoiesis-stimulating agents if Hb <10 g/dL
Electrolyte imbalance: monitor K+, adjust diet/medications
Bone-mineral disorders: calcium/vitamin D supplementation if needed
Expected Side Effects / Precautions:
ACE inhibitors: hyperkalemia, cough, angioedema
Metformin: lactic acidosis (rare, avoid in eGFR <30)
Monitor electrolytes and kidney function regularly
Monitoring / Follow-Up:
Serum creatinine, eGFR, electrolytes every 3–6 months
Urinalysis for proteinuria every 6–12 months
Blood pressure at every visit
Monitor for progression to CKD stage 4–5
Referral Criteria:
Rapidly declining renal function or eGFR <30
Persistent hyperkalemia or uncontrolled hypertension
Severe proteinuria or structural kidney abnormalities
Consider nephrology referral for advanced management
Patient Instructions:
Take medications as prescribed
Avoid over-the-counter NSAIDs or nephrotoxic agents
Maintain a kidney-friendly diet and monitor fluid intake if advised
Report swelling, fatigue, or sudden changes in urine output
Legal / Ethical Justification:
Family physicians manage early CKD to prevent progression and cardiovascular complications
Proper documentation of labs, medications, and counseling ensures medicolegal protection
Patient-centered, evidence-based care reduces morbidity and preserves kidney function
Case 2n – Benign Prostatic Hyperplasia (Chronic Management)
Diagnosis:
Benign prostatic hyperplasia causing lower urinary tract symptoms (LUTS)
Patient Presentation / Wordings:
“I have difficulty starting to urinate.”
“I wake up at night multiple times to urinate.”
“I feel my bladder is not emptying completely.”
Examination / Assessment:
Vital signs: BP, pulse
Abdominal exam: bladder distension
Digital rectal exam (DRE): assess prostate size, nodularity, tenderness
Assess urinary flow, post-void residual volume if available
Evaluate for hematuria or signs of infection
Investigations:
Urinalysis: rule out infection
Serum creatinine if concern for obstructive uropathy
PSA only if indicated by guidelines (age, risk factors)
Optional: Ultrasound for post-void residual and prostate size
Treatment / Prescription / Management:
A. Medical Therapy:
Alpha-blockers:
Tamsulosin 0.4 mg PO OD (helps relax prostate smooth muscle, improves urine flow)
5-alpha-reductase inhibitors (if prostate significantly enlarged):
Finasteride 5 mg PO OD (reduces prostate size over months)
Monitor for side effects: dizziness, hypotension, sexual dysfunction
B. Lifestyle & Supportive Measures:
Reduce evening fluid intake
Avoid bladder irritants: caffeine, alcohol
Timed voiding, double voiding techniques
Monitor symptoms using IPSS (International Prostate Symptom Score)
Expected Side Effects / Precautions:
Alpha-blockers: dizziness, postural hypotension, headache
5-alpha-reductase inhibitors: decreased libido, erectile dysfunction, breast tenderness
Monitor blood pressure and symptoms periodically
Monitoring / Follow-Up:
Symptom reassessment every 3–6 months
Repeat PSA if indicated
Monitor renal function if obstruction suspected
Adjust therapy based on symptom severity and tolerance
Referral Criteria:
Acute urinary retention
Hematuria, recurrent infections, or suspected malignancy
Poor response to medical therapy
Large residual volume or upper urinary tract obstruction
Patient Instructions:
Take medications consistently, preferably at same time daily
Avoid sudden position changes to prevent dizziness
Monitor urinary symptoms and report worsening or acute retention
Maintain scheduled follow-up appointments
Legal / Ethical Justification:
Family physicians manage BPH to improve quality of life and prevent complications
Proper documentation and monitoring protect against medicolegal claims
Evidence-based, patient-centered therapy ensures safe chronic care
Case 2o – Arthritis, Gout & Chronic Pain Management
Diagnosis:
Osteoarthritis, rheumatoid arthritis, or other chronic arthropathies
Gout (acute flares and chronic hyperuricemia)
Chronic musculoskeletal pain
Patient Presentation / Wordings:
“My knees hurt and are stiff in the morning.” (Osteoarthritis/Rheumatoid)
“I have sudden severe pain in my big toe, with redness and swelling.” (Gout)
“I have persistent joint or back pain affecting my daily activities.” (Chronic pain)
Examination / Assessment:
Joint inspection: swelling, redness, deformity, nodules
Range of motion, tenderness, warmth
Assess for systemic signs: fever, fatigue, weight loss
Gout: check for tophi, joint effusion
Functional assessment: mobility, activities of daily living
Investigations:
CBC, ESR/CRP for inflammatory arthritis
Serum uric acid for gout
X-rays: joint space narrowing, osteophytes, erosions
Optional: joint aspiration for crystals in acute gout or suspected infection
Treatment / Prescription
A. Osteoarthritis / Chronic Musculoskeletal Pain
Paracetamol 500–1000 mg orally every 6–8 hours as needed (max 4 g/day)
NSAID (Ibuprofen 400 mg orally every 8 hours) as needed for pain (use lowest effective dose, monitor renal/GI status)
Topical NSAID gel (Diclofenac 1–2%) 3–4 times daily
Physical therapy, weight management, joint protection
B. Rheumatoid Arthritis (Mild to Moderate, Primary Care Initiation / Referral)
NSAID (Ibuprofen 400 mg orally every 8 hours) for pain
Consider referral to Rheumatology for DMARD initiation (Methotrexate, Hydroxychloroquine)
Symptom control and monitoring until specialist care
C. Gout (Acute Attack)
NSAID (Indomethacin 50 mg orally three times daily) for 5–7 days
Colchicine 0.5–1 mg orally initially, then 0.5 mg every 12 hours until attack resolves
Hydration: 2–3 liters/day
Avoid purine-rich foods, alcohol
D. Chronic Gout / Prophylaxis
Allopurinol 100 mg orally once daily (titrate to target uric acid <6 mg/dL)
Lifestyle measures: weight control, hydration, dietary modifications
Expected Side Effects / Precautions:
NSAIDs: GI upset, renal impairment, hypertension
Colchicine: diarrhea, GI intolerance
Allopurinol: rash, hypersensitivity (rare), monitor renal function
Monitoring / Follow-Up:
Pain and functional status regularly
CBC, renal, and liver function if on long-term NSAIDs or allopurinol
Serum uric acid levels periodically in gout
Adjust therapy based on symptoms and tolerability
Referral Criteria:
Refractory pain or severe functional limitation
Joint deformity, significant swelling, or suspected autoimmune arthritis
Frequent gout flares despite therapy
Consider rheumatology referral for complex cases
Patient Instructions:
Take medications as prescribed
Maintain exercise and joint protection strategies
Follow dietary modifications for gout and metabolic health
Report new swelling, redness, fever, or severe pain
Legal / Ethical Justification:
Family physicians manage chronic musculoskeletal conditions to improve quality of life and prevent disability
Documentation of therapy, counseling, and monitoring protects against medicolegal issues
Evidence-based, individualized care ensures safe and ethical chronic pain management
Case 2p – Obesity & Metabolic Syndrome Management
Diagnosis:
Obesity (BMI ≥30 kg/m²)
Metabolic syndrome (central obesity plus ≥2 of the following: elevated BP, fasting glucose, triglycerides, low HDL)
Patient Presentation / Wordings:
“I am overweight and my blood sugar and cholesterol are high.”
“I want advice on losing weight and controlling my metabolic health.”
Examination / Assessment:
Vital signs: BP, pulse
Anthropometry: weight, BMI, waist circumference
Cardiovascular assessment: heart sounds, peripheral pulses
Labs: fasting glucose, HbA1c, lipid profile, liver function, renal function
Investigations:
Fasting glucose, HbA1c
Lipid profile: total cholesterol, LDL, HDL, triglycerides
Liver function tests: screen for fatty liver
Optional: ECG for cardiovascular risk assessment
Treatment / Prescription / Management:
A. Lifestyle Modifications (Cornerstone):
Diet: caloric restriction, balanced nutrition, reduced refined sugars and saturated fats
Exercise: 150 minutes/week of moderate aerobic activity + resistance training
Behavioral therapy: goal setting, self-monitoring, stress management
Limit alcohol and avoid smoking
B. Pharmacological Therapy (If Lifestyle Alone Insufficient):
For weight management: Consider orlistat 120 mg PO TID with meals containing fat
Metabolic syndrome components:
Hypertension: ACE inhibitors, ARBs, or other antihypertensives
Dyslipidemia: Statins as per guidelines
Hyperglycemia: Metformin or other antidiabetic agents if indicated
Expected Side Effects / Precautions:
Orlistat: oily stools, flatulence, fat-soluble vitamin deficiency
Statins: myalgia, liver enzyme elevation
Metformin: GI upset, lactic acidosis (rare)
Monitoring / Follow-Up:
Weight, BMI, waist circumference monthly
BP at each visit
Fasting glucose/HbA1c every 3–6 months
Lipid profile every 6–12 months
Monitor adherence to lifestyle interventions
Referral Criteria:
Morbid obesity (BMI ≥40) or BMI ≥35 with comorbidities
Failure of lifestyle and pharmacological therapy
Consider endocrinology or bariatric surgery referral if indicated
Patient Instructions:
Follow a structured diet and exercise program
Track weight, waist circumference, and lifestyle habits
Take medications as prescribed and report side effects
Attend scheduled follow-up visits for monitoring and adjustment
Legal / Ethical Justification:
Family physicians manage obesity and metabolic syndrome to reduce cardiovascular and metabolic complications
Proper documentation of counseling, lifestyle interventions, and therapy protects against medicolegal issues
Evidence-based management ensures safe, patient-centered chronic care
3. Geriatric medicine
Case 2q – Polypharmacy Review (Geriatric Patient)
Diagnosis: Polypharmacy (≥5 medications, elderly patient, risk of drug interactions)
Patient Presentation / Wordings:
“I take many medicines and sometimes forget which ones.”
“I feel dizzy, sleepy, or have nausea since starting new medications.”
“I have trouble remembering which pill is for what.”
Examination / Assessment:
Review all current medications (prescription, OTC, supplements)
Check for drug-drug interactions, dosing appropriateness for age and renal/hepatic function
Assess adherence and adverse effects
Treatment / Prescription / Management:
Deprescribe unnecessary medications: gradually taper drugs that are non-essential, risky, or redundant
Adjust doses for renal/hepatic function
Consolidate therapy: use combination drugs if safe and evidence-based
Medication reconciliation: provide a clear written medication schedule for patient/caregiver
Expected Side Effects / Cautions:
Dizziness, hypotension, hypoglycemia if insulin or antihypertensives are adjusted
Monitor for withdrawal effects if stopping CNS depressants or benzodiazepines
Monitoring:
Blood pressure, blood glucose, renal function as per drug adjustments
Watch for new adverse effects within 1–2 weeks after any changes
Follow-up medication review every 3–6 months
Referral Criteria:
Adverse reactions not manageable in primary care
Complex drug regimens (e.g., oncology, transplant, multi-organ disease)
Cognitive impairment affecting adherence
Patient Instructions:
Use pill organizers or daily schedules
Report new dizziness, confusion, or unusual symptoms promptly
Bring all medications to each follow-up
Legal/Ethical Justification:
Medication review and rationalization in older adults is within Family Medicine scope
Documenting changes and monitoring ensures patient safety and medico-legal protection
Case 2r – Falls, Confusion, Dementia, Frailty
Diagnosis Examples:
Falls in elderly (multifactorial: balance, neuropathy, medications)
Delirium / Acute Confusion
Dementia (Alzheimer’s type, vascular, mixed)
Frailty syndrome
Patient Presentation / Wordings:
“I keep tripping or falling at home.”
“I feel weak and get tired very quickly.”
“I forget things, appointments, or medications.”
“I am confused about the time, place, or people.”
Examination / Red Flags:
Gait and balance assessment
Cognitive testing (MMSE, MoCA)
Vital signs, orthostatic BP, vision/hearing evaluation
Red flags: sudden confusion, infection signs, stroke symptoms → urgent referral
Treatment / Prescription / Management:
A. Falls / Frailty:
Vitamin D 800–1000 IU orally daily
Calcium 500–1000 mg orally daily if deficient
Physical therapy / strength and balance exercises
Review and adjust medications contributing to falls (antihypertensives, sedatives)
B. Delirium / Confusion:
Identify and treat underlying cause: infection (UTI, pneumonia), electrolyte imbalance, medications
Hydration, nutrition, orientation cues
Avoid unnecessary sedatives; if severe agitation:
Haloperidol 0.5–1 mg orally or IV as short-term, low-dose (only if non-pharmacologic measures fail, monitor ECG, EPS)
C. Dementia (Mild-Moderate):
Donepezil 5 mg orally once daily (titrate to 10 mg after 4–6 weeks if tolerated)
Memantine 5–10 mg orally once daily (for moderate-severe cases)
Non-pharmacologic: cognitive stimulation, caregiver support, safety measures at home
Expected Side Effects:
Vitamin D/calcium: constipation, mild GI upset
Haloperidol: EPS, sedation, QT prolongation
Donepezil: nausea, diarrhea, bradycardia
Memantine: dizziness, headache
Monitoring:
Falls frequency, cognition, mood, nutrition, hydration
ECG if using antipsychotics
Liver/renal function for long-term dementia drugs
Referral Criteria:
Acute delirium
Recurrent falls despite intervention
Rapid cognitive decline
Severe frailty requiring multi-specialty management
Patient Instructions:
Use assistive devices for walking
Ensure safe environment at home (remove rugs, adequate lighting)
Engage in cognitive activities
Report new confusion, falls, or sudden weakness immediately
Legal/Ethical Justification:
Identification and management of frailty, delirium, and mild-moderate dementia are within Family Medicine scope
Clear referral pathways ensure patient safety and medicolegal protection
Case 2s – Pressure Ulcers / Chronic Wounds
Diagnosis Examples:
Stage 1–4 pressure ulcer (decubitus ulcer)
Chronic diabetic ulcer or venous stasis ulcer
Patient Presentation / Wordings:
“I have a sore on my heel/buttocks/ankle that is not healing.”
“The wound looks red, sometimes oozes or smells.”
“I get pain at the wound site.”
Examination / Red Flags:
Stage ulcer assessment (redness, skin breakdown, necrosis, infection)
Signs of cellulitis or osteomyelitis
Red flags: spreading infection, fever, sepsis → urgent referral
Treatment / Prescription / Management:
A. Pressure Ulcer / Chronic Wound Care:
Wound cleaning: normal saline irrigation, gentle debridement if needed
Topical therapy:
Silver sulfadiazine 1% cream for infected ulcers, apply once daily
Hydrocolloid / foam dressings for non-infected chronic wounds
Pain management:
Paracetamol 500–1000 mg orally every 6–8 hours as needed
Optimize nutrition: protein-rich diet, vitamin C, zinc supplementation
B. Infection Management (If signs of local infection):
Cephalexin 500 mg orally every 6 hours for 7–10 days (mild infection)
Refer for IV antibiotics if systemic infection or osteomyelitis suspected
Expected Side Effects:
Silver sulfadiazine: mild local irritation, rarely allergic reaction
Cephalexin: diarrhea, rash, GI upset
Monitoring:
Wound size and depth weekly
Signs of infection (redness, pus, pain, fever)
Pain control and mobility
Referral Criteria:
Stage 3–4 ulcers
Suspected osteomyelitis or necrotic tissue
Non-healing wounds >4–6 weeks despite optimal care
Patient Instructions:
Keep wound clean and dry
Change dressings as instructed
Report fever, spreading redness, or increased pain immediately
Encourage mobility and pressure relief measures
Legal/Ethical Justification:
Management of early-stage pressure ulcers and chronic wounds is within Family Medicine scope
Clear referral criteria protect patient safety and medicolegal interests
III. PEDIATRICS (Children & Infants)
Case 3a – Growth & Development Monitoring, Nutrition Counseling
Diagnosis: Growth and nutritional assessment in children
Patient Presentation / Wordings:
“My child is not gaining weight as expected.”
“He/she seems smaller than peers.”
“I’m concerned about my child’s diet and growth.”
Examination / Assessment:
Height, weight, BMI / weight-for-age, height-for-age
Head circumference (infants)
Physical examination for nutritional deficiencies (hair, skin, nails, oral cavity)
Dietary history
Management / Prescription:
A. Nutritional Counseling:
Balanced diet: age-appropriate calories, protein, vitamins, minerals
Breastfeeding support for infants <6 months
Complementary feeding from 6 months
Supplementation if deficient:
Vitamin D 400 IU orally daily (infants & children)
Iron drops 2 mg/kg/day if iron-deficient
B. Monitoring:
Weight, height, BMI every visit
Growth chart plotting
Laboratory monitoring if indicated (CBC for anemia, vitamin levels)
Referral Criteria:
Severe malnutrition (weight-for-height <–3 SD)
Suspected endocrinological or genetic cause
Failure to thrive despite optimal nutrition
Patient Instructions:
Follow diet recommendations
Provide iron-rich foods (meat, legumes) if age-appropriate
Return for follow-up at routine well-child visits or sooner if weight loss
Expected Side Effects:
Vitamin D: rare hypercalcemia if overdosed
Iron: constipation, dark stools, mild nausea
Legal/Ethical Justification:
Growth monitoring and nutrition counseling are core pediatric primary care duties
Referral ensures safety for severe or unresponsive cases
Case 3b – Immunizations (National & Travel-Related)
Diagnosis: Child requiring routine or travel-related vaccinations
Patient Presentation / Wordings:
“I want my child vaccinated according to schedule.”
“We are traveling and need extra vaccines.”
Examination / Assessment:
Check age and previous vaccine history
Identify contraindications (severe allergy, immunodeficiency)
Management / Prescription:
A. National Routine Immunizations: (example, may vary by country)
BCG (birth), HepB (birth, 6, 14 weeks), DTP/Pentavalent, Polio, Hib, PCV, Measles/MR/MMR
Provide schedule and document in vaccination card
B. Travel Vaccines (if indicated):
Typhoid, HepA, Yellow Fever, Meningococcal, depending on destination
Monitoring:
Observe 15–30 min post-vaccination for allergic reaction
Monitor for fever, local redness, or swelling
Expected Side Effects:
Mild fever, soreness at injection site
Rare: severe allergic reaction (anaphylaxis) → emergency referral
Referral Criteria:
Previous severe allergic reaction
Child with immunodeficiency or serious chronic illness
Patient Instructions:
Use paracetamol 10–15 mg/kg orally for post-vaccine fever
Report persistent high fever, seizures, or severe swelling
Legal/Ethical Justification:
Immunization is a core preventive pediatric service
Documentation and counseling ensures legal and ethical compliance
Case 3c – Fever, Respiratory, Ear, Throat, Skin, GI Infections (Children)
A. Fever (General / Viral)
Diagnosis: Fever due to viral infection (common cold, viral gastroenteritis)
Patient Presentation / Wordings:
“My child has a temperature of 38–39°C.”
“He/she feels tired, refuses food, has a mild cough or runny nose.”
Examination / Red Flags:
Temperature >40°C, lethargy, dehydration, difficulty breathing, convulsions
Signs of meningitis: neck stiffness, bulging fontanelle
Management / Prescription:
Paracetamol 10–15 mg/kg orally every 6–8 hours as needed (max 4 doses/24 h for infants)
Hydration: oral rehydration solution (ORS) 50–100 mL/kg/day if mild dehydration
Monitor for warning signs
Expected Side Effects:
Rare liver toxicity if overdose
Referral Criteria:
Persistent fever >3 days, toxic appearance, dehydration, respiratory distress, seizures
Patient Instructions:
Give antipyretics only as needed
Ensure adequate fluid intake
Return if lethargy, persistent vomiting, seizures, or breathing difficulty
B. Respiratory Infections (Common Cold, Mild Pneumonia, Bronchitis)
Diagnosis:
Viral upper respiratory infection / mild bacterial pneumonia
Patient Presentation / Wordings:
“My child has a cough, runny nose, and sometimes mild fever.”
“Difficulty breathing or rapid breathing during infection.”
Management / Prescription:
Supportive care: hydration, saline nasal drops, humidifier
Paracetamol 10–15 mg/kg orally for fever or discomfort
Antibiotics only if bacterial infection suspected (e.g., pneumonia):
Amoxicillin 40–50 mg/kg/day orally in 3 divided doses for 5–7 days
Expected Side Effects:
Amoxicillin: mild diarrhea, rash, rare allergy
Paracetamol: rare liver toxicity if overdosed
Referral Criteria:
Respiratory distress, hypoxia (SpO₂ <94%), inability to feed, persistent high fever
Patient Instructions:
Give antibiotics exactly as prescribed if bacterial infection
Monitor breathing, return if fast breathing, chest indrawing, or cyanosis
C. Ear & Throat Infections (Otitis Media, Tonsillitis, Pharyngitis)
Diagnosis:
Acute otitis media (AOM), streptococcal pharyngitis
Patient Presentation / Wordings:
“My child is pulling at the ear, cries, has a fever.”
“Sore throat, refuses to eat, mild swelling of tonsils.”
Management / Prescription:
Pain/fever: Paracetamol 10–15 mg/kg orally every 6–8 hours
Amoxicillin 40–50 mg/kg/day orally in 2–3 divided doses for 7–10 days (first-line for bacterial AOM or strep throat)
Supportive care: hydration, soft diet
Expected Side Effects:
Mild diarrhea, rash, allergic reaction (rare)
Referral Criteria:
Recurrent AOM, hearing loss, mastoiditis, severe dehydration, inability to swallow
Patient Instructions:
Complete full antibiotic course
Use warm compress for ear pain
Return if worsening pain, discharge, or persistent fever
D. Skin Infections (Impetigo, Cellulitis)
Diagnosis:
Bacterial skin infections (Staphylococcus / Streptococcus)
Patient Presentation / Wordings:
“Red sores on face/arms/legs that are oozing.”
“It looks crusty and itchy.”
Management / Prescription:
Topical mupirocin 2% ointment 2–3 times daily for 5–7 days (localized impetigo)
Oral antibiotics if extensive infection:
Cephalexin 25–50 mg/kg/day orally in 3 divided doses for 7–10 days
Gentle cleansing of lesions with mild soap
Expected Side Effects:
Topical mupirocin: local irritation
Cephalexin: mild diarrhea, rash, rare allergy
Referral Criteria:
Rapidly spreading infection, fever, systemic illness, non-healing lesions
Patient Instructions:
Wash hands before and after touching lesions
Avoid scratching
Complete oral antibiotic course if prescribed
E. Gastrointestinal Infections (Diarrhea, Food Poisoning, Vomiting)
Diagnosis: Viral gastroenteritis / mild bacterial food poisoning
Patient Presentation / Wordings:
“My child has watery stools, sometimes vomiting, and a mild fever.”
“Dehydrated, less urine than usual.”
Management / Prescription:
Hydration: ORS 50–100 mL/kg/day, small frequent sips
Zinc supplementation: 10 mg/day (<6 months) or 20 mg/day (6+ months) for 10–14 days
Avoid anti-diarrheal drugs in children
Antibiotics only if bacterial dysentery suspected (bloody stools, high fever):
Cefixime 8 mg/kg/day orally in 2 divided doses for 3–5 days
Expected Side Effects:
ORS: none if prepared correctly
Zinc: mild nausea, metallic taste
Cefixime: diarrhea, rash, allergic reaction
Referral Criteria:
Severe dehydration, persistent vomiting, bloody diarrhea, lethargy, shock
Patient Instructions:
Continue feeding as tolerated
Give ORS frequently
Return immediately if signs of dehydration (sunken eyes, lethargy, decreased urine)
Legal/Ethical Justification
Management of common pediatric infections with supportive care and first-line antibiotics is within Family Medicine scope
Clear referral criteria ensure patient safety and medicolegal protection
Case 3d – Worm Infestation, Dehydration, Anemia
A. Worm Infestation (Helminthiasis)
Diagnosis: Suspected intestinal worm infection (Ascaris, Trichuris, Hookworm, Enterobius)
Patient Presentation / Wordings:
“My child has an itchy bottom, especially at night.”
“Abdominal pain, occasional vomiting, or visible worms in stool.”
“Loss of appetite or mild anemia.”
Examination / Red Flags:
Palpable worms in stool or abdomen
Signs of malnutrition, severe anemia
Red flags: intestinal obstruction (vomiting, severe abdominal pain, distension) → urgent referral
Treatment / Prescription:
Albendazole 400 mg orally single dose (children >1 year)
Repeat dose after 2 weeks if reinfection risk is high
Mebendazole 100 mg orally twice daily for 3 days is alternative
Expected Side Effects:
Mild abdominal pain, nausea, diarrhea, rare dizziness
Monitoring:
Resolution of symptoms
Follow-up stool exam if persistent symptoms
Referral Criteria:
Intestinal obstruction, persistent vomiting, severe malnutrition, failure of initial therapy
Patient Instructions:
Maintain hygiene (wash hands, trim nails)
Wash bedding and clothes
Treat all family members if indicated
B. Dehydration
Diagnosis: Mild to moderate dehydration due to diarrhea, vomiting
Patient Presentation / Wordings:
“My child is not urinating as usual, seems sleepy, or has a dry mouth.”
“Diarrhea and vomiting started 1–2 days ago.”
Examination / Red Flags:
Sunken eyes, dry mucosa, decreased skin turgor, lethargy
Severe dehydration: shock, weak pulse, hypotension → urgent hospital referral
Treatment / Prescription:
Oral Rehydration Solution (ORS): 50–100 mL/kg/day for mild-moderate dehydration
Zinc supplementation: 10 mg/day (<6 months) or 20 mg/day (6+ months) for 10–14 days
Continue feeding (breastfeeding or age-appropriate diet)
Expected Side Effects:
Rare overhydration if excessive, nausea with rapid intake
Monitoring:
Urine output
Hydration status, weight
Signs of worsening dehydration
Referral Criteria:
Severe dehydration, shock, persistent vomiting, inability to drink
Patient Instructions:
Small frequent sips of ORS
Continue normal diet
Return immediately if lethargy, sunken eyes, or decreased urination
C. Anemia (Iron-Deficiency)
Diagnosis: Iron-deficiency anemia (common in children, may co-occur with worm infestation)
Patient Presentation / Wordings:
“My child looks pale, tires easily, and has a poor appetite.”
“Occasional shortness of breath during play.”
Examination / Red Flags:
Pallor, fatigue, tachycardia
Severe anemia (<7 g/dL Hb) → urgent referral
Treatment / Prescription:
Ferrous sulfate 3–6 mg/kg/day orally in 1–2 divided doses for 3 months
Vitamin C 25–50 mg/day orally to enhance absorption
Address underlying cause (worm infestation, poor diet)
Expected Side Effects:
Constipation, dark stools, mild nausea
Rare allergic reaction
Monitoring:
Hemoglobin and hematocrit after 1–2 months
Symptom improvement (energy, appetite)
Referral Criteria:
Severe anemia, hemoglobin <7 g/dL
Failure to respond to oral iron
Signs of cardiac compromise
Patient Instructions:
Take iron on empty stomach if tolerated
Avoid tea, milk, or calcium with iron dose
Report persistent vomiting, abdominal pain, or black/tarry stools
Legal/Ethical Justification
Management of common pediatric worm infestations, mild-moderate dehydration, and iron-deficiency anemia is within Family Medicine scope
Clear referral criteria ensure patient safety, ethical care, and medicolegal protection
Case 3e – Asthma, Allergies, Eczema
A. Asthma (Children)
Diagnosis: Mild to moderate persistent asthma
Patient Presentation / Wordings:
“My child has recurrent wheezing, coughing, especially at night or with exercise.”
“Shortness of breath, chest tightness.”
“Symptoms worsen with cold, dust, or viral infections.”
Examination / Red Flags:
Wheezing on auscultation
Tachypnea, accessory muscle use
Red flags: severe respiratory distress, cyanosis, inability to speak → urgent referral
Treatment / Prescription:
1. Controller (Maintenance) Therapy:
Inhaled corticosteroid (Fluticasone 50–100 mcg, 1–2 puffs twice daily) via spacer (adjust dose by age/severity)
2. Reliever (Rescue) Therapy:
Salbutamol (Albuterol) 100–200 mcg, 1–2 puffs every 4–6 hours as needed
3. Adjuncts:
Spacer device with mask for <5 years
Asthma action plan for parents
Expected Side Effects:
Fluticasone: oral thrush (rinse mouth), cough
Salbutamol: tremors, mild tachycardia
Monitoring:
Symptom frequency, nocturnal cough
Peak flow monitoring if feasible
Growth monitoring with long-term steroid use
Referral Criteria:
Severe or frequent exacerbations
Poor response to inhaled therapy
Recurrent hospitalization
Patient Instructions:
Teach inhaler technique
Identify triggers (dust, smoke, pets)
Seek immediate care if difficulty breathing, lips/fingertips blue
B. Allergies (Children)
Diagnosis: Allergic rhinitis, mild allergic reactions
Patient Presentation / Wordings:
“Runny nose, sneezing, itchy eyes, sometimes rash.”
“Symptoms are seasonal or after exposure to pets/dust.”
Management / Prescription:
Antihistamine:
Cetirizine 5–10 mg orally once daily (age-dependent)
Loratadine 5–10 mg orally once daily alternative
Nasal saline irrigation
Avoid triggers where possible
Expected Side Effects:
Cetirizine / Loratadine: mild drowsiness (rare)
Monitoring:
Symptom control, adverse effects, impact on school and sleep
Referral Criteria:
Severe allergic reactions, angioedema, anaphylaxis → emergency referral
Poor response to first-line therapy
Patient Instructions:
Give medication as prescribed
Keep environment dust-free, avoid allergens
Return if swelling, breathing difficulty, or persistent symptoms
C. Eczema (Atopic Dermatitis, Children)
Diagnosis: Mild to moderate atopic dermatitis
Patient Presentation / Wordings:
“Red, itchy patches on face, elbows, knees.”
“Scratching makes it worse; sometimes it oozes.”
Management / Prescription:
Topical emollients: apply liberally 3–4 times daily
Topical corticosteroids (mild, e.g., Hydrocortisone 1% cream) twice daily for 1–2 weeks
Avoid irritants: harsh soaps, fragrances, tight clothing
Antihistamines: Cetirizine 5 mg orally once daily if severe itching
Expected Side Effects:
Topical corticosteroids: skin thinning if prolonged
Antihistamines: mild drowsiness
Monitoring:
Improvement in rash, itching, sleep
Watch for secondary infection
Referral Criteria:
Severe eczema, widespread lesions, secondary infection, poor response to topical therapy
Patient Instructions:
Apply creams after bathing
Keep nails short to reduce scratching
Maintain humid environment if possible
Return if infection develops (pus, increased redness, fever)
Legal/Ethical Justification
Management of mild to moderate pediatric asthma, allergies, and eczema with first-line therapy and education is within Family Medicine scope
Clear referral criteria ensure patient safety and medicolegal protection
Case 3f – Developmental Delays (Screening & Referral)
Diagnosis: Suspected developmental delay in children (motor, speech, cognitive, social-emotional, or adaptive domains)
Patient Presentation / Wordings:
“My child is not walking/talking at the expected age.”
“He/she does not respond to names or social cues like other children.”
“Difficulty with coordination, attention, or learning at school.”
Examination / Red Flags:
Growth parameters within normal range
Neurological exam: tone, reflexes, motor milestones
Observation for social interaction, communication, behavior
Red flags: regression of milestones, seizures, neurological deficits → urgent referral
Management / Prescription:
A. Screening and Early Intervention:
Developmental milestone checklist for age-appropriate assessment
Denver Developmental Screening Test (DDST) or equivalent
Hearing and vision screening
B. Supportive Measures / Primary Care Management:
Referral to early intervention programs: physical therapy, occupational therapy, speech therapy
Parent counseling: strategies to stimulate language, motor skills, and social-emotional development
Nutrition optimization: ensure adequate caloric and micronutrient intake
Monitor comorbid conditions: anemia, chronic illness
Expected Side Effects:
Non-pharmacologic interventions have no direct side effects
Counseling may require patience and reinforcement for family
Monitoring:
Re-assess milestones every 3–6 months
Track therapy progress and school readiness
Document improvement or regression
Referral Criteria:
Significant delay in ≥2 domains
Regression of previously acquired skills
Neurological deficits, seizures, or congenital syndromes
Patient Instructions:
Engage in daily structured play, language exercises, and interactive activities
Attend all therapy sessions
Report any new neurological signs promptly
Legal/Ethical Justification:
Screening, counseling, and referral for developmental delays is within Family Medicine scope
Early identification and documentation provide medico-legal protection and ensure timely intervention
Case 3g – Neonatal Jaundice
Diagnosis: Neonatal jaundice (physiologic vs pathologic)
Patient Presentation / Wordings:
“My baby looks yellow, especially in the eyes and skin.”
“The baby is feeding poorly, seems sleepy, or irritable.”
“The yellow color appeared within the first 24–48 hours or persists beyond 2 weeks.”
Examination / Red Flags:
Assess onset, extent, and progression of jaundice
Measure serum bilirubin (total and direct)
Evaluate feeding, hydration, weight gain
Red flags: jaundice <24 hours of life, bilirubin rising >0.5 mg/dL/hr, total bilirubin >20 mg/dL, signs of sepsis, poor feeding, lethargy → urgent referral
Management / Prescription:
A. Physiologic Jaundice (mild, healthy term infants)
Frequent feeding (breastfeeding every 2–3 hours)
Monitor weight, urine, and stool output
Phototherapy only if bilirubin exceeds treatment threshold based on age and risk factors
B. Pathologic Jaundice or High-Risk Neonates
Immediate referral to neonatal unit for phototherapy or exchange transfusion
Identify underlying cause: hemolysis (ABO/Rh incompatibility), infection, G6PD deficiency
C. Supportive Care:
Maintain hydration
Monitor for lethargy, poor feeding, or signs of kernicterus (arching, high-pitched cry, seizures)
Expected Side Effects:
Phototherapy: mild dehydration, loose stools, transient rash
No medications given in mild physiologic cases
Monitoring:
Daily bilirubin levels if at-risk
Feeding adequacy
Neurological status
Referral Criteria:
Jaundice within first 24 hours
Rapid bilirubin rise
Total bilirubin exceeding phototherapy threshold
Signs of neurological compromise
Patient Instructions:
Ensure frequent feeding
Monitor stool and urine output
Return immediately if baby becomes lethargic, refuses feeds, or color worsens rapidly
Legal/Ethical Justification:
Identification, monitoring, and initial counseling for neonatal jaundice is within Family Medicine scope
Referral of high-risk infants ensures safe and ethically compliant care
Case 3h – Febrile Seizures & Breath-Holding Spells
A. Febrile Seizures
Diagnosis: Simple febrile seizure in children (6 months – 5 years)
Patient Presentation / Wordings:
“My child had a sudden jerking of limbs, sometimes with eye-rolling.”
“It lasted 1–2 minutes and occurred during a fever.”
“No prior seizure history.”
Examination / Red Flags:
Postictal drowsiness, confusion, or lethargy
Signs of CNS infection: neck stiffness, vomiting, persistent high fever → urgent referral
Management / Prescription:
1. Acute Management (During Seizure):
Ensure child is safe: lie on side, remove sharp objects
Do not place objects in mouth
If seizure >5 minutes:
Rectal Diazepam 0.5 mg/kg or Buccal Midazolam 0.3–0.5 mg/kg (emergency use)
2. Post-Seizure Care:
Antipyretics for fever: Paracetamol 10–15 mg/kg orally every 6–8 hours as needed
Identify and treat underlying cause of fever (infection)
Expected Side Effects:
Diazepam/Midazolam: drowsiness, mild respiratory depression (monitor)
Paracetamol: rare liver toxicity if overdose
Monitoring:
Observe until fully alert
Track fever episodes and seizure frequency
Referral Criteria:
Seizure lasting >15 minutes
Recurrent complex febrile seizures
Neurological deficits or atypical presentation
Suspected CNS infection
Patient Instructions:
Keep a seizure diary: duration, triggers, interventions
Seek emergency care for prolonged or repeated seizures
Treat fever promptly at home
Legal/Ethical Justification:
Initial management of simple febrile seizures is within Family Medicine scope
Clear referral criteria protect patient safety and legal accountability
B. Breath-Holding Spells
Diagnosis: Pediatric breath-holding spells (6 months – 6 years)
Patient Presentation / Wordings:
“My child stops breathing and sometimes turns blue or faints when crying or upset.”
“These episodes are brief and recover spontaneously.”
Examination / Red Flags:
Normal physical and neurological exam
Red flags: seizure activity, cyanosis unrelated to crying, underlying cardiac or metabolic disorder
Management / Prescription:
Reassurance and Education: Most children outgrow episodes by age 6
Iron supplementation if deficient:
Ferrous sulfate 3–6 mg/kg/day orally for 3 months if anemia present
Avoid punishment or overreaction during episodes
Ensure safety: prevent falls or injuries
Expected Side Effects:
Iron: constipation, dark stools, mild nausea
Monitoring:
Track frequency and triggers of spells
Monitor hemoglobin if iron deficiency treated
Referral Criteria:
Episodes with seizure-like activity, prolonged unconsciousness, cardiac syncope
Persistent or worsening frequency
Patient Instructions:
Stay calm during spells
Ensure safe environment
Correct underlying anemia if present
Return if episodes are atypical or increasing in severity
Legal/Ethical Justification:
Diagnosis and parental counseling for breath-holding spells is within Family Medicine scope
Documentation and referral for atypical cases ensures safe and legally compliant care
Case 3i – School Health, Behavioral Issues (ADHD Screening, Learning Problems)
Diagnosis: Suspected attention-deficit/hyperactivity disorder (ADHD), learning difficulties, or other school-related behavioral issues
Patient Presentation / Wordings:
“My child is inattentive, fidgety, or can’t sit still in class.”
“He/she struggles with reading, writing, or math compared to peers.”
“Teachers report impulsive or disruptive behavior.”
Examination / Red Flags:
Developmental screening: attention span, memory, social interaction
Physical exam to rule out hearing/vision problems
Red flags: sudden academic decline, aggressive behavior, self-harm → urgent referral
Management / Prescription:
A. Screening and Initial Care:
Behavioral assessment: Vanderbilt or Conners’ rating scales
Academic screening: learning difficulties, dyslexia, dyscalculia
Rule out medical causes: vision, hearing, thyroid disorders, anemia
B. Non-Pharmacologic Interventions (First-Line):
Structured daily routines
Positive reinforcement and behavior modification strategies
Parent and teacher counseling
C. Pharmacologic Management (If ADHD confirmed and severe):
Methylphenidate:
Initial: 5 mg orally twice daily (before breakfast and lunch)
Titrate by 5–10 mg/week up to 1 mg/kg/day in divided doses
Alternative: Atomoxetine 0.5–1.2 mg/kg/day orally once daily
Expected Side Effects:
Methylphenidate: insomnia, decreased appetite, mild headache, rare cardiovascular effects
Atomoxetine: GI upset, sleep disturbance, rare liver enzyme elevation
Monitoring:
Blood pressure, heart rate, weight, and height during treatment
Behavioral response and academic performance
Monitor for mood changes or new behavioral issues
Referral Criteria:
Poor response to behavioral and pharmacologic therapy
Severe learning disabilities requiring specialist intervention
Psychiatric comorbidities (depression, anxiety)
Patient Instructions:
Administer medication with meals if needed
Encourage structured homework and play routines
Regular follow-up every 4–6 weeks initially, then every 3 months
Return promptly if mood changes, severe insomnia, or growth concerns
Legal/Ethical Justification:
Screening, counseling, and management of ADHD and learning problems is within Family Medicine scope
Referral to specialists ensures safety, academic support, and medicolegal protection
IV. OB/GYN / Women's Health
Case 4a – Antenatal Check-Up (Normal Pregnancy)
Diagnosis: Healthy, uncomplicated pregnancy
Patient Presentation / Wordings:
“I am 12 weeks pregnant and want routine antenatal care.”
“I feel well, just want to ensure the baby is growing normally.”
Examination / Assessment:
Confirm gestational age, vital signs, weight
Fundal height, fetal heart rate (Doppler)
Laboratory: CBC, blood group & Rh, urine analysis, glucose, infectious screen (HIV, HBV, syphilis)
Ultrasound as indicated
Treatment / Prescription / Management:
A. Routine Antenatal Care:
Folic acid 0.4–5 mg orally daily (first trimester)
Iron sulfate 60 mg elemental iron orally daily (from 2nd trimester)
Calcium 1 g orally daily (from 2nd trimester)
Multivitamins if diet inadequate
Encourage balanced diet, exercise, hydration
B. Vaccinations:
Tdap (27–36 weeks), Influenza (seasonal)
Expected Side Effects:
Iron: constipation, dark stools, mild nausea
Folic acid & multivitamins: usually well tolerated
Monitoring:
Weight gain, BP, urine protein
Fetal growth (fundal height / ultrasound)
Hemoglobin check each trimester
Referral Criteria (High-Risk Pregnancy):
Multiple gestation, chronic hypertension, diabetes, cardiac disease
Previous obstetric complications (preterm birth, preeclampsia)
Fetal growth restriction, abnormal ultrasound
Patient Instructions:
Attend all scheduled visits
Report vaginal bleeding, abdominal pain, reduced fetal movements
Avoid alcohol, smoking, harmful medications
Legal/Ethical Justification:
Routine antenatal care is standard Family Medicine scope
Early detection of high-risk pregnancies and referral ensures safe and legally compliant care
Case 4b – Postnatal Follow-Up & Breastfeeding Advice
Diagnosis: Normal postnatal recovery, breastfeeding support
Patient Presentation / Wordings:
“I delivered it 2 weeks ago, everything seems fine, but I want a check-up.”
“I am having some trouble with breastfeeding.”
Examination / Assessment:
Vital signs, weight, temperature
Uterine involution, lochia (vaginal discharge)
Perineal or cesarean wound inspection
Breast examination for engorgement, nipple trauma
Mental health screening: mood, signs of postpartum depression
Laboratory / Investigations:
CBC if excessive bleeding or fatigue
Blood pressure if history of preeclampsia
Blood sugar if history of gestational diabetes
Treatment / Prescription / Management:
A. Routine Postnatal Care:
Continue balanced diet, hydration, mild exercise
Analgesia if needed: Paracetamol 500–1000 mg orally every 6–8 hours (max 4 g/day)
Wound care instructions (perineal hygiene, dressing care)
B. Breastfeeding Support:
Teach correct latch and positioning
Express milk if needed to relieve engorgement
Supportive measures: warm compress, cold packs, nipple creams if trauma
Encourage feeding on demand, at least 8–12 times/day in early weeks
C. Supplements (if indicated):
Iron or multivitamins if postpartum anemia
Vitamin D & Calcium if dietary intake inadequate
Expected Side Effects / Notes:
Paracetamol generally well tolerated
Breast engorgement: mild pain or tenderness
Nipple trauma: soreness, small cracks
Monitoring & Follow-Up:
Maternal vitals, weight, wound healing
Breastfeeding progress and infant weight gain
Screen for postpartum depression (e.g., EPDS score)
Follow-up at 2 weeks, 6 weeks, then as needed
Referral Criteria:
Excessive bleeding, fever, wound infection
Breast abscess, persistent nipple trauma
Signs of postpartum depression or psychosis
Infant not gaining weight adequately or signs of illness
Patient Instructions:
Attend scheduled postnatal visits
Monitor and report fever, heavy bleeding, severe pain, or breast issues
Maintain good nutrition, hydration, rest
Practice safe breastfeeding and hygiene
Legal/Ethical Justification:
Routine postnatal care and breastfeeding support are standard Family Medicine practices
Early identification and referral of complications (maternal or infant) is ethically required and legally protective
Case 4c – Menstrual Disorders: Dysmenorrhea, Menorrhagia, Amenorrhea
Diagnosis:
Dysmenorrhea – painful menstruation without underlying pathology
Menorrhagia – heavy menstrual bleeding
Amenorrhea – absence of menstruation
Patient Presentation / Wordings:
Dysmenorrhea: “I get severe cramps every period, sometimes lasting a few days.”
Menorrhagia: “My periods are very heavy; I soak pads every 2 hours and feel fatigued.”
Amenorrhea: “I haven’t had my period for 3 months, but I am not pregnant.”
Examination / Assessment:
Vital signs, pallor for anemia
Abdominal and pelvic examination
Check for signs of thyroid, PCOS, or hormonal disorders
Review menstrual history: frequency, duration, flow, associated symptoms
Laboratory / Investigations:
CBC (to assess anemia)
Hormonal profile (TSH, prolactin, LH/FSH)
Pelvic ultrasound if structural abnormality suspected (fibroids, ovarian cysts)
Pregnancy test if appropriate
Treatment / Prescription / Management:
A. Dysmenorrhea (Primary):
NSAIDs: Ibuprofen 400 mg orally every 6–8 hours with food during menstruation (max 1200 mg/day)
Lifestyle: Heat application, regular exercise
Hormonal therapy (combined oral contraceptives) if NSAIDs insufficient
B. Menorrhagia:
Iron supplementation: Ferrous sulfate 60 mg elemental iron orally daily
NSAIDs: Ibuprofen 400–600 mg orally every 6–8 hours during menstruation (reduces bleeding and cramps)
Tranexamic acid 500 mg orally 3–4 times/day during menses (up to 5 days)
Referral if structural lesions suspected (fibroids, polyps)
C. Amenorrhea:
Evaluate underlying cause: hypothalamic, pituitary, ovarian, thyroid, or hyperprolactinemia
Treat underlying cause (e.g., thyroid replacement, hormonal therapy)
Referral if secondary amenorrhea persists >6 months or abnormal hormone findings
Expected Side Effects:
NSAIDs: gastric irritation, nausea, rare renal effects
Iron: constipation, dark stools, nausea
Tranexamic acid: mild GI discomfort, rare thrombosis risk
Monitoring & Follow-Up:
Hemoglobin and iron status for menorrhagia
Symptom diary for dysmenorrhea
Menstrual pattern and lab monitoring for amenorrhea
Follow-up every 3 months or sooner if symptoms worsen
Referral Criteria:
Severe anemia, persistent or atypical bleeding
Suspected structural lesions (fibroids, polyps, ovarian masses)
Secondary amenorrhea with abnormal labs or failure of initial management
Patient Instructions:
Track menstrual cycles and symptoms
Take medications with food, as prescribed
Report dizziness, fainting, or heavy bleeding
Maintain balanced diet with adequate iron
Legal/Ethical Justification:
Initial assessment and management of menstrual disorders is within Family Medicine scope
Referral for structural or endocrine pathology ensures patient safety, ethical practice, and medico-legal compliance
Case 4d – Vaginal Discharge, Pelvic Pain, Urinary Tract Infection (UTI)
Diagnosis:
Vaginal infection (bacterial vaginosis, candidiasis, trichomoniasis)
Pelvic pain (non-obstetric, gynecologic origin)
Lower urinary tract infection (cystitis)
Patient Presentation / Wordings:
Vaginal discharge: “I have abnormal discharge with odor/itching.”
Pelvic pain: “I feel lower abdominal or pelvic discomfort.”
UTI: “I have a burning sensation while urinating, frequency, and urgency.”
Examination / Assessment:
Vital signs (fever, BP)
Abdominal and pelvic exam: tenderness, masses, cervical motion tenderness
Vaginal inspection: color, odor, consistency of discharge
Urinalysis for dysuria, hematuria, pyuria
Laboratory / Investigations:
Vaginal swab: microscopy, culture & sensitivity
Urine analysis & culture
Pregnancy test if applicable
Treatment / Prescription / Management:
A. Vaginal Infection (based on likely cause):
Bacterial vaginosis: Metronidazole 500 mg orally twice daily for 7 days OR 0.75% vaginal gel at bedtime for 5 days
Candida vulvovaginitis: Fluconazole 150 mg orally single dose OR topical clotrimazole 1% cream for 7 days
Trichomoniasis: Metronidazole 2 g orally single dose OR 500 mg twice daily for 7 days
B. UTI (Uncomplicated Cystitis):
Nitrofurantoin 100 mg orally twice daily for 5 days (if renal function normal)
OR Fosfomycin 3 g orally single dose
C. Pelvic Pain:
Analgesia: Paracetamol 500–1000 mg orally every 6–8 hours (max 4 g/day)
Treat underlying infection if identified
Expected Side Effects:
Metronidazole: nausea, metallic taste, avoid alcohol
Fluconazole: mild GI upset, headache
Nitrofurantoin: nausea, rarely pulmonary or hepatic reactions
Paracetamol: usually well tolerated, avoid overdose
Monitoring & Follow-Up:
Symptom improvement within 48–72 hours
Repeat urine or vaginal culture if persistent or recurrent
Assess for complications: pyelonephritis, pelvic inflammatory disease
Referral Criteria:
Persistent or recurrent infections
Signs of pelvic inflammatory disease (fever, severe lower abdominal pain, adnexal tenderness)
Suspected sexually transmitted infections requiring specialized care
Pregnant patients with UTI or vaginal infection not responding to standard therapy
Patient Instructions:
Complete full course of prescribed medications
Maintain genital hygiene, avoid douching
Abstain from sexual intercourse until infection treated (if STI suspected)
Hydrate adequately to flush urinary tract
Report fever, worsening pain, or abnormal bleeding
Legal/Ethical Justification:
Diagnosis and treatment of common vaginal infections and UTIs is within Family Medicine scope
Early detection of complicated infections and referral prevents morbidity and is legally and ethically required
Case 4e – Contraception Advice & Prescriptions
Diagnosis:
Need for reversible or permanent contraception
Counseling for safe family planning
Patient Presentation / Wordings:
“I want to prevent pregnancy for now.”
“I am considering options for long-term contraception.”
“I have medical conditions; which contraceptive is safe for me?”
Examination / Assessment:
Vital signs, BMI
General physical and abdominal exam
Gynecologic history: menstrual cycles, past pregnancies, STIs
Medical history: hypertension, thromboembolism, diabetes, liver disease, migraines
Sexual history: partners, risk of STIs
Laboratory / Investigations (if needed):
Blood pressure monitoring (for hormonal contraceptives)
Hb/Hct if considering IUD and heavy menses
Pregnancy test prior to initiation
Treatment / Prescription / Management:
A. Barrier Methods:
Condoms (male/female) – use with each sexual act
Patient instruction: correct use, expiration check
B. Hormonal Methods:
Combined Oral Contraceptives (COCs):
Ethinyl estradiol 30–35 mcg + Levonorgestrel 150 mcg once daily for 21 days, then 7-day pill-free interval
Start on day 1 of menses or quick-start with backup contraception for 7 days
Progestin-Only Pills (POPs):
Norethisterone 0.35 mg once daily, same time every day
Injectable Contraceptives:
Depot medroxyprogesterone acetate 150 mg IM every 3 months
C. Intrauterine Device (IUD):
Copper IUD: lasts 5–10 years
Levonorgestrel IUD: lasts 3–5 years
Inserted by trained personnel
D. Emergency Contraception (if needed):
Levonorgestrel 1.5 mg orally single dose within 72 hours of unprotected intercourse
Expected Side Effects:
COCs: nausea, breast tenderness, spotting, rare thromboembolic events
POPs: irregular bleeding
IUD: spotting, cramping initially
Injectables: irregular bleeding, weight gain, delayed return to fertility
Monitoring & Follow-Up:
BP check at initiation and periodically for hormonal methods
Assess adherence and side effects
IUD check after 4–6 weeks
Annual review of contraceptive method and medical eligibility
Referral Criteria:
History of thromboembolism, severe hypertension, liver disease, unexplained vaginal bleeding
Need for permanent sterilization
Adverse effects not manageable in primary care
Patient Instructions:
Take pills daily at same time
Report abnormal bleeding, severe headaches, chest pain, leg swelling
Use backup contraception if doses missed
Attend scheduled follow-ups
Legal/Ethical Justification:
Family physicians are legally and ethically allowed to provide contraceptive counseling and prescriptions
Screening for contraindications and referral ensures patient safety and reduces medico-legal risk
Case 4f – Menopause Management
Diagnosis:
Natural or surgical menopause
Symptoms: hot flashes, mood changes, sleep disturbances, vaginal dryness
Screening for menopause-related health risks: osteoporosis, cardiovascular disease
Patient Presentation / Wordings:
“I haven’t had my period for a year, and I’m experiencing hot flashes and night sweats.”
“I have been in a low mood and have trouble sleeping since menopause.”
“I’m worried about bone health.”
Examination / Assessment:
Vital signs, BMI
General physical and cardiovascular exam
Breast and pelvic examination
Screening for osteoporosis risk factors (family history, prior fractures)
Laboratory: FSH, estradiol if diagnosis unclear, lipid profile, fasting glucose
Treatment / Prescription / Management:
A. Lifestyle Measures:
Balanced diet with adequate calcium (1,000–1,200 mg/day) and vitamin D (800 IU/day)
Weight-bearing exercise 30 minutes daily
Limit alcohol, avoid smoking
Sleep hygiene and stress reduction techniques
B. Symptomatic Therapy:
Hormone Replacement Therapy (HRT) – if no contraindications:
Oral: Estradiol 1 mg daily ± micronized progesterone 100 mg daily (if uterus present)
Transdermal: Estradiol 0.025–0.05 mg patch twice weekly ± progesterone as above
Non-Hormonal Options:
SSRIs/SNRIs (e.g., Venlafaxine 37.5–75 mg orally daily) for hot flashes and mood
Vaginal moisturizers or low-dose vaginal estrogen for dryness
Expected Side Effects:
HRT: breast tenderness, bloating, nausea, rare thromboembolism
SSRIs/SNRIs: nausea, insomnia, mild GI upset
Vaginal estrogen: local irritation
Monitoring & Follow-Up:
Annual review for symptom control and side effects
Blood pressure, weight, breast exams, lipid profile
Bone density (DEXA scan) every 2–3 years
HRT: periodic review for continued need and safety
Referral Criteria:
History of breast cancer, thromboembolism, severe liver disease
Severe or refractory menopausal symptoms
Osteoporosis requiring specialized management
Patient Instructions:
Adhere to lifestyle measures and medications
Report unusual bleeding, breast lumps, leg swelling, chest pain
Attend scheduled follow-ups and screenings
Legal/Ethical Justification:
Managing menopausal symptoms, lifestyle counseling, and initial HRT is within Family Medicine scope
Referral for contraindications or complex cases ensures safe, ethical, and legally compliant care
Case 4g – Breast Examination & Pap Smear Screening
Diagnosis:
Routine breast and cervical cancer screening
Early detection of abnormalities requiring referral
Patient Presentation / Wordings:
“I want a routine check-up for my breasts and cervical screening.”
“I have no symptoms but want preventive care.”
Examination / Assessment:
A. Breast Examination:
Inspection: symmetry, skin changes, nipple discharge
Palpation: lumps, tenderness, axillary lymph nodes
B. Pap Smear (Cervical Screening):
Cervical cytology collection with speculum exam
Indications: age 21–65 (every 3 years if normal cytology)
Laboratory / Investigations:
Pap smear cytology
HPV testing if indicated (age >30 or abnormal cytology)
Imaging if abnormalities detected: breast ultrasound or mammogram
Treatment / Prescription / Management:
A. Normal Screening Findings:
Continue routine screening schedule
Educate on self-breast examination monthly
Maintain healthy lifestyle
B. Abnormal Findings:
Breast lump: refer for ultrasound/mammogram and surgical/oncology evaluation
Pap smear: abnormal cytology (ASC-US, LSIL, HSIL) → refer to gynecology for colposcopy and biopsy as needed
Expected Side Effects:
Pap smear: minor spotting or discomfort
Breast exam: generally well tolerated
No medication prescribed for normal findings
Monitoring & Follow-Up:
Routine breast exams: every 1–3 years (age dependent)
Self-breast exam monthly
Pap smear per guideline: every 3 years if normal
Referral Criteria:
Palpable breast lump, nipple discharge, skin changes
Abnormal Pap smear results
Strong family history of breast or cervical cancer
Patient Instructions:
Perform monthly self-breast examination
Report any new lumps, discharge, or skin changes
Attend scheduled Pap smear and follow-up appointments
Legal/Ethical Justification:
Conducting routine screening exams and initial evaluation is within Family Medicine scope
Early detection and referral of malignancies protect patient health and reduce medico-legal risk
Case 4h – Pregnancy Testing, Counseling, Referral for Complications
Diagnosis:
Confirmation of pregnancy
Early counseling for healthy pregnancy
Identification of complications requiring referral
Patient Presentation / Wordings:
“I think I might be pregnant and want to confirm.”
“I just found out I am pregnant; what should I do?”
“I have spotting/pain and am worried about my pregnancy.”
Examination / Assessment:
Vital signs: BP, pulse, weight
Abdominal exam: if gestational age >6 weeks
Obstetric history: last menstrual period, prior pregnancies, complications
Risk assessment: chronic medical conditions, medications, lifestyle factors
Laboratory / Investigations:
Urine pregnancy test (first morning sample)
Serum beta-hCG if confirmation or dating needed
Baseline labs: CBC, blood group & Rh, urine analysis
Ultrasound for confirmation of intrauterine pregnancy (if indicated)
Treatment / Prescription / Management:
A. Routine Early Pregnancy Counseling:
Prenatal vitamins:
Folic acid 0.4–5 mg orally daily
Iron supplementation if anemic
Lifestyle: avoid alcohol, smoking, unprescribed medications
Diet: balanced nutrition, hydration
Exercise: moderate, safe for pregnancy
B. Early Complication Management / Red Flags:
Advise rest and monitoring if mild spotting
Immediate referral if: severe abdominal pain, heavy bleeding, signs of ectopic pregnancy, hyperemesis, uncontrolled chronic disease
Expected Side Effects / Notes:
Prenatal vitamins: mild nausea, constipation (iron)
Counseling generally well tolerated
Monitoring & Follow-Up:
Confirmed intrauterine pregnancy follow-up: every 4 weeks until 28 weeks, then every 2 weeks until 36 weeks, then weekly
Monitor maternal vitals, weight, fetal growth
Repeat labs as per routine antenatal schedule
Referral Criteria:
Ectopic pregnancy suspicion (severe pain, bleeding, positive β-hCG without intrauterine gestation)
Recurrent miscarriage or previous obstetric complications
Medical comorbidities: diabetes, hypertension, cardiac disease
Any abnormal ultrasound or lab findings
Patient Instructions:
Confirm pregnancy early and attend regular prenatal visits
Report vaginal bleeding, abdominal pain, dizziness, or reduced fetal movements
Maintain healthy lifestyle and adherence to supplements
Legal/Ethical Justification:
Confirming pregnancy, providing early counseling, and routine management is within Family Medicine scope
Prompt referral of high-risk or complicated pregnancies ensures patient safety, ethical compliance, and medico-legal protection
V – Men’s Health
Case 5a – Erectile Dysfunction (ED) & Premature Ejaculation (PE)
Diagnosis:
Erectile dysfunction (inability to achieve/maintain erection sufficient for sexual intercourse)
Premature ejaculation (ejaculation occurring earlier than desired)
Patient Presentation / Wordings:
ED: “I have difficulty getting or keeping an erection.”
PE: “I ejaculate too quickly during intercourse and it affects my relationship.”
Examination / Assessment:
Vital signs, BMI
Cardiovascular and neurological exam
Genital exam: testicular size, penile abnormalities, secondary sexual characteristics
Review medications, alcohol, smoking, psychological stress
Laboratory / Investigations:
Fasting glucose, HbA1c (diabetes screening)
Lipid profile (CV risk)
Testosterone (total & free) if hypogonadism suspected
Other hormonal tests if indicated (LH, FSH, prolactin)
Treatment / Prescription / Management:
A. Erectile Dysfunction:
Lifestyle modification: weight reduction, smoking/alcohol cessation, exercise
PDE5 inhibitors (if no contraindications):
Sildenafil 25–50 mg orally 1 hour before sexual activity (max 100 mg/day)
Tadalafil 5–10 mg as needed or daily low dose 2.5–5 mg
Psychosexual counseling if psychological factors
B. Premature Ejaculation:
Behavioral techniques: start-stop, squeeze method
Topical anesthetic: lidocaine-prilocaine cream applied 10–15 min before intercourse
Selective serotonin reuptake inhibitors (SSRIs) if persistent:
Paroxetine 10–20 mg orally once daily
Expected Side Effects:
PDE5 inhibitors: headache, flushing, dyspepsia, visual changes
SSRIs: nausea, sleep disturbance, sexual side effects
Topical anesthetics: mild local numbness
Monitoring & Follow-Up:
Assess efficacy and tolerance after 4–6 weeks
Monitor blood pressure, cardiac status if using PDE5 inhibitors
Review adherence and side effects
Referral Criteria:
Persistent ED despite first-line therapy
Severe cardiovascular disease preventing PDE5 inhibitor use
Anatomical abnormalities (Peyronie’s disease, penile trauma)
Suspected hormonal disorders (low testosterone)
Patient Instructions:
Follow medication instructions precisely
Avoid nitrates if using PDE5 inhibitors
Report severe headache, chest pain, vision changes, or priapism
Maintain healthy lifestyle
Legal/Ethical Justification:
Initial evaluation and management of sexual dysfunction is within Family Medicine scope
Referral for complex cases ensures safe, ethical, and legally compliant care
Case 5b – Infertility (Basic Work-Up & Referral)
Diagnosis:
Male factor infertility or couple infertility (unable to conceive after ≥12 months of regular unprotected intercourse)
Patient Presentation / Wordings:
“My partner and I have been trying to conceive for over a year without success.”
“I want to know if there is any issue with my fertility.”
Examination / Assessment:
Vital signs, BMI
General physical examination
Genital exam: testicular size, varicocele, penile abnormalities, epididymis tenderness
Assessment of secondary sexual characteristics
Review past medical history, medications, lifestyle (smoking, alcohol, drugs)
Laboratory / Investigations (Basic Work-Up in Primary Care):
Semen analysis (volume, count, motility, morphology)
Hormonal profile: Testosterone, LH, FSH if indicated
Screening for infections if clinically suspected (STIs)
Treatment / Prescription / Management (Initial Steps):
Lifestyle modifications: weight optimization, smoking/alcohol cessation, avoid heat exposure to testes
Correct reversible factors (medications, infections)
Optimize management of chronic illnesses (diabetes, thyroid, hypertension)
Expected Side Effects / Notes:
Lifestyle interventions generally safe
Correcting infections may involve antibiotics (dose/duration per infection type)
Monitoring & Follow-Up:
Repeat semen analysis after 3–6 months if initial abnormalities corrected
Monitor adherence to lifestyle changes
Track any improvement in fertility
Referral Criteria:
Abnormal semen parameters persist despite lifestyle and medical optimization
History of cryptorchidism, testicular trauma, surgery, or genetic disorders
Suspected obstructive azoospermia or complex hormonal abnormalities
Couples requiring assisted reproductive technology (ART)
Patient Instructions:
Avoid smoking, alcohol, recreational drugs
Maintain healthy weight and diet
Avoid hot baths/saunas or tight clothing affecting testicular temperature
Attend follow-up for repeat semen analysis and specialist referral
Legal/Ethical Justification:
Initial fertility evaluation and basic investigations are within Family Medicine scope
Referral for specialized fertility assessment ensures ethical, safe, and legally compliant care
Case 5c – Prostatitis, BPH, Lower Urinary Tract Symptoms (LUTS)
Diagnosis:
Acute or chronic prostatitis
Benign prostatic hyperplasia (BPH)
LUTS: frequency, urgency, weak stream, nocturia, incomplete emptying
Patient Presentation / Wordings:
“I have trouble urinating: weak stream, urgency, and nocturia.”
“I have pelvic pain, burning urination, and sometimes fever.”
“I noticed my urine flow is slower than before.”
Examination / Assessment:
Vital signs (fever, BP)
Abdominal exam: bladder distension, tenderness
Digital rectal exam (DRE): prostate size, tenderness, nodules
Neurological exam for voiding dysfunction
Laboratory / Investigations:
Urinalysis and urine culture
PSA if age >50 or if prostate abnormality suspected (interpret cautiously in acute infection)
Renal function (creatinine) if obstruction suspected
Ultrasound: bladder, post-void residual, prostate size if needed
Treatment / Prescription / Management:
A. Acute Bacterial Prostatitis:
Antibiotics:
Ciprofloxacin 500 mg orally twice daily for 4 weeks OR
Trimethoprim-sulfamethoxazole 160/800 mg orally twice daily for 4 weeks
Analgesia: Paracetamol 500–1000 mg orally every 6–8 hours
Hydration and sitz baths
B. Chronic Prostatitis / LUTS / BPH (Initial):
Alpha-blockers (for LUTS / BPH):
Tamsulosin 0.4 mg orally once daily, 30 min after same meal
5-alpha-reductase inhibitors (if prostate >40 g, persistent symptoms):
Finasteride 5 mg orally once daily
Lifestyle: avoid excessive fluids before bedtime, limit caffeine/alcohol, timed voiding
Expected Side Effects:
Ciprofloxacin: nausea, diarrhea, tendonitis (rare)
Tamsulosin: dizziness, postural hypotension, retrograde ejaculation
Finasteride: decreased libido, erectile dysfunction, rarely gynecomastia
Monitoring & Follow-Up:
Symptom relief (IPSS score for LUTS) after 4–6 weeks
Repeat urinalysis/culture if prostatitis not resolved
PSA monitoring as indicated
Monitor blood pressure and side effects of alpha-blockers
Referral Criteria:
Severe urinary retention (unable to void)
Recurrent or complicated prostatitis
Suspicious prostate nodule, rapidly rising PSA, hematuria
Failure of medical management for BPH or LUTS
Patient Instructions:
Complete full antibiotic course for infection
Avoid dehydration and straining while urinating
Report fever, worsening pain, urinary retention, or hematuria
Adhere to medications and lifestyle modifications
Legal/Ethical Justification:
Family physicians can perform initial evaluation, start empiric treatment, and manage uncomplicated LUTS/BPH
Referral of complicated cases ensures safe, ethical, and legally compliant care
Case 5d – Hypogonadism Screening & Testosterone Deficiency Awareness
Diagnosis:
Primary or secondary hypogonadism (low testosterone levels causing clinical symptoms)
Patient Presentation / Wordings:
“I feel fatigued, have low libido, and difficulty gaining muscle.”
“I have erectile dysfunction, decreased energy, and mood changes.”
“I am concerned about low testosterone as I age.”
Examination / Assessment:
Vital signs, BMI
Physical exam: testicular size, body hair, muscle mass, secondary sexual characteristics
Signs of metabolic syndrome (waist circumference, blood pressure)
Review medications and chronic illnesses affecting testosterone
Laboratory / Investigations:
Morning total testosterone (before 10 am), confirm with repeat test if low
Free testosterone if needed
LH, FSH to differentiate primary vs secondary hypogonadism
Prolactin, TSH, fasting glucose, lipid profile
Optional: PSA and hematocrit if testosterone replacement considered
Treatment / Prescription / Management (Initial/Referral-Based):
Lifestyle Optimization: weight loss, exercise, sleep hygiene, limit alcohol
Address underlying causes: chronic illness, medications, substance use
Testosterone Replacement Therapy (specialist referral recommended before initiation):
Testosterone gel 50–100 mg/day
Testosterone injections 100–200 mg IM every 2–3 weeks
Monitor for contraindications: prostate cancer, hematocrit >50%, severe heart failure
Expected Side Effects:
Acne, oily skin, fluid retention
Polycythemia (increased hematocrit)
Rare: cardiovascular events, prostate enlargement
Monitoring & Follow-Up:
Repeat testosterone levels 3–6 months after therapy initiation
Hematocrit, PSA, liver function monitoring
Symptom improvement: libido, energy, mood, muscle mass
Adjust therapy based on levels and tolerance
Referral Criteria:
Persistently low testosterone with symptoms
Suspected pituitary or testicular pathology
Consider endocrinology/urology for therapy initiation
Contraindications to testosterone therapy
Patient Instructions:
Optimize lifestyle: exercise, sleep, nutrition
Report breast enlargement, severe acne, swelling, or unusual symptoms
Follow scheduled labs and specialist visits if therapy initiated
Legal/Ethical Justification:
Screening for hypogonadism and patient education is within Family Medicine scope
Testosterone therapy initiation and monitoring requires specialist input for safety, ensuring ethical and legally compliant care
VI. Dermatology
Case 6a – Acne Vulgaris
Diagnosis:
Mild, moderate, or severe acne (comedonal, inflammatory, or nodulocystic)
Patient Presentation / Wordings:
“I have pimples on my face, back, and chest.”
“I get red bumps and blackheads that sometimes scar.”
Examination / Assessment:
Distribution: face, chest, back
Lesion type: comedones, papules, pustules, nodules
Scarring, post-inflammatory hyperpigmentation
Assess for hormonal causes if adult female (PCOS, irregular menses)
Laboratory / Investigations (if indicated):
Hormonal profile in women with irregular cycles: testosterone, LH/FSH
Bacterial culture only if resistant or severe infection
Treatment / Prescription / Management:
A. Mild Acne:
Topical benzoyl peroxide 2.5–5% once daily
Topical retinoids: adapalene 0.1% at night
Gentle cleanser, avoid abrasive scrubs
B. Moderate Acne:
Topical combination therapy: benzoyl peroxide + topical antibiotic (clindamycin)
Consider oral antibiotics if extensive inflammation: doxycycline 100 mg orally twice daily for 6–8 weeks
C. Severe / Nodulocystic Acne:
Referral to dermatologist for isotretinoin therapy
Consider adjunct topical therapy
Expected Side Effects:
Topicals: dryness, erythema, mild peeling
Oral antibiotics: GI upset, photosensitivity
Avoid long-term antibiotic monotherapy due to resistance
Monitoring & Follow-Up:
Review after 6–8 weeks for response and tolerance
Monitor for side effects of oral therapy
Encourage adherence and proper skincare
Referral Criteria:
Severe, nodulocystic, or scarring acne
Hormonal abnormalities in women
Resistant to first-line therapy
Patient Instructions:
Use medications as directed, apply sparingly
Avoid picking or squeezing lesions
Protect skin from sun, use non-comedogenic products
Legal/Ethical Justification:
Initial acne management is within Family Medicine scope
Referral for severe, scarring, or resistant cases ensures ethical and safe care
Case 6b – Eczema / Dermatitis / Psoriasis
Diagnosis:
Atopic dermatitis (eczema)
Contact dermatitis (allergic or irritant)
Psoriasis (plaque, guttate, or other forms)
Patient Presentation / Wordings:
Eczema: “My skin is itchy, red, and sometimes oozes.”
Contact dermatitis: “I developed a rash after using a new soap/cream.”
Psoriasis: “I have thick, scaly, silvery plaques on my elbows, knees, or scalp.”
Examination / Assessment:
Distribution: flexural vs extensor areas, scalp, trunk, extremities
Lesion type: erythema, scaling, vesicles, lichenification
Severity scoring if psoriasis (PASI or BSA involvement)
Identify triggers: soaps, detergents, metals, medications
Laboratory / Investigations (if indicated):
Skin biopsy if diagnosis uncertain
Patch testing for contact allergens
Fasting glucose / metabolic profile if systemic therapy considered
Treatment / Prescription / Management:
A. Eczema / Dermatitis:
Topical corticosteroids (mild–moderate):
Hydrocortisone 1% cream twice daily
Moderate potency: Betamethasone valerate 0.05% cream for short course (max 2 weeks)
Emollients: frequent application, fragrance-free
Avoid triggers and irritants
Oral antihistamines for itching: Cetirizine 10 mg daily
B. Psoriasis:
Mild: Topical corticosteroids (betamethasone or clobetasol for limited periods), salicylic acid or coal tar preparations
Moderate–Severe: referral to dermatologist for systemic therapy (methotrexate, biologics)
Emollients (Hydrex) and moisturizers regularly
Expected Side Effects:
Topical corticosteroids: skin thinning, telangiectasia with prolonged use
Oral antihistamines: drowsiness (Cetirizine usually non-sedating)
Systemic therapy: monitor in specialist care
Monitoring & Follow-Up:
Assess lesion improvement within 2–4 weeks
Monitor side effects for topical steroids
Reassess triggers and patient adherence
Psoriasis: follow-up with dermatologist if progression or systemic therapy initiated
Referral Criteria:
Severe, widespread, or resistant eczema or dermatitis
Suspected psoriasis requiring systemic therapy
Signs of secondary infection (weeping, pus, fever)
Diagnostic uncertainty
Patient Instructions:
Apply creams as prescribed; avoid abrupt discontinuation
Keep skin moisturized, avoid hot showers and irritants
Report worsening rash, infection, or systemic symptoms
Legal/Ethical Justification:
Initial management of eczema, dermatitis, and mild psoriasis is within Family Medicine scope
Referral for severe or complex cases ensures safe, ethical, and legally compliant care
Case 6c – Fungal & Bacterial Skin Infections
Diagnosis:
Superficial fungal infections: tinea corporis, tinea cruris, tinea capitis, candidiasis
Bacterial infections: impetigo, folliculitis, cellulitis
Patient Presentation / Wordings:
Fungal: “I have red, itchy, circular patches on my body or groin.”
Candidiasis: “I have white patches in skin folds or moist areas.”
Bacterial: “I have red, pus-filled bumps or painful swelling on my skin.”
Examination / Assessment:
Inspect lesions: erythema, scaling, vesicles, pustules
Distribution: localized vs widespread
Signs of systemic infection: fever, lymphadenopathy
Laboratory / Investigations (if indicated):
KOH prep for fungal elements
Bacterial culture & sensitivity for resistant or severe infections
Blood work if systemic infection suspected
Treatment / Prescription / Management:
A. Superficial Fungal Infections:
Topical antifungals:
Clotrimazole 1% cream twice daily for 2–4 weeks
Terbinafine 1% cream once daily for 2–4 weeks
Oral antifungals (for extensive or scalp infection):
Terbinafine 250 mg orally daily for 2–4 weeks
Fluconazole 150 mg weekly for 2–4 weeks
B. Bacterial Skin Infections:
Impetigo / mild folliculitis:
Mupirocin 2% ointment 2–3 times daily for 5–7 days
Cellulitis / extensive infections:
Oral antibiotics: Cephalexin 500 mg orally every 6 hours for 7–10 days
Consider culture if non-responsive or severe
Expected Side Effects:
Topical antifungals: mild irritation, redness
Oral antifungals: GI upset, liver enzyme elevation (monitor in prolonged therapy)
Antibiotics: GI upset, rash, rarely allergic reaction
Monitoring & Follow-Up:
Reassess lesion resolution in 1–2 weeks
Ensure adherence to full treatment course
Repeat cultures if no improvement or recurrence
Referral Criteria:
Extensive, recurrent, or resistant infections
Signs of systemic infection (fever, spreading redness)
Suspected immunodeficiency or diabetic patient with infection
Nail or scalp infections not responding to oral therapy
Patient Instructions:
Maintain hygiene, keep affected area dry
Avoid sharing personal items
Complete the full course of medications
Report fever, spreading redness, or lack of improvement
Legal/Ethical Justification:
Diagnosis and initial management of common fungal and bacterial infections is within Family Medicine scope
Referral for severe, resistant, or systemic infections ensures patient safety and ethical compliance
Case 6d – Urticaria, Drug Rashes, Contact Allergies
Diagnosis:
Acute or chronic urticaria
Drug-induced rash
Allergic contact dermatitis
Patient Presentation / Wordings:
Urticaria: “I have itchy, red, raised welts on my skin that come and go.”
Drug rash: “I developed a rash after starting a new medication.”
Contact allergy: “I got a red, itchy rash after touching a new soap or metal.”
Examination / Assessment:
Inspect rash: hives, erythema, vesicles, bullae
Distribution: localized vs generalized
Signs of systemic involvement (facial swelling, difficulty breathing, hypotension)
Review recent medications, topical agents, environmental exposures
Laboratory / Investigations (if indicated):
CBC with eosinophils for severe allergic reactions
Liver and renal function if systemic drug reaction suspected
Allergy testing / patch testing for persistent contact dermatitis
Treatment / Prescription / Management:
A. Urticaria:
Non-sedating antihistamines:
Cetirizine 10 mg orally once daily (can increase to 20 mg if needed)
Loratadine 10 mg orally once daily
Avoid known triggers
Severe cases: short course oral corticosteroids (Prednisolone 20–30 mg daily for 5–7 days, specialist supervision)
B. Drug Rash / Contact Allergy:
Discontinue suspected drug or trigger
Topical corticosteroids: Hydrocortisone 1% cream for mild reactions
Oral antihistamines as above for pruritus
Cool compresses, emollients, barrier creams
Expected Side Effects:
Antihistamines: drowsiness (less common with non-sedating)
Corticosteroids: skin thinning if topical prolonged use, systemic side effects if oral
Rare: severe allergic reaction (anaphylaxis)
Monitoring & Follow-Up:
Assess improvement in 48–72 hours for mild reactions
Monitor for signs of systemic involvement
Referral if chronic or recurrent urticaria persists beyond 6 weeks
Referral Criteria:
Severe or generalized rash with systemic symptoms (angioedema, anaphylaxis)
Persistent or chronic urticaria not responding to first-line therapy
Suspected drug reaction requiring specialist evaluation (e.g., Stevens-Johnson syndrome)
Patient Instructions:
Avoid known triggers or offending medications
Use antihistamines as directed
Seek immediate care for swelling of lips/tongue, difficulty breathing, or widespread rash
Legal/Ethical Justification:
Initial assessment and treatment of urticaria, drug rashes, and contact allergies is within Family Medicine scope
Immediate recognition and referral for severe reactions ensures patient safety and medico-legal compliance
Case 6e – Hair and Scalp Disorders (Alopecia, Dandruff)
Diagnosis:
Androgenetic alopecia (male/female pattern hair loss)
Alopecia areata
Seborrheic dermatitis / dandruff
Telogen effluvium
Patient Presentation / Wordings:
“I am losing hair on my scalp, especially at the temples/top.”
“I have an itchy, flaky scalp with dandruff.”
“My hair falls out suddenly in patches.”
Examination / Assessment:
Scalp inspection: pattern, patches, scaling, redness
Hair pull test to assess shedding
Assess for scarring vs non-scarring alopecia
Evaluate associated skin conditions (eczema, psoriasis)
Review medications, stress, hormonal status, nutrition
Laboratory / Investigations (if indicated):
CBC, ferritin, thyroid profile (hypothyroidism)
Hormonal profile (testosterone, DHEAS) for androgenetic alopecia
Scalp biopsy if scarring alopecia suspected
Treatment / Prescription / Management:
A. Dandruff / Seborrheic Dermatitis:
Medicated shampoo containing ketoconazole 2% or selenium sulfide 1–2%, 2–3 times per week
Topical antifungal cream for inflamed areas if needed
B. Androgenetic Alopecia:
Male: Minoxidil 5% solution/topical foam twice daily
Female: Minoxidil 2–5% topical solution, consider hormonal therapy if indicated
Lifestyle: nutrition, stress reduction
C. Alopecia Areata / Telogen Effluvium:
Mild: Topical corticosteroids (clobetasol 0.05% scalp solution or foam)
Severe / extensive: refer to dermatologist for systemic therapy (oral corticosteroids, immunotherapy)
Expected Side Effects:
Minoxidil: mild scalp irritation, hypertrichosis (unwanted hair growth)
Topical corticosteroids: skin thinning with prolonged use
Medicated shampoos: dryness, mild irritation
Monitoring & Follow-Up:
Assess hair regrowth and symptom improvement every 6–12 weeks
Monitor for adverse effects of topical therapy
Repeat labs if nutritional or hormonal causes suspected
Referral Criteria:
Rapidly progressive, scarring, or patchy alopecia
Non-responsive to initial therapy
Suspected autoimmune or systemic cause
Significant psychosocial impact
Patient Instructions:
Apply topical treatments consistently
Avoid harsh hair treatments (bleach, heat styling)
Use medicated shampoos as directed
Report worsening hair loss or scalp inflammation
Legal/Ethical Justification:
Initial management of common hair and scalp disorders is within Family Medicine scope
Referral for severe, scarring, or resistant cases ensures safe, ethical, and legally compliant care
Case 6f – Scabies, Lice, Nail Infections
Diagnosis:
Scabies (Sarcoptes scabiei infestation)
Pediculosis (head/body lice)
Onychomycosis (fungal nail infection)
Bacterial nail infections (paronychia)
Patient Presentation / Wordings:
Scabies: “I have intense itching, especially at night, with small bumps between my fingers and wrists.”
Lice: “I notice itching and small nits on my scalp.”
Nail infection: “My nails are thick, discolored, or painful.”
Examination / Assessment:
Inspect skin/nails for lesions, burrows, pustules
Scalp examination for lice/nits
Check surrounding skin for secondary infection
Assess for systemic symptoms (fever, lymphadenopathy)
Laboratory / Investigations (if indicated):
Skin scraping for scabies mites if diagnosis uncertain
KOH preparation or fungal culture for nail infections
Bacterial culture for paronychia if severe or resistant
Treatment / Prescription / Management:
A. Scabies:
Permethrin 5% cream: apply from neck to toes, leave for 8–14 hours, repeat in 7 days if needed
Treat close contacts simultaneously
Wash clothing and bedding in hot water
B. Lice:
Permethrin 1% lotion or shampoo: apply to scalp, leave 10 minutes, rinse, repeat in 7–10 days
Fine-tooth combing to remove nits
Treat household contacts if affected
C. Nail Infections:
Fungal (onychomycosis):
Oral terbinafine 250 mg daily for 6 weeks (fingernails) or 12 weeks (toenails)
Topical antifungals for mild cases (ciclopirox nail lacquer)
Bacterial paronychia:
Mild: warm compresses
Moderate/severe: oral antibiotics (e.g., Cephalexin 500 mg orally every 6 hours for 7–10 days)
Expected Side Effects:
Permethrin: mild skin irritation, burning
Oral antifungals: GI upset, liver enzyme elevation (monitor in prolonged therapy)
Antibiotics: GI upset, rash, allergic reaction
Monitoring & Follow-Up:
Assess resolution of itching/lesions after 1–2 weeks
Repeat treatment if infestation persists
Monitor liver function for prolonged antifungal therapy
Evaluate for secondary infection
Referral Criteria:
Severe, widespread, or refractory infestations
Immunocompromised patients
Extensive nail involvement resistant to oral therapy
Secondary bacterial infection requiring specialist care
Patient Instructions:
Complete full course of treatment
Wash bedding, clothing, and combs
Avoid sharing personal items
Report persistent itching, spreading lesions, or signs of systemic infection
Legal/Ethical Justification:
Diagnosis and initial management of common infestations and nail infections is within Family Medicine scope
Referral for complicated or resistant cases ensures safe, ethical, and legally compliant care
Case 6g – Minor Procedures (Wart or Skin Tag Removal)
Diagnosis:
Common warts (verruca vulgaris)
Skin tags (acrochordons)
Patient Presentation / Wordings:
“I have small growths on my skin that bother me.”
“I want these warts/skin tags removed for cosmetic reasons.”
Examination / Assessment:
Inspect lesion: size, number, location, signs of infection
Assess surrounding skin and anatomical location for procedural safety
Review bleeding risk: history of coagulopathy, anticoagulant use
Assess for underlying skin malignancy if lesion atypical
Laboratory / Investigations (if indicated):
None typically required for routine warts/skin tags
Biopsy if lesion atypical, pigmented, or rapidly changing
Treatment / Procedure / Management:
A. Warts:
Cryotherapy with liquid nitrogen (if trained)
Topical salicylic acid 17–40% daily application for 4–12 weeks
Electrocautery or curettage if available and trained
B. Skin Tags:
Snip excision with sterile scissors or scalpel after local anesthesia (if trained)
Cryotherapy can also be used
Expected Side Effects:
Mild pain, redness, blistering at treatment site
Rare: infection, scarring, pigment changes
Local anesthesia: temporary numbness or minor bleeding
Monitoring & Follow-Up:
Assess wound healing within 1–2 weeks
Monitor for infection or recurrence
Repeat procedure if lesion persists
Referral Criteria:
Lesions in sensitive or high-risk areas (face, genitals, eyes)
Atypical, rapidly growing, or pigmented lesions
Multiple or recurrent warts resistant to first-line treatment
Patient with bleeding disorder or immunocompromised
Patient Instructions:
Keep area clean and dry
Avoid picking or scratching
Apply any prescribed topical treatment as directed
Report redness, swelling, pus, or unusual changes
Legal/Ethical Justification:
Minor procedures like wart or skin tag removal are within Family Medicine scope if trained
Referral for suspicious or complicated lesions ensures ethical, safe, and legally compliant care
Case 6h – Suspicious Skin Lesions (Biopsy or Referral for Malignancy)
Diagnosis:
Suspicious skin lesion requiring evaluation for malignancy (e.g., melanoma, basal cell carcinoma, squamous cell carcinoma)
Patient Presentation / Wordings:
“I have a mole that has changed in size, color, or shape.”
“There is a new skin lesion that bleeds or does not heal.”
“I noticed a dark spot that is irregular and growing.”
Examination / Assessment:
Inspect lesion using ABCDE criteria:
A: Asymmetry
B: Border irregularity
C: Color variation
D: Diameter >6 mm
E: Evolution / change over time
Palpate lesion for firmness, ulceration, or tenderness
Examine regional lymph nodes for enlargement
Laboratory / Investigations (if indicated):
Skin biopsy (punch, shave, or excisional) if trained and confident
Dermoscopy if available
Imaging if lesion suspicious for deeper invasion (specialist referral)
Treatment / Management:
Initial:
Document size, location, and appearance
Take high-quality clinical photographs
Avoid untrained excision of suspicious lesions
Referral:
Urgent referral to dermatology or surgical oncology for biopsy and definitive management
Expected Side Effects / Notes:
Biopsy risks (if performed by trained clinician): bleeding, infection, scarring
Delay in referral may worsen prognosis for malignant lesions
Monitoring & Follow-Up:
Ensure patient attends specialist appointment promptly
Track lesion changes until evaluation completed
Educate patient to report new or changing lesions
Referral Criteria:
Any lesion suspicious for malignancy (melanoma, non-healing ulcer, rapidly growing or pigmented lesion)
Lesions with atypical appearance, ulceration, bleeding, or recurrence
Patients at high risk: fair skin, family history of skin cancer, immunocompromised
Patient Instructions:
Avoid trauma to the lesion
Do not attempt self-removal
Monitor other moles or spots for changes
Attend referral appointment promptly
Legal/Ethical Justification:
Family physicians must recognize suspicious lesions but biopsy/removal should only be performed if trained
Referral to dermatology or surgical oncology ensures timely, safe, and legally compliant management of potential malignancy
VII. ENT / EYE ENT
Case 7a – Otitis Media, Otitis Externa, Wax, Sinusitis, Allergic Rhinitis
Diagnosis:
Otitis media (acute or chronic)
Otitis externa (swimmer’s ear)
Cerumen impaction (ear wax)
Acute or chronic sinusitis
Allergic rhinitis
Patient Presentation / Wordings:
Otitis media: “I have ear pain, sometimes with fever or hearing loss.”
Otitis externa: “My ear is itchy, painful, and sometimes draining fluid.”
Wax: “I have reduced hearing and a feeling of fullness in the ear.”
Sinusitis: “I have nasal congestion, facial pain, and purulent nasal discharge.”
Allergic rhinitis: “I have sneezing, itchy eyes, and runny nose, especially seasonally.”
Examination / Assessment:
Ear: otoscopy for inflammation, discharge, tympanic membrane status
Nose: inspection for discharge, congestion, polyps
Sinus tenderness on palpation
Throat: pharyngeal exam if concomitant infection
Allergic signs: nasal mucosa pale/swollen, conjunctival injection
Laboratory / Investigations (if indicated):
Ear swab culture if resistant infection
Sinus imaging (CT) if chronic/recurrent sinusitis
Allergy testing for persistent allergic rhinitis
Treatment / Prescription / Management:
A. Otitis Media (Acute, Uncomplicated):
Analgesia: Paracetamol 500–1000 mg every 6–8 hours
Amoxicillin 500 mg orally every 8 hours for 5–7 days
Warm compress for pain relief
B. Otitis Externa:
Topical antibiotic + steroid ear drops: Ciprofloxacin + Hydrocortisone, 3–4 drops twice daily for 7 days
Keep ear dry
C. Cerumen Impaction:
Ear irrigation with saline or carbamide peroxide 6.5% drops
Manual removal if trained
D. Sinusitis (Acute, Uncomplicated):
Analgesia: Paracetamol or NSAIDs
Nasal saline irrigation
Decongestants (pseudoephedrine 60 mg orally every 6 hours for max 5 days)
Antibiotics only if bacterial infection suspected: Amoxicillin 500 mg every 8 hours for 7–10 days
E. Allergic Rhinitis:
Intranasal corticosteroids: Fluticasone 50 mcg, 1–2 sprays per nostril daily
Oral antihistamines: Cetirizine 10 mg daily
Avoid allergens, maintain nasal hygiene
Expected Side Effects:
Antibiotics: GI upset, rash
Topical steroids: mild irritation
Decongestants: insomnia, hypertension
Antihistamines: drowsiness (less with non-sedating)
Monitoring & Follow-Up:
Reassess symptoms within 5–7 days
Monitor for worsening pain, fever, discharge
Repeat ear/nasal exam if symptoms persist
Referral Criteria:
Severe, recurrent, or complicated otitis media/externa
Suspected mastoiditis or intracranial complications
Chronic sinusitis not responding to therapy
Severe allergic rhinitis unresponsive to medical therapy
Patient Instructions:
Complete full course of antibiotics if prescribed
Keep ears dry in otitis externa
Avoid allergen exposure and follow nasal hygiene for allergic rhinitis
Report fever, worsening pain, or hearing loss
Legal/Ethical Justification:
Initial evaluation and management of common ENT conditions is within Family Medicine scope
Referral of complicated or non-responsive cases ensures safe, ethical, and legally compliant care
Case 7b – Sore Throat, Tonsillitis, Pharyngitis
Diagnosis:
Viral or bacterial pharyngitis/tonsillitis
Group A Streptococcal (GAS) infection if bacterial
Patient Presentation / Wordings:
“I have a sore throat, pain from swallowing, and mild fever.”
“My tonsils are swollen with white spots.”
“I have throat discomfort, sometimes with ear pain.”
Examination / Assessment:
Oropharyngeal exam: tonsillar enlargement, exudates, erythema
Palpate cervical lymph nodes
Assess for fever, cough, nasal symptoms
Evaluate severity: hydration, airway compromise
Laboratory / Investigations (if indicated):
Rapid antigen detection test (RADT) for GAS
Throat swab culture if RADT unavailable or negative with high suspicion
Treatment / Prescription / Management:
A. Viral Pharyngitis:
Analgesia: Paracetamol 500–1000 mg every 6–8 hours
Hydration, throat lozenges, warm salt-water gargle
Symptomatic care only
B. Bacterial / GAS Pharyngitis:
First-line:
Penicillin V 500 mg orally every 6 hours for 10 days
Amoxicillin 500 mg orally every 8 hours for 10 days (alternative)
Analgesia as above
Expected Side Effects:
Antibiotics: GI upset, rash, rarely allergic reaction
Analgesics: mild GI discomfort with NSAIDs
Monitoring & Follow-Up:
Reassess symptoms in 48–72 hours
Monitor for resolution of fever, pain, and lymphadenopathy
Seek urgent care for airway compromise
Referral Criteria:
Severe tonsillar enlargement with airway obstruction
Peritonsillar abscess (unilateral swelling, trismus, muffled voice)
Recurrent or non-responsive bacterial infections
Suspected complications: rheumatic fever, post-streptococcal glomerulonephritis
Patient Instructions:
Complete full antibiotic course if prescribed
Hydrate and rest
Report worsening pain, drooling, or difficulty breathing
Avoid sharing utensils or close contact to prevent spread
Legal/Ethical Justification:
Initial assessment and management of pharyngitis/tonsillitis is within Family Medicine scope
Referral for severe or complicated cases ensures safe, ethical, and legally compliant care
Case 7c – Epistaxis
Diagnosis:
Anterior or posterior nosebleed (epistaxis)
Patient Presentation / Wordings:
“I have sudden bleeding from my nose.”
“Blood is coming from one nostril, sometimes with clotting.”
Examination / Assessment:
Inspect anterior nasal cavity for bleeding site (Kiesselbach’s plexus common)
Assess hemodynamic status: BP, heart rate, signs of hypovolemia
Review medications: anticoagulants, NSAIDs
Check for trauma, nasal deformities, or underlying coagulopathy
Laboratory / Investigations (if indicated):
CBC, PT/INR if recurrent or severe bleeding
Nasal endoscopy if posterior bleed suspected or recurrent
Coagulation profile if on anticoagulants or history of bleeding disorders
Treatment / Management:
A. Initial Management of Anterior Epistaxis:
Sit patient upright, lean forward
Apply direct pressure to soft part of nose for 10–15 minutes
Topical vasoconstrictor: Oxymetazoline 0.05% spray once, can repeat after 10 minutes if needed
Apply ice pack to nose/cheeks to reduce bleeding
Nasal packing if bleeding persists
B. Posterior Epistaxis / Severe Cases:
Requires ENT referral for posterior packing, cauterization, or surgical intervention
Expected Side Effects:
Local discomfort, mild nasal irritation
Rare: nasal mucosa injury with aggressive packing
Monitoring & Follow-Up:
Observe for 1–2 hours after bleeding stops
Monitor BP, pulse, and signs of anemia if significant blood loss
Schedule follow-up for recurrent epistaxis
Referral Criteria:
Posterior epistaxis
Recurrent or uncontrolled bleeding despite initial measures
Suspected trauma, tumor, or coagulopathy
Hemodynamic instability
Patient Instructions:
Avoid nose picking, blowing nose, or heavy lifting for 24–48 hours
Use saline nasal spray to prevent dryness
Seek urgent care if bleeding recurs or is heavy
Legal/Ethical Justification:
Initial management of epistaxis is within Family Medicine scope
Prompt referral of uncontrolled or posterior epistaxis ensures patient safety and legal compliance
Case 7d – Vertigo (BPPV, Vestibular Neuritis)
Diagnosis:
Benign Paroxysmal Positional Vertigo (BPPV)
Vestibular neuritis / labyrinthitis
Patient Presentation / Wordings:
BPPV: “I feel dizzy when I turn my head or get out of bed; it lasts seconds.”
Vestibular neuritis: “I have sudden, severe spinning vertigo, nausea, and imbalance for hours to days.”
Examination / Assessment:
Vital signs, neurological exam
Dix-Hallpike maneuver for BPPV
Observe nystagmus direction and duration
Vestibular function assessment (Romberg, gait)
Rule out central causes: sudden weakness, slurred speech, visual changes
Laboratory / Investigations (if indicated):
Generally clinical diagnosis
MRI brain if central cause suspected or atypical features present
Audiometry if hearing loss is present
Treatment / Prescription / Management:
A. BPPV:
Canalith repositioning maneuvers (Epley or Semont)
Vestibular rehabilitation exercises if recurrent
Anti-vertigo medications rarely needed (Meclizine 25–50 mg orally up to 3 times daily, short-term)
B. Vestibular Neuritis:
Short course of vestibular suppressants (Meclizine 25 mg orally 1–3 times daily for 1–3 days max)
Anti-nausea: Ondansetron 4–8 mg orally as needed
Encourage early mobilization and vestibular exercises
Avoid prolonged use of vestibular suppressants
Expected Side Effects:
Meclizine: drowsiness, dry mouth
Ondansetron: headache, constipation, mild dizziness
Monitoring & Follow-Up:
Assess symptom resolution within 1–2 weeks
Monitor for persistent imbalance or new neurological symptoms
Repeat vestibular rehab as needed
Referral Criteria:
Suspected central vertigo (stroke, tumor, multiple sclerosis)
Persistent vertigo >2 weeks or recurrent despite therapy
Severe hearing loss or new neurological deficits
Patient Instructions:
Perform canalith repositioning maneuvers as instructed
Move slowly, avoid sudden head movements
Hydrate adequately, maintain safety to prevent falls
Report new neurological symptoms immediately
Legal/Ethical Justification:
Initial diagnosis and management of peripheral vertigo (BPPV, vestibular neuritis) is within Family Medicine scope
Referral for central or complicated vertigo ensures safe, ethical, and legally compliant care
Case 7e – Eye Conditions (Conjunctivitis, Stye, Blepharitis)
Diagnosis:
Conjunctivitis: viral, bacterial, or allergic
Stye (hordeolum)
Blepharitis (anterior or posterior)
Patient Presentation / Wordings:
Conjunctivitis: “My eyes are red, itchy, and watery. Sometimes I have a pus discharge.”
Stye: “I have a painful swelling on my eyelid, near the lash line.”
Blepharitis: “My eyelids are red, itchy, with crusting around lashes.”
Examination / Assessment:
Inspect eyelids, conjunctiva, cornea
Check for discharge, swelling, and tenderness
Visual acuity assessment
Rule out keratitis or uveitis (photophobia, blurred vision, severe pain)
Laboratory / Investigations (if indicated):
Swab for culture if bacterial conjunctivitis is severe or resistant
Slit-lamp examination if referral required
Treatment / Prescription / Management:
A. Conjunctivitis:
Viral: supportive care — artificial tears, cold compresses
Bacterial: topical antibiotics
Chloramphenicol 0.5% eye drops, 1 drop every 2–4 hours for 5–7 days
Allergic: antihistamine drops
Olopatadine 0.1% one drop twice daily
B. Stye (Hordeolum):
Warm compresses 10–15 minutes, 3–4 times daily
Topical antibiotic ointment if secondary bacterial infection (e.g., erythromycin 0.5% ointment 3 times daily)
C. Blepharitis:
Eyelid hygiene: warm compresses, gentle lid scrubs with diluted baby shampoo
Topical antibiotic ointment if bacterial involvement (e.g., erythromycin 0.5% twice daily for 7–10 days)
Artificial tears for associated dryness
Expected Side Effects:
Eye drops/ointment: mild stinging, redness, irritation
Antibiotics: rare allergic reaction
Warm compresses: mild transient discomfort
Monitoring & Follow-Up:
Improvement within 3–5 days for bacterial conjunctivitis
Stye: resolution in 1–2 weeks
Blepharitis: chronic, may require ongoing lid hygiene
Monitor vision, pain, discharge
Referral Criteria:
Severe pain, photophobia, or reduced vision (suspect keratitis, glaucoma, or ulcer)
Recurrent or non-resolving stye/blepharitis
Corneal involvement or suspected malignancy
Patient Instructions:
Wash hands before touching eyes
Avoid contact lens use during infection
Apply warm compresses as instructed
Complete full course of drops/ointments if prescribed
Legal/Ethical Justification:
Initial assessment and treatment of common eye conditions is within Family Medicine scope
Referral of sight-threatening or complicated cases ensures safe, ethical, and legally compliant care
Case 7f – Eye Foreign Body Removal
Diagnosis:
Superficial corneal or conjunctival foreign body
Patient Presentation / Wordings:
“Something is in my eye; it feels scratchy or painful.”
“My eye is red, watery, and I feel discomfort when blinking.”
Examination / Assessment:
Visual acuity check
Slit-lamp examination if available
Inspect for corneal abrasion or embedded foreign body
Fluorescein staining to assess corneal epithelial defect
Laboratory / Investigations (if indicated):
None for routine superficial foreign bodies
Referral if suspected intraocular foreign body (penetrating trauma)
Treatment / Management:
A. Superficial Conjunctival/Corneal Foreign Body:
Topical anesthetic drops for comfort
Removal with sterile cotton swab, irrigation with saline, or sterile needle if trained
Check for rust ring in metallic foreign body; may require ophthalmology removal
B. Post-Removal Care:
Topical antibiotic drops (e.g., Chloramphenicol 0.5%, 1 drop 3–4 times daily for 5–7 days)
Lubricating artificial tears to promote healing
Expected Side Effects:
Mild discomfort, tearing, redness after removal
Rare: corneal abrasion or secondary infection
Monitoring & Follow-Up:
Reassess in 24–48 hours for symptom resolution
Monitor visual acuity, pain, and signs of infection
Refer if persistent redness, pain, or vision changes
Referral Criteria:
Deep, penetrating, or intraocular foreign body
Rust ring not removable in clinic
Corneal ulceration or infection
Visual acuity deterioration
Patient Instructions:
Avoid rubbing eye
Use prescribed antibiotic drops as directed
Protect eye from dust or trauma
Report worsening pain, redness, or vision changes immediately
Legal/Ethical Justification:
Removal of superficial conjunctival or corneal foreign bodies is within Family Medicine scope if trained
Referral for deep or complicated cases ensures patient safety and legal compliance
Case 7g – Refractive Errors Screening
Diagnosis:
Myopia (nearsightedness)
Hyperopia (farsightedness)
Astigmatism
Presbyopia
Patient Presentation / Wordings:
“I have difficulty seeing distant/near objects clearly.”
“I squint to read or watch things far away.”
“I have eye strain or headaches when reading.”
Examination / Assessment:
Visual acuity testing using Snellen chart (distance)
Near vision testing with reading chart
Pin-hole test to differentiate refractive error from other causes
External eye exam: cornea, lens clarity, pupil reaction
Basic fundoscopy if trained
Laboratory / Investigations (if indicated):
Not typically required for routine refractive error
Referral for cycloplegic refraction if pediatric or complex case
Treatment / Management:
Prescription of corrective lenses (glasses or contact lenses) after formal refraction by optometrist/ophthalmologist
Patient education on proper lens use and eye care
Expected Side Effects / Notes:
Headache or eye strain if lenses not properly fitted
Contact lens irritation if hygiene inadequate
Monitoring & Follow-Up:
Re-evaluate vision annually or sooner if vision changes
Check for progression of myopia or presbyopia in adults
Refer for specialty care if unusual visual symptoms appear
Referral Criteria:
Children with amblyopia risk or strabismus
Sudden loss of vision or visual field defects
Suspected ocular pathology beyond refractive error
Inability to achieve normal visual acuity with correction
Patient Instructions:
Use prescribed corrective lenses consistently
Schedule regular eye exams
Protect eyes from prolonged strain and UV exposure
Legal/Ethical Justification:
Screening for refractive errors is within Family Medicine scope
Referral to optometry or ophthalmology ensures safe and accurate prescription and management
Case 7h – Red Eye
Diagnosis:
Conjunctivitis (viral, bacterial, allergic)
Corneal ulcer / keratitis
Acute angle-closure glaucoma (suspected if severe pain, blurred vision, halos)
Other causes: uveitis, scleritis (refer if suspected)
Patient Presentation / Wordings:
“My eye is red, painful, and watery.”
“I see halos around lights, have a headache, or blurred vision.”
“There is discharge or sensitivity to light.”
Examination / Assessment:
Visual acuity
External eye inspection: redness, discharge, corneal clarity
Pupillary reaction, intraocular pressure if trained
Fluorescein staining for corneal abrasions or ulcer
Look for systemic symptoms (fever, headache, nausea)
Laboratory / Investigations (if indicated):
Corneal scraping and culture if corneal ulcer suspected
Intraocular pressure measurement for glaucoma
Referral for slit-lamp examination if uncertain
Treatment / Management:
A. Mild Conjunctivitis (Viral/Allergic):
Supportive care: artificial tears, cold compresses
Oral/ocular antihistamines for allergic cases
B. Bacterial Conjunctivitis:
Chloramphenicol 0.5% eye drops, 1 drop 3–4 times daily for 5–7 days
C. Corneal Ulcer / Suspected Glaucoma / Severe Pain:
Immediate referral to ophthalmology; do not start topical steroids or other interventions without specialist supervision
Expected Side Effects / Notes:
Mild stinging with eye drops
Delay or mismanagement can lead to vision loss in ulcers or glaucoma
Monitoring & Follow-Up:
Reassess mild conjunctivitis in 48–72 hours
Monitor for worsening pain, vision changes, or purulent discharge
Ensure urgent ophthalmology referral if red flags present
Referral Criteria:
Severe pain, photophobia, decreased vision
Corneal ulcer, keratitis, or suspected glaucoma
Recurrent or non-resolving red eye
Any suspicion of sight-threatening condition
Patient Instructions:
Avoid rubbing the eye
Use prescribed drops as directed
Seek urgent care if vision changes, severe pain, or halos appear
Legal/Ethical Justification:
Initial evaluation and management of mild conjunctivitis is within Family Medicine scope
Prompt referral for red eye with warning signs ensures patient safety, preserves vision, and is legally and ethically compliant
VIII. CARDIOVASCULAR MEDICINE
Case 8a – Hypertension (All Grades)
Diagnosis:
Primary (essential) hypertension
Secondary hypertension if indicated by red flags
Patient Presentation / Wordings:
“My blood pressure readings are high.”
“I feel fine but was told my BP is elevated.”
Symptoms (if severe): headache, dizziness, palpitations, blurred vision
Examination / Assessment:
Measure BP on two separate occasions, both arms
Assess for target organ damage: heart, kidney, eyes, brain
BMI, waist circumference, cardiovascular risk factors
Fundoscopy for hypertensive retinopathy
Cardiac exam: heart sounds, murmurs, edema
Laboratory / Investigations:
CBC, electrolytes, renal function, fasting glucose, lipid profile
Urinalysis (proteinuria)
ECG for baseline cardiac status
Echocardiography if indicated (LVH, heart failure)
Further workup if secondary hypertension suspected
Treatment / Prescription / Management:
A. Lifestyle Measures (All Grades):
Low-salt diet (<2.3 g sodium/day)
Regular aerobic exercise (30 min/day, 5 days/week)
Weight reduction if overweight/obese
Limit alcohol, quit smoking
Stress management
B. Pharmacologic Therapy:
First-line (monotherapy or combination):
ACE inhibitor: Enalapril 5–20 mg orally once daily
ARB: Losartan 50–100 mg once daily
Thiazide diuretics: Hydrochlorothiazide 12.5–25 mg once daily
Calcium channel blocker: Amlodipine 5–10 mg once daily
Combination therapy:
If BP not controlled with single agent after 4–6 weeks
Example: ACE inhibitor + thiazide or CCB
Expected Side Effects:
ACE inhibitors: cough, hyperkalemia, rarely angioedema
ARBs: dizziness, hyperkalemia
Thiazides: hypokalemia, hyperuricemia
CCBs: peripheral edema, headache, flushing
Monitoring & Follow-Up:
BP check every 2–4 weeks until controlled
Electrolytes, renal function 1–2 times/year
Annual assessment for target organ damage
Referral Criteria:
Secondary hypertension suspicion (young age, resistant hypertension, abrupt onset)
Hypertensive crisis (BP >180/120 mmHg with organ damage)
Severe or resistant hypertension despite 3 medications
Patient Instructions:
Take medications as prescribed
Maintain lifestyle modifications
Monitor home BP if possible
Report symptoms like severe headache, chest pain, vision changes
Legal/Ethical Justification:
Diagnosis, lifestyle counseling, and pharmacologic management of uncomplicated hypertension is within Family Medicine scope
Early identification and referral of complicated or secondary hypertension ensures patient safety and legal compliance
Case 8b – Ischemic Heart Disease (IHD), Angina, Post-MI Follow-Up
Diagnosis:
Stable angina
Post-myocardial infarction (MI) management
Ischemic heart disease (IHD) risk assessment
Patient Presentation / Wordings:
“I have chest discomfort when exerting myself, relieved by rest.”
“I had a heart attack a few months ago and want follow-up.”
Symptoms may include dyspnea, fatigue, palpitations
Examination / Assessment:
Vital signs: BP, heart rate
Cardiac exam: heart sounds, murmurs, signs of heart failure
Peripheral pulses
Assess risk factors: diabetes, smoking, dyslipidemia, family history
Evaluate for post-MI complications: arrhythmias, heart failure
Laboratory / Investigations:
ECG: baseline and follow-up
Cardiac enzymes if acute symptoms
Lipid profile, fasting glucose
Echocardiography for ventricular function
Stress test if indicated for ischemia evaluation
Treatment / Prescription / Management:
A. Stable Angina / Secondary Prevention Post-MI:
Anti-anginal therapy:
Beta-blocker: Metoprolol 25–100 mg orally twice daily
Nitrate (sublingual): Glyceryl trinitrate 0.3–0.6 mg as needed
Calcium channel blocker (if beta-blocker contraindicated): Amlodipine 5–10 mg daily
Antiplatelet therapy:
Aspirin 75–100 mg daily
Clopidogrel 75 mg daily if dual therapy indicated
Lipid-lowering therapy:
Atorvastatin 20–40 mg daily
ACE inhibitor / ARB:
For post-MI, hypertension, or LV dysfunction: Enalapril 5–20 mg daily
B. Lifestyle Measures:
Low-salt, heart-healthy diet
Regular aerobic activity as tolerated
Smoking cessation, weight management
Stress reduction
Expected Side Effects:
Beta-blockers: bradycardia, fatigue
Nitrates: headache, dizziness
CCBs: peripheral edema, flushing
Statins: myalgia, rare liver enzyme elevation
Antiplatelets: GI upset, bleeding risk
Monitoring & Follow-Up:
Assess symptom control and exercise tolerance every 4–6 weeks initially
Monitor BP, heart rate, lipid profile, liver function for statins
ECG or stress test if symptoms recur
Referral Criteria:
Unstable angina (pain at rest, crescendo angina)
Recurrent post-MI chest pain
Heart failure symptoms: dyspnea, edema
Suspected arrhythmia or ischemic complications
Patient Instructions:
Take medications as prescribed and do not stop abruptly
Recognize angina warning signs and seek urgent care if pain persists >15 minutes
Maintain lifestyle modifications
Attend all follow-up appointments
Legal/Ethical Justification:
Family physicians can manage stable angina and routine post-MI follow-up
Referral for acute coronary syndrome or complicated post-MI cases ensures patient safety and medico-legal compliance
Case 8c – Palpitations / Arrhythmias
Diagnosis:
Supraventricular tachycardia (SVT)
Atrial fibrillation (AF)
Premature atrial or ventricular contractions (PACs/PVCs)
Sinus tachycardia or bradycardia
Patient Presentation / Wordings:
“I feel my heart racing or skipping beats.”
“I have sudden episodes of fast heartbeat, sometimes with dizziness.”
“My heart feels irregular.”
Examination / Assessment:
Vital signs: heart rate, BP, orthostatic changes
Cardiac auscultation for irregular rhythm, murmurs
Assess for symptoms: syncope, chest pain, dyspnea, palpitations triggers
Check thyroid status and medications that may induce arrhythmia
Laboratory / Investigations:
ECG for rhythm diagnosis
Holter monitor if intermittent palpitations
Electrolytes, thyroid function tests
Echocardiography if structural heart disease suspected
Treatment / Prescription / Management:
A. Initial Management (Stable Patient):
Identify and remove triggers (caffeine, alcohol, stimulants, medications)
Reassurance for benign palpitations (PACs/PVCs)
Beta-blockers (e.g., Metoprolol 25–50 mg orally twice daily) if symptomatic
B. Specific Arrhythmias:
Atrial Fibrillation:
Rate control: Beta-blocker or CCB (if not contraindicated)
Anticoagulation if CHA₂DS₂-VASc score ≥2 (refer for initiation)
SVT:
Vagal maneuvers initially
Beta-blockers if recurrent
Referral for cardiology if frequent or unstable
Expected Side Effects:
Beta-blockers: bradycardia, fatigue, dizziness
CCBs: hypotension, peripheral edema
Monitoring & Follow-Up:
ECG follow-up for rhythm monitoring
Monitor BP and heart rate
Review symptoms and triggers at each visit
Adjust therapy based on response and side effects
Referral Criteria:
Syncope, severe palpitations, chest pain, or shortness of breath
Hemodynamically unstable arrhythmia
Recurrent or resistant arrhythmias requiring advanced therapy (ablation, anticoagulation management)
Suspicion of structural heart disease
Patient Instructions:
Record palpitations: timing, duration, triggers
Avoid stimulants and medications that may worsen arrhythmia
Seek urgent care for severe dizziness, syncope, or chest pain
Attend follow-up appointments and ECGs as advised
Legal/Ethical Justification:
Initial evaluation, ECG interpretation, and management of benign arrhythmias is within Family Medicine scope
Referral for complex or high-risk arrhythmias ensures patient safety and medico-legal compliance
Case 8d – Heart Failure
Diagnosis:
Heart failure with reduced ejection fraction (HFrEF)
Heart failure with preserved ejection fraction (HFpEF)
Mild, moderate, or severe based on symptoms and functional status (NYHA I–IV)
Patient Presentation / Wordings:
“I get short of breath when climbing stairs or walking.”
“I have swelling in my legs or ankles.”
“I feel fatigued and tire easily.”
Examination / Assessment:
Vital signs: BP, heart rate, oxygen saturation
Cardiac exam: S3/S4, murmurs, jugular venous distension
Respiratory exam: crackles, basal rales
Peripheral edema, ascites, weight gain
Assess functional capacity (NYHA classification)
Laboratory / Investigations:
CBC, electrolytes, renal function, BNP/NT-proBNP if available
ECG
Echocardiography for ejection fraction and structural abnormalities
Chest X-ray if pulmonary congestion suspected
Treatment / Prescription / Management:
A. Mild Heart Failure (NYHA I–II, Stable):
ACE inhibitors / ARBs: Enalapril 5–20 mg daily
Beta-blockers: Carvedilol 3.125–25 mg twice daily or Metoprolol succinate 25–200 mg daily
Diuretics (if fluid retention): Furosemide 20–40 mg orally once daily, titrate as needed
Aldosterone antagonists: Spironolactone 25 mg daily if EF <35% and symptomatic
Lifestyle: sodium restriction, fluid monitoring, daily weight, exercise as tolerated
B. Severe / Decompensated Heart Failure:
Immediate referral to cardiology or emergency care
Consider IV diuretics, inotropes, or advanced therapies
Expected Side Effects:
ACE inhibitors: cough, hyperkalemia, hypotension
Beta-blockers: bradycardia, fatigue
Diuretics: electrolyte imbalance, dehydration
Spironolactone: hyperkalemia, gynecomastia
Monitoring & Follow-Up:
Weight monitoring daily to detect fluid retention
BP, renal function, electrolytes periodically
Symptom review: dyspnea, edema, fatigue
Adjust medications based on tolerance and response
Referral Criteria:
NYHA III–IV symptoms
Pulmonary edema, hypotension, or hypoxia
Rapidly worsening symptoms
Need for advanced therapies (device, transplant, IV therapy)
Patient Instructions:
Daily weight and fluid monitoring
Adhere strictly to medications
Report sudden weight gain (>2 kg in 2 days), worsening shortness of breath, or leg swelling
Maintain low-salt diet and activity as advised
Legal/Ethical Justification:
Family physicians can manage mild, stable heart failure
Referral of severe or decompensated heart failure ensures patient safety and medico-legal compliance
Case 8e – Peripheral Vascular Disease / Edema Evaluation
Diagnosis:
Peripheral arterial disease (PAD) / PVD
Venous insufficiency
Generalized or localized edema
Patient Presentation / Wordings:
“My legs hurt when walking and feel tired or crampy.”
“I notice swelling in my ankles and feet, especially at the end of the day.”
“My legs feel cold or numb, or I have skin changes.”
Examination / Assessment:
Inspect lower limbs: color, hair loss, ulcers, varicosities
Palpate pulses: dorsalis pedis, posterior tibial, popliteal
Measure ankle-brachial index (ABI) if available
Check for pitting edema, symmetry, and distribution
Assess for signs of heart, kidney, or liver disease contributing to edema
Laboratory / Investigations:
CBC, renal function, electrolytes
Lipid profile, fasting glucose
Doppler ultrasound of lower limbs if PVD suspected
Echocardiography if heart failure suspected
Treatment / Prescription / Management:
A. Peripheral Arterial Disease / PVD:
Lifestyle: smoking cessation, regular exercise (supervised walking program)
Antiplatelet therapy: Aspirin 75–100 mg daily
Statins: Atorvastatin 20–40 mg daily
Control hypertension and diabetes
B. Venous Insufficiency / Edema:
Compression stockings 20–30 mmHg during the day
Leg elevation when resting
Exercise: walking to improve calf pump function
C. Pharmacologic:
Diuretics for symptomatic edema if fluid overload (Furosemide 20–40 mg orally daily, titrate as needed)
Avoid unnecessary long-term diuretics in PVD
Expected Side Effects:
Aspirin: GI irritation, bleeding
Statins: myalgia, rare liver enzyme elevation
Diuretics: electrolyte imbalance, dehydration
Compression stockings: discomfort if improperly fitted
Monitoring & Follow-Up:
Assess symptom improvement: claudication distance, edema reduction
Monitor BP, renal function, electrolytes if on diuretics
Evaluate for progression of skin changes or ulcers
Referral Criteria:
Severe or progressive claudication limiting activities
Non-healing ulcers or gangrene
Suspected deep vein thrombosis (DVT)
Symptomatic edema not explained by PVD/venous insufficiency (consider cardiac, renal, hepatic causes)
Patient Instructions:
Daily foot and leg inspection
Wear compression stockings as advised
Elevate legs when resting
Report new pain, color changes, ulcers, or sudden swelling
Legal/Ethical Justification:
Family physicians can evaluate and manage mild PVD and edema
Referral for advanced vascular disease or unexplained edema ensures safe, ethical, and legally compliant care
IX. RESPIRATORY MEDICINE
Case 9a – Asthma and COPD Management
Diagnosis:
Asthma (intermittent, mild, moderate, severe)
Chronic Obstructive Pulmonary Disease (COPD)
Patient Presentation / Wordings:
Asthma: “I have wheezing, shortness of breath, chest tightness, or cough, worse at night or with triggers.”
COPD: “I have a chronic cough with sputum and shortness of breath that worsens on exertion.”
Examination / Assessment:
Vital signs: BP, heart rate, respiratory rate, SpO₂
Respiratory exam: wheezing, prolonged expiration, accessory muscle use
Peak flow measurement (for asthma)
Evaluate smoking history, occupational exposures
Laboratory / Investigations:
Spirometry (diagnosis and severity assessment)
Chest X-ray if first presentation or suspected complication
Oxygen saturation (pulse oximetry)
Sputum analysis if infection suspected
Treatment / Prescription / Management:
A. Asthma:
Relievers (PRN):
Salbutamol inhaler 100–200 mcg, 1–2 puffs every 4–6 hours as needed
Controllers:
Low-dose inhaled corticosteroid (ICS): Budesonide 200–400 mcg twice daily
Add long-acting beta-agonist (LABA) if moderate–severe: Formoterol 12–24 mcg twice daily
Other:
Patient education, trigger avoidance, inhaler technique
B. COPD:
Mild–Moderate:
Short-acting bronchodilator (Salbutamol 100–200 mcg PRN)
Moderate–Severe:
Long-acting bronchodilator (Tiotropium 18 mcg daily or LABA inhaler)
Add ICS if frequent exacerbations
Expected Side Effects:
Inhaled beta-agonists: tremor, palpitations
ICS: oral thrush, hoarseness
Tiotropium: dry mouth, rare urinary retention
Monitoring & Follow-Up:
Symptom diary and peak flow (asthma)
Spirometry yearly or if symptoms worsen
Review inhaler technique, adherence, and exacerbations
Referral Criteria:
Frequent exacerbations or poor control despite therapy
Severe symptoms: SpO₂ <90%, hypercapnia, cyanosis
Diagnostic uncertainty (e.g., atypical imaging or overlap syndromes)
Need for pulmonary rehabilitation or oxygen therapy
Patient Instructions:
Avoid triggers: allergens, smoke, occupational dust
Use inhaler correctly and carry reliever at all times
Seek urgent care for severe dyspnea, cyanosis, or inability to speak full sentences
Legal/Ethical Justification:
Family physicians can manage mild–moderate asthma and COPD
Referral of severe, uncontrolled, or atypical cases ensures patient safety and medico-legal compliance
Case 9b – Acute Bronchitis / Mild–Moderate Pneumonia
Diagnosis:
Acute bronchitis (usually viral)
Community-acquired pneumonia (mild–moderate, outpatient management)
Patient Presentation / Wordings:
Acute bronchitis: “I have a cough, sometimes with sputum, mild fever, and fatigue for 1–2 weeks.”
Pneumonia: “I have cough, fever, shortness of breath, sometimes chest discomfort.”
Examination / Assessment:
Vital signs: temperature, BP, heart rate, respiratory rate, SpO₂
Respiratory exam: crackles, wheezes, decreased breath sounds
Assess severity: ability to eat, drink, ambulate, SpO₂ ≥90%
Rule out red flags: high fever, confusion, hypotension, tachypnea
Laboratory / Investigations:
Chest X-ray if pneumonia suspected
Pulse oximetry
CBC if bacterial infection suspected
Sputum culture if severe or non-resolving
Treatment / Prescription / Management:
A. Acute Bronchitis (Viral):
Supportive care: fluids, rest, humidified air
Analgesics / antipyretics: Paracetamol 500–1000 mg every 6–8 hours
Cough suppressants only if troublesome at night: Dextromethorphan 10–20 mg up to 4 times daily
B. Mild–Moderate Community-Acquired Pneumonia:
First-line oral antibiotics:
Amoxicillin 1 g orally three times daily for 5–7 days
Alternative (allergic): Doxycycline 100 mg orally twice daily for 5–7 days or Azithromycin 500 mg day 1, then 250 mg daily days 2–5
Supportive care: fluids, rest, antipyretics
Expected Side Effects:
Antibiotics: GI upset, rash, diarrhea
Analgesics: mild GI upset
Dextromethorphan: dizziness, mild drowsiness
Monitoring & Follow-Up:
Reassess symptoms in 48–72 hours
Monitor temperature, respiratory status, SpO₂
Seek urgent care if worsening cough, shortness of breath, or high fever
Referral Criteria:
Severe pneumonia: SpO₂ <90%, hypotension, tachypnea >30/min
Complicated pneumonia (pleural effusion, empyema)
Immunocompromised patients or comorbidities
Failure to respond to first-line therapy
Patient Instructions:
Complete full course of antibiotics if prescribed
Stay hydrated, rest, and avoid smoking
Monitor breathing, fever, and general condition
Seek urgent care if severe dyspnea, chest pain, or confusion
Legal/Ethical Justification:
Family physicians can manage mild–moderate pneumonia and acute bronchitis
Referral of severe, complicated, or non-responsive cases ensures patient safety and legal compliance
Case 9c – Tuberculosis Screening and Referral
Diagnosis:
Suspected active pulmonary TB
Latent TB infection (screening)
Patient Presentation / Wordings:
“I have a cough lasting more than 2–3 weeks.”
“I have fever, night sweats, weight loss, or fatigue.”
History of TB exposure, immunosuppression, or travel to high-risk areas
Examination / Assessment:
Vital signs, weight, general condition
Respiratory exam: auscultation for crackles, decreased breath sounds
Assess risk factors: HIV, diabetes, malnutrition, close contacts
Evaluate for extrapulmonary TB if symptoms present
Laboratory / Investigations:
Sputum smear microscopy and culture for acid-fast bacilli (AFB)
GeneXpert MTB/RIF (if available) for rapid detection and rifampicin resistance
Chest X-ray
Tuberculin skin test (TST) or IGRA for latent TB screening
Treatment / Prescription / Management:
A. Screening / Suspected Latent TB:
No routine antibiotics; referral for TB program for latent TB therapy if indicated (e.g., Isoniazid preventive therapy)
B. Suspected or Confirmed Active TB:
Immediate referral to national TB program or pulmonology
Do not start empirical multi-drug TB therapy in clinic without program guidance
Educate patient on isolation, cough hygiene, and contact tracing
Expected Side Effects:
For latent or active TB treatment (to be initiated by specialist): hepatotoxicity, GI upset, peripheral neuropathy
Monitoring & Follow-Up:
Symptom monitoring until evaluation by TB program
Adherence and reporting once therapy is initiated under program
Referral Criteria:
Any suspected active TB (pulmonary or extrapulmonary)
Drug-resistant TB suspicion
Immunocompromised patients (HIV, transplant, chronic steroids)
Patient Instructions:
Cover mouth when coughing
Avoid close contact until evaluated
Attend all referral appointments
Report weight loss, fever, night sweats, or hemoptysis promptly
Legal/Ethical Justification:
Screening and identification of suspected TB is within Family Medicine scope
Referral to TB program ensures safe, standardized care and legal compliance for public health
Case 9d – COVID-19, Influenza, and Viral Respiratory Illness
Diagnosis:
COVID-19 (mild to moderate)
Seasonal influenza
Other viral respiratory infections
Patient Presentation / Wordings:
Fever, cough, sore throat, runny nose, fatigue
Shortness of breath (if severe COVID-19)
Body aches, headache, loss of taste or smell (COVID-19)
Examination / Assessment:
Vital signs: temperature, BP, heart rate, respiratory rate, SpO₂
Respiratory exam: breath sounds, accessory muscle use
Assess hydration, mental status, and comorbidities
Identify red flags: severe dyspnea, hypoxia, confusion
Laboratory / Investigations:
COVID-19 PCR or rapid antigen test
Influenza rapid antigen test if indicated
Pulse oximetry
Chest X-ray if severe symptoms or comorbidities
Treatment / Prescription / Management:
A. Mild Illness (Outpatient):
Symptomatic care:
Paracetamol 500–1000 mg every 6–8 hours for fever/pain
Adequate hydration and rest
Saline nasal drops/spray, throat lozenges
Antitussives only if necessary for sleep
B. COVID-19 Specific:
Isolation for recommended period (as per local guidelines)
Monitor SpO₂ at home; seek urgent care if <94% or worsening symptoms
Antivirals (e.g., Paxlovid) only if eligible and prescribed under protocol
C. Influenza:
Oseltamivir 75 mg orally twice daily for 5 days if within 48 hours of symptom onset and at-risk population
Expected Side Effects:
Paracetamol: rare liver toxicity if overdosed
Oseltamivir: nausea, vomiting
COVID-19 antivirals: GI upset, headache, drug interactions
Monitoring & Follow-Up:
Daily symptom check and temperature monitoring
Pulse oximetry if at-risk or older age
Reassess for red flags: worsening dyspnea, chest pain, confusion
Referral Criteria:
SpO₂ <94%, severe dyspnea, or respiratory distress
High-risk patients with comorbidities (cardiac, pulmonary, renal, immunosuppressed)
Persistent fever >5–7 days or complications (pneumonia, secondary infection)
Patient Instructions:
Maintain isolation and hygiene measures
Rest, hydrate, and take medications as advised
Seek urgent care if severe symptoms develop
Report worsening cough, breathing difficulty, or confusion immediately
Legal/Ethical Justification:
Family physicians can manage mild viral respiratory illnesses and provide guidance on isolation and supportive care
Referral for severe or high-risk cases ensures patient safety and legal/public health compliance
Case 9e – Occupational Lung Disease Screening
Diagnosis:
Suspected occupational lung disease (e.g., silicosis, asbestosis, coal worker’s pneumoconiosis, occupational asthma)
Early detection in at-risk workers
Patient Presentation / Wordings:
“I work in construction/mining/factory and have a cough or shortness of breath.”
“I notice wheezing, chest tightness, or fatigue at work.”
Asymptomatic workers may present for routine screening
Examination / Assessment:
Vital signs: BP, heart rate, respiratory rate, SpO₂
Respiratory exam: auscultate for crackles, wheezes, reduced breath sounds
Assess exercise tolerance, occupational history (duration, exposure type, protective equipment)
Evaluate for comorbidities
Laboratory / Investigations:
Chest X-ray (baseline and follow-up for fibrosis or nodules)
Spirometry (lung function assessment)
High-resolution CT if abnormal findings on X-ray or high suspicion
Pulse oximetry
Treatment / Prescription / Management:
No pharmacologic therapy for asymptomatic screening
Preventive measures:
Use personal protective equipment (PPE) and masks
Reduce exposure to dust, fumes, or chemicals
Smoking cessation counseling
Expected Side Effects / Notes:
Screening is non-invasive; minimal risk from X-ray radiation
Early detection allows timely intervention before irreversible lung damage
Monitoring & Follow-Up:
Repeat spirometry and chest X-ray periodically (frequency depends on exposure and guidelines)
Monitor for symptoms: cough, dyspnea, wheezing
Education on early reporting of respiratory symptoms
Referral Criteria:
Abnormal spirometry or imaging
Symptomatic workers (cough, dyspnea, hemoptysis)
Progressive or disabling disease
Suspected occupational asthma or interstitial lung disease
Patient Instructions:
Use PPE consistently at work
Avoid smoking and environmental lung irritants
Report new respiratory symptoms promptly
Attend follow-up screening appointments
Legal/Ethical Justification:
Screening for occupational lung disease is within Family Medicine scope
Referral of symptomatic or abnormal cases ensures patient safety, early intervention, and compliance with occupational health regulations
Case 9f – Smoking Cessation Programs
Diagnosis:
Tobacco use disorder / nicotine dependence
Patient Presentation / Wordings:
“I want to quit smoking but find it difficult.”
“I have been smoking for years and want help to stop.”
Examination / Assessment:
Assess smoking history: duration, quantity, type of tobacco
Evaluate nicotine dependence (e.g., Fagerström test)
Screen for comorbidities: cardiovascular disease, COPD, depression
Motivation and readiness to quit
Laboratory / Investigations:
Optional: baseline lung function (spirometry)
Optional: carbon monoxide breath test for counseling motivation
Treatment / Prescription / Management:
A. Behavioral Interventions:
Motivational interviewing
Structured counseling (individual or group)
Identify triggers and coping strategies
Set quit date and follow-up plan
B. Pharmacologic Therapy (if indicated):
Nicotine Replacement Therapy (NRT):
Patch: 21 mg/day for 6 weeks, then taper
Gum: 2 mg or 4 mg as needed, up to 24 pieces/day
Non-Nicotine Medications:
Bupropion SR 150 mg daily for 3 days, then 150 mg twice daily for 7–12 weeks
Varenicline 0.5 mg daily for 3 days, then 0.5 mg twice daily for 4 days, then 1 mg twice daily for 12 weeks
Expected Side Effects:
NRT: mild skin irritation (patch), mouth irritation (gum)
Bupropion: insomnia, dry mouth, rare seizures
Varenicline: nausea, vivid dreams, mood changes
Monitoring & Follow-Up:
Weekly contact in first month, then monthly
Monitor withdrawal symptoms, adherence, side effects
Reinforce behavioral strategies and motivation
Repeat spirometry or CO test as motivational feedback
Referral Criteria:
Severe nicotine dependence not responding to first-line therapy
Psychiatric comorbidities requiring specialist support
Pregnant or breastfeeding women (specialist guidance for pharmacotherapy)
Patient Instructions:
Set a quit date and prepare support system
Use prescribed medications as directed
Avoid triggers and high-risk situations for relapse
Seek help promptly if severe cravings or mood changes occur
Legal/Ethical Justification:
Smoking cessation counseling and first-line pharmacotherapy are within Family Medicine scope
Referral for complex cases or special populations ensures safe, ethical, and legally compliant care
X. GASTROENTEROLOGY
Case 10a – Dyspepsia / GERD / Gastritis / Peptic Ulcer Disease (PUD)
Diagnosis:
Non-ulcer dyspepsia
Gastroesophageal reflux disease (GERD)
Gastritis
Peptic ulcer disease (H. pylori–related or NSAID-induced)
Patient Presentation / Wordings:
“I have burning in my chest or upper abdomen, especially after meals.”
“I feel bloated, nauseated, or have early satiety.”
“I notice black stools or vomit that looks like coffee grounds.”
Examination / Assessment:
Vital signs
Abdominal exam: epigastric tenderness, organomegaly
Evaluate for alarm features: weight loss, anemia, vomiting, GI bleeding
Assess NSAID or aspirin use, alcohol, smoking
Laboratory / Investigations:
CBC (anemia), liver function tests
H. pylori testing: urea breath test, stool antigen, or serology
Upper GI endoscopy if alarm features present
Treatment / Prescription / Management:
A. Lifestyle Measures:
Avoid spicy, fatty, acidic foods
Avoid alcohol, caffeine, smoking
Elevate head of bed for GERD
Weight reduction if overweight
B. Pharmacologic Therapy:
Proton Pump Inhibitors (PPI):
Omeprazole 20 mg orally once daily before breakfast for 4–8 weeks
H2-Receptor Antagonist (alternative):
Ranitidine 150 mg orally twice daily (if PPI not tolerated)
H. pylori Eradication (if positive):
Standard triple therapy:
Amoxicillin 1 g twice daily
Clarithromycin 500 mg twice daily
Omeprazole 20 mg twice daily
Duration: 14 days
Expected Side Effects:
PPIs: headache, diarrhea, rare hypomagnesemia
Antibiotics: GI upset, diarrhea, allergic reactions
Monitoring & Follow-Up:
Symptom review after 4–8 weeks
Test-of-cure H. pylori testing 4 weeks after therapy
Monitor for GI bleeding signs: melena, hematemesis
Referral Criteria:
Alarm features: unexplained weight loss, anemia, vomiting, bleeding
Non-responsive symptoms despite 8 weeks of therapy
Suspicion of malignancy or complicated ulcer (perforation, obstruction)
Patient Instructions:
Take medications as prescribed
Avoid triggers and NSAIDs
Report black stools, vomiting blood, or worsening pain
Legal/Ethical Justification:
Family physicians can manage uncomplicated dyspepsia, GERD, and H. pylori therapy
Referral for alarm features ensures safe, ethically, and legally compliant care
Case 10b – Constipation / Diarrhea / IBS / Hemorrhoids
Diagnosis:
Functional constipation
Acute or chronic diarrhea
Irritable bowel syndrome (IBS, constipation- or diarrhea-predominant)
Hemorrhoids (internal or external)
Patient Presentation / Wordings:
Constipation: “I have infrequent bowel movements, hard stools, or straining.”
Diarrhea: “I have loose, watery stools, sometimes with urgency.”
IBS: “I have abdominal pain relieved by bowel movements with alternating constipation and diarrhea.”
Hemorrhoids: “I notice bright red blood on toilet paper or a lump at the anus.”
Examination / Assessment:
Abdominal exam: tenderness, distension, masses
Rectal exam: hemorrhoids, anal fissures, occult blood
Evaluate for red flags: weight loss, anemia, nocturnal symptoms, blood in stool
Laboratory / Investigations:
CBC, electrolytes if chronic or severe symptoms
Stool analysis: culture, ova & parasites, C. difficile toxin if indicated
Colonoscopy if red flags present or age >50
Treatment / Prescription / Management:
A. Constipation:
Dietary fiber: Psyllium 3–5 g orally 1–3 times daily
Osmotic laxatives: Lactulose 15–30 mL orally once daily
Lifestyle: hydration, regular exercise
B. Diarrhea:
Oral rehydration solution (ORS)
Loperamide 2 mg orally after first loose stool, max 8 mg/day for adults (not for bloody diarrhea or infection suspected)
Avoid anti-motility drugs if infection suspected
C. IBS:
Symptom-targeted therapy:
Constipation-predominant: fiber, osmotic laxatives
Diarrhea-predominant: loperamide as above
Antispasmodics: Hyoscine butylbromide 10 mg orally up to 3 times daily
D. Hemorrhoids:
Topical treatments: Hydrocortisone 1% cream 2–3 times daily for 1 week
Sitz baths, high-fiber diet, hydration
Expected Side Effects:
Fiber: bloating, flatulence
Laxatives: cramping, diarrhea
Loperamide: constipation, dizziness
Topical hydrocortisone: local irritation
Monitoring & Follow-Up:
Symptom review after 1–2 weeks
Monitor for red flags: rectal bleeding, anemia, weight loss
Ensure hydration and stool consistency improvement
Referral Criteria:
Red flags: rectal bleeding, unexplained weight loss, anemia, nocturnal diarrhea
Severe or refractory IBS
Complicated hemorrhoids (thrombosed, prolapsed)
Patient Instructions:
Increase fiber and fluids gradually
Maintain regular bowel habits
Use medications as prescribed and avoid overuse
Report persistent blood in stool, severe pain, or change in bowel habits
Legal/Ethical Justification:
Family physicians can manage functional constipation, diarrhea, IBS, and uncomplicated hemorrhoids
Referral for red-flag conditions ensures patient safety and medico-legal compliance
Case 10c – Hepatitis Screening (A, B, C) and Follow-Up
Diagnosis:
Screening for viral hepatitis A, B, and C
Follow-up for chronic hepatitis carriers
Patient Presentation / Wordings:
“I want to be screened for hepatitis.”
“I had a needle stick or blood transfusion in the past.”
“I have risk factors like unsafe injections, tattoos, or multiple sexual partners.”
Examination / Assessment:
Vital signs
General exam: jaundice, pallor, hepatomegaly
Assess risk factors: travel, occupational exposure, sexual history, family history
Laboratory / Investigations:
Hepatitis A: Anti-HAV IgM for acute, Anti-HAV IgG for immunity
Hepatitis B: HBsAg, anti-HBs, anti-HBc (total and IgM)
Hepatitis C: Anti-HCV antibodies, HCV RNA PCR if positive
Liver function tests (ALT, AST, bilirubin, ALP, albumin)
Treatment / Prescription / Management:
A. Screening / Preventive Measures:
Vaccination:
Hepatitis A: 2 doses, 6 months apart
Hepatitis B: 3 doses (0, 1, 6 months)
Counsel on safe injections, safe sex, avoiding sharing needles
B. Follow-Up for Chronic Carriers:
Monitor liver function tests every 6–12 months
Ultrasound of liver annually for high-risk patients (cirrhosis, HBV/HCV carriers)
Referral to gastroenterology/hepatology for:
Positive HBsAg or HCV RNA
Evidence of cirrhosis or elevated ALT/AST
Expected Side Effects:
Vaccines: mild fever, injection site pain, transient malaise
Routine monitoring: minimal risk
Monitoring & Follow-Up:
Regular liver function tests and viral load if positive
Monitor for symptoms of liver disease: jaundice, abdominal swelling, fatigue
Reinforce lifestyle measures: avoid alcohol, hepatotoxic drugs
Referral Criteria:
Positive HBsAg or HCV RNA
Evidence of liver fibrosis or cirrhosis
Persistent ALT elevation or symptomatic hepatitis
Complications: hepatocellular carcinoma suspicion
Patient Instructions:
Complete vaccination schedule
Avoid sharing needles, practice safe sex
Attend follow-up for monitoring of chronic hepatitis
Report jaundice, abdominal swelling, or persistent fatigue
Legal/Ethical Justification:
Family physicians can perform screening, preventive counseling, and vaccination
Referral of confirmed or complicated hepatitis cases ensures safe, evidence-based care and legal compliance
Case 10d – Cholelithiasis and Pancreatitis
Diagnosis:
Cholelithiasis (gallstones, symptomatic or asymptomatic)
Acute pancreatitis (mild to severe)
Patient Presentation / Wordings:
Cholelithiasis: “I have intermittent right upper abdominal pain, sometimes after fatty meals.”
Pancreatitis: “I have severe upper abdominal pain radiating to the back, nausea, and vomiting.”
Examination / Assessment:
Vital signs: BP, pulse, temperature, respiratory rate
Abdominal exam: tenderness in right upper quadrant (RUQ), Murphy’s sign, distension, guarding
Assess hydration and hemodynamic stability
Check for jaundice, fever, or signs of peritonitis
Laboratory / Investigations:
CBC, serum amylase and lipase (pancreatitis)
Liver function tests, bilirubin, ALP
Serum electrolytes, renal function
Ultrasound abdomen: gallstones, biliary obstruction
CT scan if pancreatitis suspected and severity assessment needed
Treatment / Prescription / Management:
A. Cholelithiasis (Symptomatic, Uncomplicated):
Pain management:
Paracetamol 500–1000 mg every 6–8 hours
NSAIDs if no contraindication: Ibuprofen 400 mg orally every 8 hours
Low-fat diet advice
Referral to surgery for elective cholecystectomy if recurrent or complicated
B. Acute Pancreatitis (Initial Stabilization before Referral):
Nil per mouth (NPO) for initial period
IV fluids: Ringer’s lactate 2–4 L/day, adjusted to hemodynamics
Analgesia: IV or oral opioids (e.g., Morphine 2–5 mg IV or Tramadol 50 mg orally as needed)
Antiemetics: Ondansetron 4 mg IV or orally every 8 hours
Monitor vitals, urine output, electrolytes
Admit or refer to hospital for further management
Expected Side Effects:
NSAIDs: GI irritation, bleeding risk
Opioids: constipation, nausea, sedation
IV fluids: electrolyte imbalance if excessive
Monitoring & Follow-Up:
Symptom relief and pain control
Monitor for fever, hypotension, tachycardia
Monitor labs: amylase, lipase, liver function, electrolytes
Referral Criteria:
All confirmed acute pancreatitis cases
Complicated cholelithiasis: cholecystitis, obstructive jaundice, cholangitis
Persistent severe pain, hemodynamic instability, or organ failure
Patient Instructions:
Avoid fatty meals and alcohol
Report worsening abdominal pain, fever, vomiting, or jaundice
Attend surgical or hospital referral promptly
Legal/Ethical Justification:
Family physicians can provide initial stabilization and analgesia
Referral for definitive care (surgery or hospitalization) ensures patient safety and medico-legal compliance
Case 10e – Malabsorption / Fatty Liver Disease / Obesity Counseling
Diagnosis:
Malabsorption syndromes (e.g., celiac disease, pancreatic insufficiency, post-infectious)
Non-alcoholic fatty liver disease (NAFLD)
Overweight / obesity
Patient Presentation / Wordings:
Malabsorption: “I have chronic diarrhea, bloating, weight loss, or nutrient deficiencies.”
Fatty liver: “I was told my liver enzymes are high” or “I have mild right upper abdominal discomfort.”
Obesity: “I want help losing weight” or BMI >25
Examination / Assessment:
Vital signs, BMI, waist circumference
Abdominal exam: hepatomegaly, tenderness
Signs of nutrient deficiencies: pallor, glossitis, skin changes, edema
Lifestyle assessment: diet, physical activity, alcohol consumption
Laboratory / Investigations:
CBC, electrolytes, liver function tests, lipid profile
Fasting glucose, HbA1c
Serum albumin, iron studies, vitamin B12, folate, vitamin D
Ultrasound liver for NAFLD
Specific tests as indicated: celiac serology, stool fat, pancreatic function
Treatment / Prescription / Management:
A. Malabsorption:
Treat underlying cause (e.g., gluten-free diet for celiac, pancreatic enzyme replacement)
Supplement deficiencies: iron, vitamin D, calcium, B12, folate as needed
Dietary counseling for balanced intake
B. Fatty Liver Disease (NAFLD):
Weight loss 5–10% body weight gradually
Control metabolic risk factors: diabetes, dyslipidemia
Avoid alcohol and hepatotoxic drugs
Consider vitamin E or other hepatoprotective therapy only under specialist guidance
C. Obesity Counseling:
Lifestyle modification: balanced diet, caloric restriction, regular aerobic and resistance exercise
Behavioral interventions: goal-setting, food diary, motivational support
Pharmacotherapy if BMI ≥30 or ≥27 with comorbidities (Orlistat 120 mg TID with meals, specialist review recommended)
Expected Side Effects:
Vitamin supplements: GI upset if high doses
Orlistat: oily stools, abdominal cramps, flatulence
Lifestyle changes: initial muscle soreness
Monitoring & Follow-Up:
Weight, BMI, waist circumference monthly
Liver function tests, lipid profile, glucose every 3–6 months
Nutrient levels if supplementation is ongoing
Assess adherence to diet and exercise plans
Referral Criteria:
Severe malabsorption or nutritional deficiency
Cirrhosis, fibrosis, or rapidly worsening liver function
Obesity not responding to lifestyle interventions or needing bariatric evaluation
Patient Instructions:
Follow dietary and exercise recommendations
Avoid alcohol and hepatotoxic medications
Report new symptoms: jaundice, fatigue, persistent diarrhea, unexplained weight loss
Attend follow-up labs and appointments
Legal/Ethical Justification:
Family physicians can manage mild to moderate malabsorption, NAFLD, and obesity counseling
Referral for complex, severe, or resistant cases ensures safe, evidence-based, and legally compliant care
XI. NEPHROLOGY / UROLOGY
Case 11a – UTI / Renal Colic / Stones
Diagnosis:
Urinary tract infection (cystitis, uncomplicated)
Renal colic / ureteric stones
Patient Presentation / Wordings:
UTI: “I have burning urination, frequency, urgency, sometimes suprapubic pain.”
Renal colic: “I have severe flank pain radiating to my groin, sometimes nausea or vomiting.”
Examination / Assessment:
Vital signs: BP, pulse, temperature
Abdominal exam: costovertebral angle tenderness, suprapubic tenderness
Assess for fever, hemodynamic stability
Evaluate for red flags: sepsis, obstruction
Laboratory / Investigations:
Urinalysis: leukocytes, nitrites, hematuria
Urine culture if complicated or recurrent
Serum creatinine, electrolytes
Ultrasound or non-contrast CT if renal colic suspected
Treatment / Prescription / Management:
A. Uncomplicated UTI:
Nitrofurantoin 100 mg orally twice daily for 5 days
OR Fosfomycin 3 g orally single dose
Adequate hydration, analgesia (Paracetamol 500–1000 mg orally as needed)
B. Renal Colic / Stones:
Pain management: NSAIDs (Diclofenac 50 mg orally or IM TID) or opioids if severe
Hydration: oral or IV fluids as tolerated
Alpha-blockers (Tamsulosin 0.4 mg daily) to facilitate stone passage if indicated
Expected Side Effects:
Nitrofurantoin: nausea, rarely pulmonary reactions
NSAIDs: GI upset, renal impairment
Tamsulosin: dizziness, hypotension
Monitoring & Follow-Up:
Symptom resolution, urine sterility
Imaging follow-up for stone passage or obstruction
Monitor renal function if severe colic or recurrent stones
Referral Criteria:
Obstructed or infected stones
Persistent hematuria or pain
Recurrent or complicated UTIs
Renal function impairment
Patient Instructions:
Hydrate adequately
Complete full antibiotic course
Report fever, worsening pain, or inability to pass urine
Avoid nephrotoxic drugs without consultation
Legal/Ethical Justification:
Family physicians can manage uncomplicated UTI and mild renal colic
Referral of complicated, obstructed, or infected stones ensures safe, legally compliant care
Case 11b – Chronic Kidney Disease (CKD) Screening
Diagnosis:
Early or suspected CKD
At-risk patients: diabetes, hypertension, elderly, family history
Patient Presentation / Wordings:
Often asymptomatic: “I want to check my kidneys”
Mild fatigue, ankle swelling, nocturia may be reported
History of diabetes, hypertension, recurrent UTIs, or nephrotoxic drug use
Examination / Assessment:
Vital signs: BP, pulse
General exam: pallor, edema, skin changes
Abdominal exam: kidney palpation if possible
Cardiovascular assessment: for comorbidities
Laboratory / Investigations:
Serum creatinine, eGFR calculation
Urinalysis: proteinuria, hematuria, casts
Urine albumin-to-creatinine ratio (ACR)
Electrolytes, CBC if indicated
Blood pressure monitoring
Treatment / Prescription / Management:
A. Lifestyle & Risk Factor Control:
Blood pressure control (target <130/80 mmHg)
Glycemic control in diabetics
Avoid nephrotoxic drugs (NSAIDs, certain antibiotics)
Maintain hydration and healthy diet
B. Pharmacologic Interventions:
ACE inhibitors or ARBs for proteinuria / hypertension (e.g., Lisinopril 10–20 mg daily)
Statins if dyslipidemia present
Diuretics if edema or fluid overload
Expected Side Effects:
ACE inhibitors: cough, hyperkalemia, rarely angioedema
ARBs: hyperkalemia, hypotension
Diuretics: electrolyte imbalance, dehydration
Monitoring & Follow-Up:
eGFR and serum creatinine every 3–6 months
Urine protein/ACR annually or more frequently if elevated
Monitor electrolytes and BP
Referral Criteria:
eGFR <30 mL/min/1.73 m²
Rapid decline in renal function (>5 mL/min/yr)
Persistent proteinuria or hematuria
Resistant hypertension or CKD complications
Patient Instructions:
Attend regular lab follow-ups
Avoid nephrotoxic drugs and herbal supplements
Report swelling, reduced urine output, or fatigue
Maintain lifestyle modifications
Legal/Ethical Justification:
Family physicians can screen, identify, and manage early CKD
Referral for advanced or complicated cases ensures safe, evidence-based, and legally compliant care
Case 11c – Proteinuria / Hematuria Work-Up
Diagnosis:
Proteinuria (isolated or with CKD)
Hematuria (microscopic or macroscopic)
Possible glomerular or urologic causes
Patient Presentation / Wordings:
Proteinuria: “My urine test showed protein”
Hematuria: “I noticed blood in urine” or “Lab showed microscopic blood”
Often asymptomatic; may have edema, hypertension, or dysuria
Examination / Assessment:
Vital signs: BP, pulse
General exam: edema, pallor, rash (possible systemic causes)
Abdominal exam: kidney palpation, bladder exam
Examine for comorbidities: diabetes, hypertension, infections
Laboratory / Investigations:
Urinalysis: protein, RBCs, casts, infection
Urine protein-to-creatinine ratio or 24-hour urine protein
CBC, serum creatinine, eGFR, electrolytes
Urine culture if infection suspected
Ultrasound kidneys/bladder if structural cause suspected
Further work-up by nephrology if glomerular disease suspected
Treatment / Prescription / Management:
A. Initial Management (Family Physician):
Treat underlying infection if present (UTI)
Control BP (ACE inhibitors or ARBs) if proteinuria
Optimize glycemic control in diabetics
Hydration and lifestyle advice
B. Referral:
Persistent proteinuria or hematuria >3 months
Proteinuria >1 g/day or nephrotic-range
Hematuria with flank pain, clot, or structural abnormalities
Reduced eGFR or CKD progression
Expected Side Effects / Notes:
ACE inhibitors: cough, hyperkalemia
Observation and lifestyle measures: minimal risk
Monitoring & Follow-Up:
Recheck urinalysis and urine protein/creatinine ratio
Monitor renal function (eGFR, creatinine)
Monitor BP and comorbid conditions
Patient Instructions:
Maintain hydration
Report persistent blood in urine, swelling, or reduced urine output
Attend follow-up lab appointments
Avoid nephrotoxic drugs
Legal/Ethical Justification:
Family physicians can perform initial work-up and risk stratification
Referral for persistent or significant proteinuria/hematuria ensures safe, evidence-based care and medico-legal compliance
Case 11d – BPH / Prostatitis
Diagnosis:
Benign Prostatic Hyperplasia (BPH)
Acute or chronic prostatitis
Patient Presentation / Wordings:
BPH: “I have difficulty starting urination, weak stream, frequency, or nocturia.”
Prostatitis: “I have pelvic pain, dysuria, urinary frequency, sometimes fever or malaise.”
Examination / Assessment:
Vital signs: BP, pulse, temperature
Abdominal exam: bladder distension
Digital rectal exam (DRE): assess prostate size, tenderness, nodules
Evaluate for red flags: hematuria, recurrent infections, urinary retention
Laboratory / Investigations:
Urinalysis and urine culture
Serum creatinine and PSA if indicated
Ultrasound or post-void residual measurement in BPH
Consider prostate swab or semen analysis for chronic prostatitis
Treatment / Prescription / Management:
A. BPH:
Alpha-blockers: Tamsulosin 0.4 mg orally once daily
5-alpha-reductase inhibitors (for larger prostates or long-term therapy): Finasteride 5 mg orally once daily
Lifestyle: fluid management, avoid bladder irritants
B. Prostatitis:
Acute bacterial prostatitis:
Ciprofloxacin 500 mg orally twice daily for 2–4 weeks
Analgesics: Paracetamol 500–1000 mg orally as needed
Chronic bacterial prostatitis:
Fluoroquinolone (Ciprofloxacin 500 mg orally twice daily) for 4–6 weeks
Expected Side Effects:
Alpha-blockers: dizziness, hypotension, retrograde ejaculation
5-alpha-reductase inhibitors: decreased libido, erectile dysfunction
Fluoroquinolones: GI upset, tendonitis (rare), photosensitivity
Monitoring & Follow-Up:
Symptom score assessment (IPSS) for BPH
Urinalysis and culture post-treatment for prostatitis
Monitor renal function if urinary obstruction
Reassess PSA if elevated
Referral Criteria:
Acute urinary retention or obstructive complications
Recurrent or complicated prostatitis
Suspicion of prostate malignancy (nodules, rising PSA)
Hematuria or recurrent UTI despite therapy
Patient Instructions:
Take medications as prescribed
Maintain adequate hydration
Report fever, inability to urinate, or worsening urinary symptoms
Avoid excessive alcohol and bladder irritants
Legal/Ethical Justification:
Family physicians can manage uncomplicated BPH and prostatitis
Referral for complicated, obstructive, or malignant suspicion ensures safe, evidence-based, and legally compliant care
Case 11e – Urinary Catheterization
Indication / Diagnosis:
Acute urinary retention
Obstructive uropathy (BPH, urethral stricture, post-surgical)
Accurate urine output monitoring in critically ill patients
Patient Presentation / Wordings:
“I am unable to pass urine.”
“I have severe lower abdominal discomfort with no urination.”
“I have swelling or kidney issues requiring close urine monitoring.”
Examination / Assessment:
Vital signs: BP, pulse, temperature
Abdominal exam: distended bladder, suprapubic tenderness
Assess for contraindications: urethral trauma, severe urethral strictures
Evaluate mental status and patient cooperation
Laboratory / Investigations (if applicable):
Urinalysis if infection suspected
Renal function: serum creatinine, electrolytes
Ultrasound bladder scan (to confirm retention if available)
Procedure / Management:
Use sterile technique for catheter insertion (Foley or intermittent as indicated)
Lubricate and gently insert catheter; secure properly
Collect urine sample for culture if infection suspected
Monitor urine output and signs of infection
Expected Side Effects / Complications:
Local irritation or discomfort
Urinary tract infection (most common)
Urethral trauma, hematuria
Bladder spasms
Monitoring & Follow-Up:
Daily assessment for infection, catheter patency, and urine output
Monitor for fever, suprapubic pain, hematuria
Remove catheter as soon as clinically feasible
Referral Criteria:
Failed catheterization
Urethral trauma or strictures
Persistent urinary retention after catheterization
Recurrent infections despite proper catheter care
Patient Instructions:
Maintain hygiene around catheter site
Report fever, cloudy urine, or bleeding
Drink adequate fluids unless restricted
Avoid tugging or dislodging catheter
Legal/Ethical Justification:
Catheterization is within the scope of trained family physicians for initial management
Referral for complicated cases ensures patient safety and medico-legal compliance
XII. ENDOCRINOLOGY
Case 12a – Diabetes (Type 1, Type 2, Gestational)
Diagnosis:
Type 1 Diabetes Mellitus (autoimmune, insulin-dependent)
Type 2 Diabetes Mellitus (insulin resistance)
Gestational Diabetes Mellitus (GDM)
Patient Presentation / Wordings:
Polyuria, polydipsia, polyphagia, unexplained weight loss (Type 1)
Fatigue, blurred vision, recurrent infections, overweight (Type 2)
Detected during routine pregnancy screening (GDM)
Examination / Assessment:
Vital signs, BMI, waist circumference
Blood pressure measurement
Foot exam: neuropathy, ulcers, infections
Signs of insulin resistance (acanthosis nigricans)
Laboratory / Investigations:
Fasting blood glucose, HbA1c
Random blood glucose or OGTT for GDM
Urine microalbumin
Lipid profile
Kidney function (serum creatinine, eGFR)
Treatment / Prescription / Management:
A. Type 1 Diabetes:
Insulin therapy:
Basal-bolus regimen: e.g., Glargine once daily + rapid-acting insulin before meals
Blood glucose monitoring (self-monitoring SMBG)
Carbohydrate counting and dietary counseling
B. Type 2 Diabetes:
Lifestyle modification: diet, exercise, weight management
Oral hypoglycemics:
Metformin 500 mg orally twice daily, titrate to 1–2 g/day
Add additional agents (SGLT2 inhibitors, DPP-4 inhibitors) if target not achieved
C. Gestational Diabetes:
Diet and exercise first-line
Insulin if glucose targets not met
Monitor fetal growth and maternal glucose
Expected Side Effects:
Insulin: hypoglycemia, weight gain
Metformin: GI upset, rare lactic acidosis
SGLT2 inhibitors: UTI, dehydration
Sulfonylureas: hypoglycemia
Monitoring & Follow-Up:
HbA1c every 3–6 months
SMBG or home glucose monitoring
Annual retinal exam, foot exam, kidney function
Blood pressure and lipid profile monitoring
Referral Criteria:
Poorly controlled diabetes despite therapy
Complications: nephropathy, retinopathy, neuropathy
Type 1 or gestational diabetes requiring insulin initiation or adjustment
Patient Instructions:
Adhere to diet, exercise, and medication regimen
Monitor for hypoglycemia and hyperglycemia symptoms
Attend all scheduled follow-ups and lab testing
Foot care and infection prevention
Legal/Ethical Justification:
Family physicians can diagnose and manage uncomplicated diabetes
Referral for complications or complex insulin management ensures safe, evidence-based, and legally compliant care
Case 12b – Thyroid Disorders (Hypothyroidism & Hyperthyroidism)
Diagnosis:
Hypothyroidism (primary or secondary)
Hyperthyroidism (Graves’ disease, toxic nodular goiter)
Patient Presentation / Wordings:
Hypothyroidism: “I feel tired, cold, constipated, and my skin is dry.”
Hyperthyroidism: “I have palpitations, weight loss despite good appetite, tremors, heat intolerance, anxiety.”
Examination / Assessment:
Vital signs: BP, pulse, temperature
Thyroid exam: enlargement, nodules, tenderness
Signs of hypo: bradycardia, delayed reflexes, dry skin
Signs of hyper: tachycardia, tremors, goiter, exophthalmos (if Graves’)
Laboratory / Investigations:
TSH, Free T4, Free T3
Anti-thyroid antibodies if autoimmune suspected (TPO-Ab, TRAb)
ECG if arrhythmia suspected
Ultrasound thyroid if nodules or enlargement
Treatment / Prescription / Management:
A. Hypothyroidism:
Levothyroxine 25–100 µg orally once daily (adjust based on TSH)
Start low dose in elderly or cardiac disease, titrate gradually
B. Hyperthyroidism:
First-line: Anti-thyroid drugs
Methimazole 10–30 mg orally once daily
Propylthiouracil (PTU) 50–150 mg orally 2–3 times daily (especially in 1st trimester pregnancy)
Symptomatic control: Beta-blockers (Propranolol 10–40 mg orally TID) for palpitations, tremors
Expected Side Effects:
Levothyroxine: rare palpitations, insomnia if over-replaced
Methimazole/PTU: rash, agranulocytosis (rare), liver toxicity
Beta-blockers: bradycardia, hypotension, fatigue
Monitoring & Follow-Up:
TSH and Free T4 every 6–8 weeks after dose adjustment
CBC and liver function if on anti-thyroid drugs
Monitor symptoms: energy, heart rate, weight changes
Referral Criteria:
Thyroid nodules or suspicious masses
Pregnancy with uncontrolled hyperthyroidism
Severe or refractory hypo- or hyperthyroidism
Cardiac complications from thyroid disease
Patient Instructions:
Take levothyroxine on empty stomach, separate from calcium/iron supplements
Report fever, sore throat, jaundice, palpitations, or unexplained symptoms
Attend all lab follow-ups for dose adjustments
Legal/Ethical Justification:
Family physicians can manage uncomplicated thyroid disorders with lab guidance
Referral for nodules, pregnancy, or refractory cases ensures safe, legally compliant care
Case 12c – Adrenal and Pituitary Disorder Screening
Diagnosis / Screening:
Adrenal disorders: Addison’s disease, Cushing’s syndrome
Pituitary disorders: hypopituitarism, prolactinoma, acromegaly
Patient Presentation / Wordings:
Adrenal insufficiency: “I feel very tired, dizzy, crave salt, have darkening of skin, nausea.”
Cushing’s: “I notice weight gain, round face, abdominal striae, easy bruising.”
Pituitary disorders: “I have headaches, vision changes, menstrual irregularities, or galactorrhea.”
Examination / Assessment:
Vital signs: BP (orthostatic), pulse
General exam: skin pigmentation, bruising, striae
Abdominal exam: central obesity, fat distribution
Neurological: visual fields, cranial nerves
Assess for growth abnormalities, delayed puberty, galactorrhea
Laboratory / Investigations:
Morning cortisol, ACTH
Dexamethasone suppression test if Cushing suspected
Serum electrolytes, glucose, kidney function
Prolactin, TSH, LH, FSH, IGF-1 as indicated
MRI pituitary if mass suspected
Treatment / Prescription / Management:
A. Initial Screening and Risk Reduction (Family Physician):
Identify high-risk patients: long-term steroids, unexplained fatigue, growth or menstrual abnormalities
Correct reversible causes: electrolyte imbalances, optimize blood pressure
B. Referral:
Confirmed abnormal cortisol or pituitary hormone levels
Signs of mass effect (visual changes, severe headaches)
Severe electrolyte disturbances or adrenal crisis
Expected Side Effects / Notes:
Minimal during screening; lab tests generally safe
If initial steroid replacement is started prior to referral: monitor for hyperglycemia, fluid retention
Monitoring & Follow-Up:
Track symptoms: fatigue, blood pressure, weight changes
Repeat labs as indicated until specialist evaluation
Patient Instructions:
Report dizziness, severe weakness, nausea, visual changes
Avoid abrupt steroid withdrawal if on chronic steroids
Attend specialist referral promptly if tests are abnormal
Legal/Ethical Justification:
Family physicians can screen and identify adrenal or pituitary disorders
Early recognition and referral ensures safe, evidence-based, and legally compliant care
Case 12d – PCOS / Obesity / Metabolic Syndrome
Diagnosis:
Polycystic ovary syndrome (PCOS)
Obesity
Metabolic syndrome (abdominal obesity, dyslipidemia, hypertension, insulin resistance)
Patient Presentation / Wordings:
PCOS: “I have irregular periods, acne, excess hair growth, or difficulty conceiving.”
Obesity: “I want help losing weight.”
Metabolic syndrome: often asymptomatic; detected via labs or routine check-up
Examination / Assessment:
Vital signs: BP, pulse
BMI, waist circumference
Signs of hyperandrogenism: hirsutism, acne, alopecia
Assess for insulin resistance: acanthosis nigricans
Cardiovascular risk factors: dyslipidemia, hypertension
Laboratory / Investigations:
Fasting glucose, HbA1c
Lipid profile
Serum testosterone, LH, FSH, prolactin (if PCOS suspected)
Ultrasound pelvis for ovarian morphology
Liver function tests if NAFLD suspected
Treatment / Prescription / Management:
A. Lifestyle Modification (All Cases):
Diet: caloric restriction, balanced macronutrients
Exercise: at least 150 minutes/week aerobic + resistance training
Weight loss goal: 5–10% body weight over 6 months
B. PCOS Specific:
Combined oral contraceptives for menstrual regularity and hyperandrogenism
Metformin 500 mg orally once or twice daily if insulin resistance present
C. Metabolic Syndrome / Obesity:
Statins for dyslipidemia if indicated
Antihypertensives for elevated BP
Diabetes prevention: Metformin if impaired glucose tolerance or high-risk
Expected Side Effects:
Oral contraceptives: mild nausea, breast tenderness, rare thromboembolism
Metformin: GI upset, diarrhea, rarely lactic acidosis
Statins: myalgia, rarely elevated liver enzymes
Monitoring & Follow-Up:
Weight, BMI, waist circumference monthly
Fasting glucose, HbA1c, lipid profile every 3–6 months
Blood pressure at each visit
Monitor symptoms: menstrual regularity, hirsutism improvement
Referral Criteria:
Infertility or failure of PCOS treatment
Severe obesity needing bariatric or specialist management
Metabolic syndrome with complications (cardiovascular, diabetes)
Patient Instructions:
Adhere to lifestyle changes and prescribed medications
Track menstrual cycles and report irregularities
Attend lab and follow-up visits
Avoid smoking and limit alcohol
Legal/Ethical Justification:
Family physicians can manage mild to moderate PCOS, obesity, and metabolic syndrome
Referral for complex, resistant, or fertility-related cases ensures safe, evidence-based, and legally compliant care
XIII. NEUROLOGY
Case 13a – Headache (Migraine, Tension, Cluster)
Diagnosis:
Migraine (with or without aura)
Tension-type headache
Cluster headache
Patient Presentation / Wordings:
Migraine: “I have a throbbing, unilateral headache with nausea, sensitivity to light or sound.”
Tension: “I have a dull, pressure-like headache, often bilateral, worse with stress.”
Cluster: “I have severe, one-sided pain around the eye, often with tearing or nasal congestion, occurring in bouts.”
Examination / Assessment:
Vital signs, neurological exam
Fundoscopy to rule out raised ICP
Assess for red flags: sudden onset, neurological deficits, fever, vomiting, trauma
Laboratory / Investigations:
Usually clinical diagnosis
Neuroimaging (CT/MRI) if red flags or atypical features
Treatment / Prescription / Management:
A. Migraine:
Acute:
NSAIDs: Ibuprofen 400–600 mg orally as needed
Triptans (Sumatriptan 50–100 mg orally) if moderate/severe
Preventive (if ≥4 attacks/month): propranolol 40–80 mg orally daily, amitriptyline 10–25 mg at night
B. Tension Headache:
NSAIDs or acetaminophen as needed
Stress management, physiotherapy, posture correction
C. Cluster Headache:
Acute: Oxygen therapy 100% at 7–12 L/min for 15–20 min
Triptans (sumatriptan SC 6 mg) if oxygen unavailable
Preventive: verapamil 80–120 mg orally TID, titrate under supervision
Expected Side Effects:
NSAIDs: GI upset, rarely bleeding
Triptans: chest tightness, dizziness
Beta-blockers: bradycardia, fatigue
Monitoring & Follow-Up:
Track frequency, intensity, triggers of headaches
Monitor for medication overuse headaches
Adjust preventive therapy as needed
Referral Criteria:
Sudden-onset “thunderclap” headache
New neurological deficits
Headache in immunocompromised patient or with fever
Poor response to standard therapy
Patient Instructions:
Maintain headache diary
Avoid known triggers
Use medications as prescribed, not exceeding recommended doses
Seek urgent care for severe or atypical headache
Legal/Ethical Justification:
Family physicians can manage primary headaches and provide preventive therapy
Referral for red-flag or complicated cases ensures safe, evidence-based, and legally compliant care
Case 13b – Seizures (Stabilization, Initial Treatment, Referral)
Diagnosis:
First seizure or recurrent seizure disorder (epilepsy)
Status epilepticus (emergency)
Patient Presentation / Wordings:
“I had a sudden episode of convulsions and lost consciousness.”
“My child/adult shakes, stiffens, or falls suddenly, then becomes confused afterward.”
Examination / Assessment:
Vital signs: airway, breathing, circulation
Neurological exam post-ictal: orientation, strength, reflexes
Assess for trauma, tongue bite, incontinence
Identify provoking factors: fever, hypoglycemia, toxins, infection
Laboratory / Investigations:
Blood glucose, electrolytes
CBC, renal and liver function
Neuroimaging (CT/MRI) if new-onset seizure or abnormal exam
EEG for recurrent seizures
Treatment / Prescription / Management:
A. Acute Seizure / Status Epilepticus Stabilization:
Ensure airway, breathing, circulation
IV/IM benzodiazepine:
Lorazepam 4 mg IV slowly (repeat in 10–15 min if seizure continues)
Diazepam 10 mg IV or rectal if IV not available
Protect patient from injury
B. Chronic Seizure Management (after stabilization and referral):
Initiate antiepileptic drugs (AEDs) under specialist guidance:
Levetiracetam 500 mg orally twice daily (titrated)
Alternatively, sodium valproate 500–1000 mg/day (depending on age, sex, comorbidities)
Expected Side Effects:
Benzodiazepines: sedation, respiratory depression (monitor closely)
AEDs: dizziness, fatigue, GI upset, weight changes, liver enzyme elevation
Monitoring & Follow-Up:
Seizure frequency and triggers
Blood tests for AED therapy (liver, renal function)
Adherence to therapy and safety measures
Referral Criteria:
First seizure in adult or child
Status epilepticus or prolonged seizure >5 min
Neurological deficits, abnormal imaging, or refractory seizures
Suspected secondary cause (tumor, infection, trauma)
Patient Instructions:
Avoid driving or operating machinery until cleared
Take medications as prescribed; do not stop abruptly
Maintain seizure diary
Seek urgent care for prolonged seizures or injury
Legal/Ethical Justification:
Family physicians can stabilize acute seizures and initiate work-up
Referral for diagnosis confirmation, AED initiation, and monitoring ensures safe, legally compliant care
Case 13c – Stroke Recognition and Emergency Referral
Diagnosis:
Acute ischemic or hemorrhagic stroke
Transient ischemic attack (TIA)
Patient Presentation / Wordings:
“Sudden weakness or numbness on one side of my body.”
“I have slurred speech, facial droop, vision changes, or dizziness.”
Onset within minutes to hours
Examination / Assessment:
Vital signs: BP, pulse, temperature, oxygen saturation
Neurological exam: NIH Stroke Scale (if trained)
Assess cranial nerves, motor strength, sensation, speech, coordination
Rapid assessment for red flags: airway compromise, severe headache, vomiting
Laboratory / Investigations (if immediately available):
Blood glucose (rule out hypoglycemia)
CBC, electrolytes, renal function
Immediate neuroimaging (CT/MRI) at referral center
Treatment / Prescription / Management (Initial at Family Physician):
Emergency stabilization:
Airway, breathing, circulation
Oxygen if SpO₂ <94%
IV access, glucose correction if hypoglycemia
BP control if severely elevated (consult local protocols)
Do NOT administer thrombolytics at primary care level
Rapid referral to hospital with stroke unit or emergency care
Expected Side Effects / Notes:
Supportive care at initial stage has minimal risk
Delays in referral can worsen morbidity and mortality
Monitoring & Follow-Up:
Continuous monitoring during transport
Observe for deterioration: decreased consciousness, airway compromise, seizures
Referral Criteria (Mandatory):
All suspected acute stroke or TIA patients
New-onset neurological deficit
Any patient with sudden severe headache, visual loss, or speech disturbance
Patient Instructions:
Call emergency services immediately
Do not drive self to hospital if neurological deficit present
Inform family/caregiver to assist with rapid transport
Legal/Ethical Justification:
Family physicians must recognize stroke and initiate emergency care
Immediate referral and stabilization is standard of care and legally required to prevent permanent disability or death
Case 13d – Peripheral Neuropathy (Diabetic, Nutritional)
Diagnosis:
Diabetic peripheral neuropathy
Nutritional neuropathy (Vitamin B12, folate deficiency)
Patient Presentation / Wordings:
“I have numbness, tingling, or burning in my feet or hands.”
“My balance is off, or I feel pain at night in my feet.”
Risk factors: long-standing diabetes, poor diet, alcohol excess
Examination / Assessment:
Vital signs
Neurological exam: sensory testing (vibration, pinprick, temperature), reflexes
Foot exam: skin changes, ulcers, infections
Gait and balance assessment
Laboratory / Investigations:
Blood glucose, HbA1c (for diabetics)
Vitamin B12, folate, and other relevant nutritional labs
Renal and liver function if using medications metabolized by these organs
Treatment / Prescription / Management:
A. Glycemic / Nutritional Management:
Optimize blood sugar in diabetics (diet, medications)
Correct deficiencies: Vitamin B12 1000 mcg IM weekly × 4 weeks then monthly OR orally 1000–2000 mcg daily; folate 5 mg daily
B. Symptomatic Relief:
Gabapentin 300 mg orally at night, titrate to 900–1800 mg/day
Pregabalin 75 mg orally at night, titrate as needed
Duloxetine 30–60 mg orally daily (if neuropathic pain)
Expected Side Effects:
Gabapentin/pregabalin: dizziness, somnolence, peripheral edema
Duloxetine: nausea, dry mouth, fatigue
Vitamin B12/folate: generally well tolerated
Monitoring & Follow-Up:
Assess pain relief and functional improvement
Repeat labs for nutritional deficiencies
Monitor renal function if using gabapentin/pregabalin
Referral Criteria:
Rapidly progressive neuropathy
Foot ulcers, infections, or Charcot foot
Refractory neuropathic pain
Suspected secondary causes (autoimmune, toxin exposure)
Patient Instructions:
Monitor feet daily for injuries
Adhere to medications and nutritional supplementation
Maintain glycemic control
Report new numbness, weakness, or infections promptly
Legal/Ethical Justification:
Family physicians can manage early neuropathy, identify reversible causes, and provide symptomatic treatment
Referral for severe, complicated, or refractory cases ensures safe, evidence-based, and legally compliant care
Case 13e – Parkinsonism, Tremor, Weakness Evaluation
Diagnosis:
Parkinsonism (idiopathic Parkinson’s disease or secondary)
Essential tremor
Non-specific muscle weakness (neurological or metabolic cause)
Patient Presentation / Wordings:
“My hands tremble when I’m resting or holding something.”
“I feel slow, stiff, or have trouble with balance.”
“My grip is weak; I drop things often.”
Examination / Assessment:
Neurological exam: tone (rigidity), tremor (resting vs. action), bradykinesia, posture, gait, reflexes
Cranial nerves: facial expression, voice tone
Musculoskeletal: strength testing, muscle bulk
Systemic review: thyroid, metabolic, medication history (antipsychotics, metoclopramide)
Bedside Tests (if available):
Finger tapping, hand movement speed tests
Postural instability check
Check for asymmetry (Parkinson’s often unilateral initially)
Laboratory / Investigations:
CBC, renal/liver function, fasting glucose
Thyroid function (rule out hyperthyroidism-related tremor)
Serum B12, electrolytes if weakness present
Neuroimaging (MRI/CT brain) — at referral center if indicated
Treatment / Prescription / Management (Initial Primary Care):
A. Parkinsonism (Suspected):
If previously diagnosed: continue dopaminergic therapy:
Levodopa + Carbidopa (e.g., 100/25 mg) orally 2–3 times daily (start low, titrate)
Encourage physiotherapy, fall prevention, and mobility aids
Nutritional support (adequate fiber, hydration)
B. Essential Tremor:
Propranolol 20–40 mg orally twice daily, titrate to effect (max 160 mg/day)
Alternatives: Primidone 25–50 mg nightly (if propranolol contraindicated)
C. Nonspecific Weakness:
Address reversible causes: nutritional (B12, folate), endocrine (thyroid), medication review
Encourage gentle exercise and balanced nutrition
Expected Side Effects:
Levodopa: nausea, dizziness, orthostatic hypotension, dyskinesia (with long-term use)
Propranolol: bradycardia, fatigue, hypotension, asthma exacerbation
Primidone: sedation, nausea (start low, titrate slowly)
Monitoring & Follow-Up:
Symptom improvement (mobility, tremor control, daily activities)
Monitor BP (esp. with propranolol or levodopa)
Assess for cognitive changes, falls, depression
Referral Criteria:
New diagnosis of parkinsonism
Rapid progression or atypical symptoms (e.g., early falls, autonomic dysfunction)
Poor response to treatment or severe tremor
Any focal weakness suggesting central lesion (stroke, tumor, neuropathy)
Patient Instructions:
Take medication at regular times, avoid abrupt discontinuation
Maintain safe environment to prevent falls
Regular exercise and balanced diet
Attend neurologist or rehabilitation appointments
Legal/Ethical Justification:
Family physicians can identify early parkinsonian features, initiate safe symptomatic care, and ensure timely specialist referral
Maintaining mobility and independence is part of ethical, patient-centered chronic care management
XIV. MENTAL HEALTH / PSYCHIATRY
Case 14a – Anxiety, Depression, Stress, Insomnia
Diagnosis:
Generalized Anxiety Disorder (GAD)
Major Depressive Disorder (mild–moderate)
Stress-related insomnia
Patient Presentation / Wordings:
“I feel sad, anxious, and can’t sleep properly.”
“I’ve lost interest in things I used to enjoy.”
“My thoughts keep racing; I can’t relax.”
“I’m under a lot of stress lately and can’t focus.”
Examination / Assessment:
Mental status examination (appearance, mood, affect, thought process, insight)
Screen with PHQ-9 (for depression) and GAD-7 (for anxiety)
Rule out medical causes: thyroid disorder, anemia, medication effects
Assess for suicidal thoughts or self-harm risk
Laboratory / Investigations (as needed):
CBC, TSH, blood glucose (rule out organic causes)
Urine drug screen if substance use suspected
Treatment / Prescription / Management:
A. Non-Pharmacological (Always First-Line):
Counseling, reassurance, and stress management
Cognitive-behavioral therapy (CBT) referral if available
Sleep hygiene advice: fixed bedtime, limit caffeine/screens, relaxation
Physical activity, social interaction, mindfulness
B. Pharmacological (If Moderate/Severe or Persistent):
Antidepressant / Anxiolytic Options:
Sertraline 25–50 mg orally daily, titrate up to 100–150 mg as needed
Escitalopram 10 mg orally daily, titrate to 20 mg/day
Clonazepam 0.25–0.5 mg orally at night (short-term only, max 2 weeks) for acute anxiety or insomnia
For Insomnia (short-term adjunct):
Melatonin 3–5 mg at night
Trazodone 50 mg orally at bedtime (if depression with insomnia)
Expected Side Effects:
SSRIs: nausea, headache, mild sexual dysfunction (usually transient)
Clonazepam: sedation, dependence (avoid long-term use)
Trazodone: drowsiness, dry mouth
Monitoring & Follow-Up:
Reassess mood and anxiety at 2–4 weeks
Watch for suicidal ideation after starting antidepressants
Taper benzodiazepines after 2 weeks to avoid dependence
Evaluate response every month for 3 months, then periodically
Referral Criteria:
Suicidal or homicidal thoughts
Psychotic symptoms (hallucinations, delusions)
Poor response to two antidepressants
Severe functional impairment
Suspected bipolar disorder
Patient Instructions:
Take medication regularly; do not stop abruptly
Improvement may take 2–4 weeks
Avoid alcohol or sedatives
Engage in counseling and healthy lifestyle habits
Reach out immediately if feeling unsafe or suicidal
Legal / Ethical Justification:
Family physicians can diagnose and manage mild-to-moderate anxiety and depression safely
Ensuring suicide risk screening, informed consent, and timely referral fulfills ethical and legal responsibility
Documentation of counseling and medication rationale is required for medico-legal safety
Case 14b – Panic Attacks, PTSD, Adjustment Disorder
Diagnosis:
Panic Disorder / Panic Attack
Post-Traumatic Stress Disorder (PTSD)
Adjustment Disorder (emotional/behavioral reaction to identifiable stressor)
Patient Presentation / Wordings:
“I suddenly feel like I can’t breathe — my heart races, I think I’m dying.” (Panic Attack)
“I keep having nightmares and flashbacks from a terrible event.” (PTSD)
“Since I lost my job/divorce/family issue, I feel low and anxious.” (Adjustment Disorder)
Examination / Assessment:
Mental status exam: mood, affect, insight, orientation
Rule out organic causes: arrhythmia, hyperthyroidism, hypoglycemia, substance withdrawal
Panic Attack criteria: abrupt surge of intense fear with ≥4 of—palpitations, sweating, chest pain, choking, fear of dying
PTSD features: intrusive memories, avoidance, hyperarousal ≥1 month
Adjustment disorder: emotional/behavioral symptoms within 3 months of a stressor
Laboratory / Investigations (as indicated):
ECG (to rule out cardiac cause in panic attacks)
TSH, CBC, glucose (exclude medical mimics)
Treatment / Prescription / Management:
A. Non-Pharmacological (First-Line):
Psychoeducation: explain panic is not life-threatening
Breathing and relaxation exercises
CBT referral (most effective for panic and PTSD)
Stress management, social support, avoid triggers (e.g. caffeine, stimulants)
B. Pharmacological (Symptomatic / Moderate–Severe Cases):
For Panic Disorder / PTSD / Adjustment Disorder:
Sertraline 25–50 mg daily, titrate up to 100–200 mg (FDA-approved for PTSD/panic)
Paroxetine 10–20 mg daily, titrate slowly (alternative)
Clonazepam 0.25–0.5 mg twice daily (short-term, 1–2 weeks max, for panic control)
Propranolol 10–20 mg as needed before anxiety-provoking events (performance anxiety type)
Expected Side Effects:
SSRIs: transient nausea, sleep changes, mild sexual dysfunction
Benzodiazepines: sedation, dependence, withdrawal risk
Propranolol: hypotension, fatigue, avoid in asthma
Monitoring & Follow-Up:
Reassess every 2–4 weeks for symptom response
Monitor for increased anxiety initially (first week of SSRI)
Gradual taper of benzodiazepines within 2 weeks
Continue SSRI for 6–12 months after remission
Referral Criteria:
Severe PTSD with flashbacks, dissociation, or suicidal ideation
Panic attacks unresponsive to SSRI and CBT
Substance abuse or self-harm risk
Complex adjustment disorders with major functional decline
Patient Instructions:
Take medication regularly; do not stop suddenly
Panic attacks are self-limited; use slow breathing to regain control
Engage in therapy sessions consistently
Avoid alcohol, caffeine, or illicit substances
Seek emergency help for suicidal or violent thoughts
Legal / Ethical Justification:
Family physicians can diagnose and manage mild-to-moderate panic and stress-related disorders within primary care scope
Early counseling and correct use of SSRIs are ethically sound, evidence-based approaches
Immediate referral for suicidal, psychotic, or severe trauma-related presentations ensures medico-legal protection
Case 14c – Substance Abuse Screening and Counseling
Diagnosis:
Substance Use Disorder (alcohol, tobacco, cannabis, opioids, benzodiazepines, or stimulants)
Risky or harmful use pattern
Patient Presentation / Wordings:
“I’ve been drinking/smoking more than usual; I can’t stop.”
“I feel shaky, anxious, or irritable when I don’t use it.”
“I want to quit, but I relapse again and again.”
Examination / Assessment:
History: type of substance, duration, frequency, last use, withdrawal symptoms
Screening tools:
AUDIT-C (Alcohol Use Disorders Identification Test)
CAGE questionnaire (Cut down, Annoyed, Guilty, Eye-opener)
DAST-10 (Drug Abuse Screening Test)
Physical exam: vitals, signs of withdrawal (tremor, sweating, tachycardia), liver stigmata, oral/dental health, track marks
Laboratory / Investigations:
CBC, LFTs, RFTs
Urine drug screen (if available)
Blood glucose, electrolytes
ECG if stimulant or alcohol dependence suspected
Treatment / Prescription / Management:
A. Non-Pharmacological (Core Management):
Motivational interviewing (non-judgmental, supportive)
Set quit goals and relapse prevention plan
Identify triggers and coping strategies
Family education and involvement
Referral to addiction counselor / rehabilitation if needed
B. Pharmacological Options (Depending on Substance):
1. Alcohol Dependence:
Thiamine 100 mg orally daily (to prevent Wernicke’s encephalopathy)
Disulfiram 250 mg orally daily (only after 12 hrs alcohol-free; supervised use)
Naltrexone 50 mg orally daily (reduces craving)
2. Opioid Dependence:
Buprenorphine/Naloxone 2/0.5 mg to 8/2 mg daily under specialist supervision
Symptomatic withdrawal management:
Diazepam 5–10 mg TDS (short-term)
Loperamide, antiemetics, hydration
3. Nicotine Dependence:
Nicotine replacement therapy (patch/gum/lozenge)
Bupropion 150 mg orally once daily for 3 days, then BID (7–12 weeks)
Varenicline 0.5 mg daily for 3 days, then 0.5 mg BID × 4 days, then 1 mg BID (12 weeks)
Expected Side Effects:
Naltrexone: nausea, headache, fatigue
Disulfiram: metallic taste, severe reaction if alcohol consumed
Bupropion: insomnia, dry mouth, contraindicated in seizures
Varenicline: vivid dreams, nausea
Nicotine patch: local irritation
Monitoring & Follow-Up:
Weekly initially, then monthly
Monitor withdrawal symptoms, cravings, relapse triggers
Periodic LFTs for those on naltrexone or disulfiram
Reinforce abstinence and positive reinforcement
Referral Criteria:
Severe withdrawal (delirium tremens, seizures)
Polysubstance use or comorbid psychiatric illness
Failure of outpatient management
High relapse risk or social instability
Patient Instructions:
Never stop suddenly without guidance (especially alcohol or opioids)
Avoid triggers and keep support contacts available
Seek help immediately if relapse occurs
Inform family/caregiver to monitor progress
Maintain hydration, nutrition, and sleep hygiene
Legal / Ethical Justification:
Screening and brief intervention for substance abuse are within Family Physician’s scope and ethically mandated for public health
Documentation of consent, education, and safe prescribing protects medico-legal integrity
Controlled medications (e.g., buprenorphine) should only be prescribed under authorized protocols
Case 14d – Suicidal Ideation: Immediate Stabilization and Referral
Diagnosis:
Suicidal ideation / risk of self-harm
Underlying mood or psychiatric disorder (e.g., major depression, bipolar disorder, psychosis)
Patient Presentation / Wordings:
“I don’t want to live anymore.”
“Everyone would be better off without me.”
“I’ve thought about how I might do it.”
“I’ve tried hurting myself before.”
Examination / Assessment:
Ensure privacy, calm, non-judgmental tone
Assess intent, plan, means, and timeframe (“Have you thought about how or when?”)
Evaluate for protective factors (family, religion, children, hope for future)
Screen for underlying depression, psychosis, or substance abuse
Look for physical signs of self-harm or intoxication
Immediate Management / Stabilization:
A. Ensure Safety (First Priority):
Never leave the patient alone
Remove access to lethal means (medications, weapons, poisons)
Involve family or trusted contact immediately
Arrange safe environment or hospital transfer
B. Medical Management (If Needed):
Treat coexisting agitation, anxiety, or intoxication symptomatically
Diazepam 5–10 mg orally/IM for acute agitation (short-term only)
If medically unstable (overdose, trauma, intoxication): stabilize airway, breathing, circulation and transfer to ER
Referral (Mandatory):
All suicidal patients require urgent psychiatric evaluation
If imminent risk → Emergency referral to nearest hospital with 24-hr psychiatric/emergency service
If passive ideation only (no plan) → same-day psychiatric referral with close monitoring and family support
Patient & Family Counseling:
Explain that suicidal thoughts are a medical emergency, not a moral failure
Reassure that help is available and effective
Encourage family to supervise, remove harmful objects, and maintain supportive presence
Provide suicide helpline contacts (Pakistan examples: UMANG Helpline 0311-7786264, Rozan Helpline 0800-22444)
Documentation (Legal Requirement):
Record verbatim statements (“patient said…”), risk assessment, and actions taken
Note names of persons informed, time of referral, and hand-over details
Document that patient was not left unsupervised
Legal / Ethical Justification:
Duty of care obligates immediate risk containment and referral
Family physicians must not attempt outpatient management of active suicidal intent
Timely documentation, family notification, and safe transfer fulfill ethical and legal standards
Failure to act promptly may constitute negligence under medico-legal review
Expected Outcome:
Crisis containment and prevention of self-harm
Transition to inpatient or specialist care for definitive treatment
Restoration of safety, support, and long-term mental health plan
Case 14e – Grief Counseling, Family and Marital Therapy
Diagnosis:
Normal grief reaction (bereavement)
Prolonged or complicated grief disorder
Family or marital conflict / relationship stress
Patient Presentation / Wordings:
“I can’t stop crying or thinking about my loss.”
“It’s been months, and I still can’t function normally.”
“We’re having constant arguments at home.”
“My spouse and I can’t communicate anymore.”
Examination / Assessment:
Observe affect, mood, speech, and emotional control
Assess for sleep, appetite, concentration, and functioning
Rule out major depressive episode (loss of pleasure, hopelessness, suicidal thoughts)
Explore relationship dynamics (communication, stressors, abuse, finances, parenting issues)
Use open-ended, empathetic questions — allow ventilation of feelings
Classification / Differentiation:
Type
Duration
Features
Management
Normal grief
<6 months
Sadness, crying, preserved self-worth
Supportive counseling
Complicated grief
>6 months
Functional impairment, guilt, suicidal ideation
CBT + antidepressant + referral
Marital/family conflict
Variable
Anger, resentment, communication breakdown
Family therapy, conflict resolution
Treatment / Management Plan:
A. Non-Pharmacological (Mainstay):
Supportive Counseling:
Encourage emotional expression (“It’s okay to feel sad.”)
Normalize grief response — avoid labeling it as illness unless prolonged
Reinforce coping skills: prayer, journaling, social support, daily routine
Marital / Family Therapy Techniques:
Active listening and non-blaming communication
Identify mutual goals
Set agreed “time-outs” during conflict escalation
Refer to trained family therapist / psychologist if available
Lifestyle & Stress Management:
Encourage adequate sleep, nutrition, physical activity
Avoid alcohol, sedatives, or impulsive decisions
B. Pharmacological (Only if Depressive or Anxiety Features):
Sertraline 25–50 mg orally daily, titrate up to 100–150 mg as needed
Clonazepam 0.25–0.5 mg at night (short-term ≤2 weeks) for sleep/anxiety
Continue therapy at least 6 months if initiated for complicated grief
Expected Side Effects:
Sertraline: mild nausea, headache, transient sleep changes
Clonazepam: drowsiness, dependence risk if prolonged
Monitoring & Follow-Up:
Reassess every 2–4 weeks
Watch for suicidal ideation or worsening depression
Family feedback regarding communication progress
Gradual tapering of medications when mood stabilizes
Referral Criteria:
Persistent grief >6 months with functional decline
Suicidal thoughts, severe depression, or substance use
Domestic violence or abuse suspicion
Unresolvable marital issues needing specialized psychotherapy
Patient & Family Instructions:
Grieving is a process — allow time, seek support, avoid isolation
Avoid major decisions in early bereavement (selling property, remarriage)
Keep communication open, practice empathy
Seek professional help if sadness or anger becomes overwhelming
Legal / Ethical Justification:
Providing emotional and relational counseling is a recognized scope for family physicians
Respect for patient confidentiality and non-judgmental attitude is ethically essential
Early identification of complicated grief or domestic abuse fulfills medico-legal responsibility for patient safety
Case 14f – ADHD, Learning Difficulties, Behavioral Disorders
Diagnosis:
Attention-Deficit / Hyperactivity Disorder (ADHD) — Inattentive / Hyperactive / Combined type
Learning Disability (reading, writing, mathematics)
Oppositional Defiant Disorder (ODD) or Conduct Disorder (behavioral)
Patient Presentation / Wordings:
Parent/teacher: “He can’t sit still or focus on homework.”
“Always forgets things, loses items, and interrupts others.”
“Grades are falling despite average intelligence.”
“Argues, defies rules, or gets angry easily.”
Examination / Assessment:
Observation: restlessness, fidgeting, poor attention span, impulsive talking
Developmental & Academic History: milestones, school performance, peer relations
Screening Tools:
ADHD: Vanderbilt or Conners Rating Scale
Learning Disorders: school psychologist / educational testing
Rule Out: anxiety, depression, sleep deprivation, hearing/vision issues, thyroid problems
Classification / Differentiation:
Condition
Key Features
Duration
Typical Age
Primary Management
ADHD
Inattention, impulsivity, hyperactivity
>6 months
<12 yrs
Behavior therapy ± medication
Learning Disorder
Difficulty reading/writing/math
School age
Variable
Educational intervention
ODD / Conduct Disorder
Angry, defiant, aggressive
Persistent
Late childhood / teens
Family therapy, behavioral modification
Treatment / Management Plan:
A. Non-Pharmacological (Mainstay):
Parental / Family Counseling:
Explain ADHD is neurodevelopmental, not “bad behavior”
Encourage consistent routines, clear expectations, positive reinforcement
Use “time-out” instead of harsh punishment
Behavioral Interventions:
Token economy / reward charts
Break tasks into smaller, manageable parts
Minimize distractions during study time
Encourage sports, structured activities
School-Based Strategies:
Teacher awareness, seating near front, extra time for tests
Individualized Education Plan (IEP) or special education referral
Psychological Support:
Cognitive-Behavioral Therapy (CBT) for impulse control
Social skills training for peer relationships
B. Pharmacological (for diagnosed ADHD, if behavior therapy insufficient):
Methylphenidate (Ritalin) 5 mg once or twice daily, increase gradually to 20–30 mg/day
orAtomoxetine (Strattera) 0.5–1.2 mg/kg/day (non-stimulant alternative)
(To be prescribed by or under supervision of a psychiatrist / pediatric neurologist.)
Expected Side Effects:
Stimulants: appetite loss, insomnia, irritability, tachycardia
Atomoxetine: mild nausea, fatigue, mood swings
Monitoring & Follow-Up:
Review every 4–6 weeks initially
Monitor weight, appetite, BP, pulse
Academic progress and parental feedback
Adjust dose or behavioral plan as needed
Referral Criteria:
Diagnostic uncertainty
Co-existing depression, anxiety, or conduct disorder
Academic regression despite interventions
Complex medication adjustment or side-effects
Patient & Family Instructions:
Maintain consistent sleep and study schedule
Praise small improvements, avoid criticism
Regular follow-up for medication review
Balance academics with physical activity
Legal / Ethical Justification:
Early identification and referral reduce risk of school dropout or behavioral escalation
Maintaining confidentiality and non-stigmatizing approach protects patient rights
Family physician can screen, support, and coordinate multidisciplinary management
XV. ORTHOPEDICS / MUSCULOSKELETAL
Case 15a – Sprains, Strains, Tendinitis, Back Pain
Diagnosis:
Soft tissue injury (e.g. ankle sprain, lumbar strain, rotator cuff tendinitis, mechanical back pain)
Patient Presentation / Wordings:
“I twisted my ankle yesterday; it’s swollen and painful.”
“My lower back hurts after lifting something heavy.”
“Pain around shoulder/elbow with repetitive movement.”
Examination / Assessment:
Inspect for swelling, bruising, deformity
Palpate for tenderness, warmth
Check range of motion, neurovascular status (distal pulses, sensation)
For back pain: assess posture, straight-leg raise, red flags (neurologic deficit, incontinence, fever, trauma, weight loss)
Treatment / Prescription / Management:
A. Conservative (RICE Protocol):
Rest: avoid aggravating movement
Ice: 15–20 min every 4–6 hrs for first 48 hrs
Compression: elastic bandage or support
Elevation: keep affected limb raised
B. Analgesics / Anti-inflammatory:
Paracetamol 500 mg PO every 6 hours as needed
Ibuprofen 400 mg PO every 8 hours with food (max 1200–1600 mg/day)
OR Diclofenac 50 mg PO twice daily for 5–7 days
Topical NSAID gel (diclofenac or ketoprofen) twice daily locally
C. Muscle Relaxant (if severe muscle spasm):
Thiocolchicoside 4 mg PO twice daily or Tizanidine 2 mg twice daily for up to 5 days
D. Physiotherapy / Rehabilitation:
Gradual mobilization once pain subsides
Stretching, strengthening, posture correction
Expected Side Effects:
NSAIDs: gastric upset, dyspepsia, rare GI bleed
Muscle relaxants: drowsiness, dizziness
Monitoring / Follow-Up:
Re-evaluate after 5–7 days
If pain persists or worsens → re-examine for fracture or tendon rupture
Chronic back pain (>6 weeks): consider imaging (X-ray / MRI)
Referral Criteria:
Suspected fracture or dislocation
Ligament/tendon rupture (loss of joint stability or power)
Red flags in back pain:
Neurologic deficit (weakness, numbness, bladder/bowel symptoms)
History of malignancy, fever, weight loss
Unrelenting night pain
Patient Instructions:
Avoid heavy lifting or sports until full recovery
Use proper posture during sitting/standing/lifting
Warm up before exercise; wear supportive footwear
Maintain ideal body weight
Legal / Ethical Justification:
Management within family physician’s scope — soft-tissue injuries and non-fracture back pain are standard primary care cases
Clear documentation of mechanism, treatment, and advice protects against liability
Referral of possible fractures or neurological involvement fulfills duty of care
Case 15b – Fracture First Aid, Immobilization & Referral
Diagnosis:
Suspected or confirmed bone fracture (closed or open)
Patient Presentation / Wordings:
“I fell and now my arm hurts and looks deformed.”
“I can’t move my leg properly after an accident.”
“There’s swelling, pain, and I heard a crack sound.”
Examination / Assessment:
Inspection: deformity, swelling, bruising, open wound, bleeding
Palpation: tenderness, crepitus, abnormal mobility (avoid excessive movement)
Neurovascular check: distal pulses, capillary refill, sensation, movement
Vitals: rule out shock (especially in major limb injuries)
Avoid unnecessary manipulation — only gentle alignment if distal circulation is compromised.
Immediate Management (First Aid):
A. Immobilization:
Upper limb:
Apply sling or splint (wooden, cardboard, or rolled newspaper) from above and below the joint.
Forearm fractures: elbow bent 90°, wrist supported.
Lower limb:
Immobilize using backslab or tie injured leg to the uninjured leg.
Avoid weight-bearing.
Neck/back injuries: immobilize with collar or spine board.
B. Pain Relief:
Paracetamol 1 g PO every 6 hours or
Diclofenac 50 mg PO twice daily with food
If severe: Injection Ketorolac 30 mg IM single dose
C. Wound Care (for open fractures):
Control bleeding with pressure dressing
Do not attempt to push bone ends inside
Cover with sterile gauze
Tetanus prophylaxis:
If unvaccinated / uncertain → Tetanus toxoid 0.5 mL IM
If dirty wound → add Tetanus immunoglobulin 250 IU IM opposite arm
D. IV Access & Fluids (if shock):
Normal saline or Ringer lactate bolus 500–1000 mL
Elevate limb if possible
Expected Side Effects:
NSAIDs: gastric irritation, nausea
Ketorolac injection: pain at site, transient dizziness
Monitoring / Follow-Up:
Recheck distal pulses and sensation after immobilization
Maintain limb elevation to reduce swelling
Keep patient NPO if referral for surgery expected
Referral Criteria:
All confirmed or suspected fractures requiring imaging and orthopedic evaluation
Open fractures, compound injuries, neurovascular compromise
Pelvic, spine, skull, or femoral fractures — emergency referral
Fracture in children (growth plate involvement) — pediatric ortho referral
Patient Instructions:
Keep splint dry and clean
Elevate limb and apply ice packs to reduce swelling
Do not remove splint until advised
Return immediately if fingers/toes become cold, pale, or numb
Legal / Ethical Justification:
Providing immediate stabilization and pain relief before referral is within the family physician’s duty of care
Early immobilization reduces disability risk and demonstrates professional competence
Documentation of time, mechanism, first aid given, and referral pathway is legally protective
Case 15c – Osteoarthritis (OA) & Rheumatoid Arthritis (RA) Follow-Up
Diagnosis:
Osteoarthritis (degenerative joint disease)
Rheumatoid arthritis (autoimmune inflammatory polyarthritis)
Patient Presentation / Wordings:
Osteoarthritis:
“My knees hurt when I walk or climb stairs.”
“Stiffness after sitting for a while, but improves with movement.”
“The joint feels swollen or creaky.”
Rheumatoid Arthritis:
“My fingers are stiff in the morning for more than half an hour.”
“Both hands and wrists are painful and swollen.”
“I feel tired and weak with body aches.”
Examination / Assessment:
Parameter
Osteoarthritis
Rheumatoid Arthritis
Joint Involvement
Weight-bearing (knees, hips, spine)
Small joints (MCP, PIP, wrists) symmetrically
Stiffness
< 30 minutes
> 30–60 minutes
Swelling
Bony enlargement
Soft, tender, warm synovitis
Deformities
Heberden’s nodes, varus/valgus knee
Ulnar deviation, boutonnière, swan-neck
Labs
Usually normal
↑ ESR, CRP, +RF, +Anti-CCP
Imaging
Joint space narrowing, osteophytes
Erosions, juxta-articular osteopenia
Treatment / Prescription / Management:
A. Non-Pharmacologic:
Weight reduction (especially in knee OA)
Regular low-impact exercise (swimming, cycling, walking)
Physiotherapy for range of motion and strengthening
Warm compress or local heat
Assistive devices (knee support, cane)
B. Pharmacologic:
1. Pain & Inflammation Control:
Paracetamol 500–1000 mg PO every 6 hours (first-line for OA)
Ibuprofen 400 mg PO every 8 hours or Diclofenac 50 mg PO twice daily
Topical NSAID gel twice daily
If gastritis risk: add Omeprazole 20 mg PO daily
2. Disease-Modifying (RA-specific): (Initiated or continued under rheumatologist supervision)
Methotrexate 7.5–15 mg once weekly + Folic acid 5 mg once weekly (next day)
Hydroxychloroquine 200 mg PO daily
Prednisolone 5–10 mg daily (short-term control, taper as advised)
Expected Side Effects:
NSAIDs: gastric irritation, fluid retention, elevated BP
Methotrexate: nausea, mouth ulcers, hepatotoxicity (monitor LFTs)
Steroids: weight gain, hyperglycemia, osteoporosis
Monitoring / Follow-Up:
Assess pain, stiffness, and mobility each visit
Weight, BP, renal and liver function (esp. with NSAIDs / DMARDs)
Rheumatology follow-up every 3–6 months
Encourage compliance with exercise and joint protection
Referral Criteria:
Diagnostic uncertainty (RA vs OA vs gout)
Rapid joint destruction, deformity, or systemic features
Poor response to first-line therapy
Adverse effects of DMARDs
Suspected septic arthritis
Patient Instructions:
Avoid squatting, heavy lifting, or high-impact exercise
Maintain healthy weight and balanced diet
Use warm compresses for stiffness
Continue physiotherapy regularly
Adhere strictly to DMARDs schedule (if RA)
Legal / Ethical Justification:
OA and RA management with basic analgesia and lifestyle modification is within family physician scope
Early referral to rheumatology for DMARD initiation ensures safe, guideline-based practice
Documenting pain assessment, treatment plan, and follow-up frequency is medico-legally protective
Case 15d – Sports Injuries
Diagnosis:
Acute musculoskeletal injuries related to sports (sprains, strains, contusions, minor ligament injuries, overuse injuries)
Patient Presentation / Wordings:
“I twisted my ankle while playing football; it’s swollen and painful.”
“My shoulder hurts after throwing during practice.”
“I feel pain in my knee when running or jumping.”
“My wrist is sore from repeated tennis swings.”
Examination / Assessment:
Inspect for swelling, bruising, deformity
Palpate for tenderness, warmth, joint line pain
Assess range of motion and strength
Check ligament stability (e.g., anterior drawer test for ankle)
Neurovascular exam for distal pulses, sensation, and motor function
Evaluate mechanism of injury and acute vs chronic overuse
Treatment / Prescription / Management:
A. Immediate Care (Acute Injuries):
RICE Protocol: Rest, Ice, Compression, Elevation
Immobilization if instability suspected (splint, brace)
Pain relief:
Paracetamol 500–1000 mg PO every 6 hours
NSAIDs: Ibuprofen 400 mg PO every 8 hours with food, max 1200–1600 mg/day
Short-term activity modification — avoid sport until pain-free
B. Overuse / Chronic Sports Injuries:
Physiotherapy: stretching, strengthening, range-of-motion exercises
Gradual return to sport after pain-free movement
Ergonomic / technique assessment to prevent recurrence
C. Adjunctive Measures:
Topical NSAID gels for localized pain
Supportive devices: ankle brace, knee sleeve, wrist strap
Heat therapy for chronic stiffness; ice for acute swelling
Expected Side Effects:
NSAIDs: gastrointestinal upset, renal impairment with prolonged use
Topical gels: mild skin irritation
Monitoring / Follow-Up:
Reassess after 3–7 days for pain, swelling, and functional recovery
Evaluate range of motion and joint stability before resuming sports
Persistent pain or swelling → consider imaging (X-ray, MRI)
Referral Criteria:
Suspected fracture, dislocation, or ligament tear
Persistent pain >2–3 weeks despite conservative management
Signs of joint instability or recurrent injury
Professional athlete requiring advanced imaging or rehabilitation
Patient Instructions:
Adhere to rest and physiotherapy regimen
Avoid returning to sports until fully pain-free
Use protective equipment and correct techniques
Report new swelling, deformity, or loss of function immediately
Legal / Ethical Justification:
Family physicians can safely manage minor sports injuries with first-line conservative measures
Early recognition of serious injuries and timely referral reduces risk of long-term disability
Documentation of injury, management advice, and follow-up ensures medico-legal protection
Case 15e – Gout & Bursitis
Diagnosis:
Gout: acute monoarticular arthritis due to uric acid crystal deposition
Bursitis: inflammation of a bursa (shoulder, elbow, knee, or hip)
Patient Presentation / Wordings:
Gout:
“My big toe has been red, swollen, and extremely painful since last night.”
“Pain is sudden, severe, and worse at night.”
“I have had similar attacks before, mostly in the big toe or ankle.”
Bursitis:
“My shoulder/elbow/knee is swollen and tender.”
“Pain worsens with movement or pressure on the joint.”
“I don’t have a fever, but it feels stiff and sore.”
Examination / Assessment:
Feature
Gout
Bursitis
Swelling
Red, warm, tender joint
Localized swelling over bursa
Pain
Severe, acute onset, usually single joint
Mild–moderate, aggravated by movement
ROM
Usually reduced due to pain
Painful but passive motion may be preserved
Systemic
Usually afebrile
Usually afebrile unless septic
Labs
Serum uric acid, CBC, CRP, ESR
CBC, ESR if needed
Imaging
X-ray: punched-out erosions (chronic)
Ultrasound: bursal fluid
Treatment / Prescription / Management:
A. Gout – Acute Attack:
NSAID: Ibuprofen 400–600 mg PO every 8 hours (max 2400 mg/day)
OR Diclofenac 50 mg PO twice daily for 5–7 days
Colchicine 0.5–1 mg PO initially, then 0.5 mg 1–2 times daily (caution in renal impairment)
Rest affected joint, elevate if possible
Apply cold packs for comfort
B. Gout – Long-Term / Prevention: (if recurrent attacks)
Allopurinol 100 mg PO daily, titrate up (target uric acid <6 mg/dL)
Lifestyle: avoid alcohol, red meat, high-fructose drinks; maintain hydration
C. Bursitis:
Rest the affected joint, avoid repetitive movements
NSAIDs for pain: Ibuprofen 400 mg PO TID for 5–7 days
Ice 15–20 min, 3–4 times/day initially
Consider local corticosteroid injection if chronic or severe (by trained physician)
Expected Side Effects:
NSAIDs: GI upset, kidney impairment, hypertension
Colchicine: diarrhea, nausea, abdominal pain
Corticosteroid injection: local pain, infection risk
Monitoring / Follow-Up:
Reassess pain, swelling, and joint function in 3–7 days
Monitor uric acid levels if on long-term allopurinol
Monitor for NSAID side effects: GI, renal, cardiovascular
Evaluate for underlying metabolic syndrome or renal disease in recurrent gout
Referral Criteria:
Septic arthritis suspected (fever, erythema, purulent joint fluid)
Recurrent or polyarticular gout not controlled with medication
Chronic bursitis unresponsive to conservative management
Significant joint deformity or functional limitation
Patient Instructions:
Rest affected joint during acute flare
Maintain adequate hydration
Avoid triggers: alcohol, organ meats, sugary drinks
Follow medication schedule strictly
Seek prompt care for sudden fever, severe pain, or inability to move the joint
Legal / Ethical Justification:
Diagnosing and treating acute gout and bursitis is within family physician scope
Early recognition of severe or septic cases and referral ensures patient safety and medico-legal compliance
Documentation of presentation, management, and follow-up protects against legal claims
XVI. SURGICAL / EMERGENCY CARE
Case 16a – Wound Care, Cleaning, Dressing, and Suturing
Diagnosis:
Acute laceration, abrasion, or minor traumatic wound
Patient Presentation / Wordings:
“I cut my hand with a knife; it’s bleeding.”
“I scraped my knee on the pavement.”
“There is a deep cut on my forearm that may need stitches.”
Examination / Assessment:
Inspect wound: size, depth, contamination, location
Check bleeding: arterial (pulsatile) vs venous (oozing)
Assess tendon, nerve, or vascular involvement
Examine for foreign bodies
Check tetanus vaccination status
Treatment / Prescription / Management:
A. Immediate Wound Care:
Hemostasis: direct pressure, elevation
Cleaning:
Irrigate with normal saline or clean water
Remove debris carefully
Avoid harsh antiseptics in deep tissue
Antiseptic Application:
Povidone-iodine 10% or chlorhexidine 0.05–0.1%
Dressing:
Sterile gauze, non-adherent layer, light compression
Suturing:
Indications: wound >1–2 cm, deep, gaping edges, over joints/fingers
Local lidocaine 1–2% with or without epinephrine for anesthesia
Use appropriate suture material:
Nylon / Prolene for skin
Absorbable (Vicryl) for subcutaneous tissue
B. Pain Relief:
Paracetamol 500–1000 mg PO every 6 hours as needed
Ibuprofen 400 mg PO every 8 hours with food if inflammation present
C. Antibiotic Prophylaxis (if high-risk wound):
Amoxicillin-clavulanate 625 mg PO every 8 hours × 5 days
Indications: contaminated wounds, animal bites, delayed presentation, immunocompromised
D. Tetanus Prophylaxis:
Tetanus toxoid 0.5 mL IM if vaccination incomplete
Add TIG 250 IU IM for high-risk wounds
Expected Side Effects:
Topical antiseptics: mild skin irritation
NSAIDs: GI upset, renal effects
Antibiotics: diarrhea, rash, hypersensitivity
Monitoring / Follow-Up:
Change dressing daily or every 48 hours
Watch for infection: redness, warmth, pus, fever
Suture removal:
Face: 5–7 days
Limbs: 10–14 days
Referral Criteria:
Wounds with tendon, nerve, or vascular injury
Large or complex lacerations requiring operative repair
Deep puncture wounds with high infection risk
Animal bites needing surgical debridement
Patient Instructions:
Keep wound clean and dry
Take prescribed antibiotics completely
Report increased pain, swelling, or discharge
Avoid strenuous use of affected limb until healed
Legal / Ethical Justification:
Family physicians are expected to perform primary wound management and minor suturing
Timely care reduces infection, scarring, and disability
Documentation of wound assessment, treatment, and follow-up protects against legal claims
Case 16b – Minor Surgical Procedures (Abscess Drainage, Nail Removal)
Diagnosis:
Localized abscess (skin or soft tissue)
Ingrown or infected nail (paronychia or onychocryptosis)
Patient Presentation / Wordings:
Abscess: “There’s a painful, red swelling on my arm that’s filled with pus.”
Nail: “My toe is painful, red, and swollen at the nail edge; it’s hard to walk.”
Examination / Assessment:
Inspect swelling: size, redness, warmth, fluctuation
Assess for surrounding cellulitis or systemic infection
Check nail for ingrown edge, infection, or granulation tissue
Evaluate for comorbidities (diabetes, immunocompromised status)
Assess tetanus vaccination status
Treatment / Prescription / Management:
A. Abscess Drainage:
Anesthesia: Local infiltration with lidocaine 1–2%
Incision & Drainage:
Sterile technique, small incision over point of maximal fluctuation
Express pus gently; send sample for culture if recurrent or severe
Irrigation: Clean cavity with saline
Packing: Optional with sterile gauze for deeper abscesses
Dressing: Sterile gauze and light compression
B. Nail Removal / Ingrown Nail Management:
Anesthesia: Digital nerve block with lidocaine 1–2%
Partial Nail Avulsion:
Remove affected nail edge carefully
Chemical cauterization of matrix if recurrent (phenol 88%)
Dressing: Non-adherent gauze, change daily
Elevation and Ice: Reduce post-procedure swelling
C. Pain Relief:
Paracetamol 500–1000 mg PO every 6 hours as needed
Ibuprofen 400 mg PO every 8 hours with food if inflammation present
D. Antibiotic Therapy (if indicated):
Amoxicillin-clavulanate 625 mg PO every 8 hours × 5–7 days
Indications: surrounding cellulitis, immunocompromised, diabetic patient
E. Tetanus Prophylaxis:
Tetanus toxoid 0.5 mL IM if vaccination incomplete
Add TIG 250 IU IM for high-risk wounds
Expected Side Effects:
Mild pain, swelling, or bleeding at site
NSAIDs: GI upset, renal effects
Antibiotics: diarrhea, rash, hypersensitivity
Monitoring / Follow-Up:
Daily dressing changes until healing
Watch for increased redness, pus, fever
Nail regrowth assessment in 2–4 weeks
Referral Criteria:
Large abscesses extending to deep fascia
Immunocompromised patients or diabetes with infection
Recurrent ingrown nail despite conservative management
Systemic infection signs (fever, tachycardia, cellulitis spreading)
Patient Instructions:
Keep the site clean and dry
Complete prescribed antibiotics
Elevate limb (abscess or toe) and avoid pressure
Report worsening pain, swelling, fever, or discharge
Avoid tight footwear for nail procedures until healed
Legal / Ethical Justification:
Family physicians are expected to manage minor surgical procedures safely
Early drainage or nail removal prevents systemic infection, chronic pain, and complications
Accurate documentation of procedure, anesthesia, antibiotics, and follow-up ensures medicolegal protection
Case 16c – Burn Management (First Aid, Fluid Guidance, Referral)
Diagnosis:
Minor to moderate thermal, chemical, or electrical burns
Superficial, partial-thickness, or deep burns
Patient Presentation / Wordings:
“I spilled hot water on my arm; it’s red and painful.”
“My child touched a stove and has a blister on his hand.”
“There’s a burn on my leg with swelling and fluid-filled blisters.”
Examination / Assessment:
Inspect burn: size (percentage of body surface area), depth (superficial, partial, full-thickness)
Assess for location: face, hands, feet, perineum, joints (higher risk of functional impairment)
Check for inhalation injury: soot around mouth/nose, cough, hoarseness
Evaluate tetanus vaccination status
Assess for comorbidities affecting healing (diabetes, immunosuppression)
Treatment / Prescription / Management:
A. Immediate First Aid:
Stop the burning process
Cool the burn:
Run cool (not ice-cold) water for 10–20 minutes
Avoid ice directly on skin to prevent further tissue injury
Remove constrictive clothing/jewelry before swelling occurs
Cover burn:
Sterile, non-adherent dressing or clean cloth
B. Pain Relief:
Paracetamol 500–1000 mg PO every 6 hours as needed
Ibuprofen 400 mg PO every 8 hours with food if inflammation present
C. Wound Care / Dressing:
Topical antibiotic: Silver sulfadiazine 1% cream or fusidic acid for minor burns
Non-adherent sterile dressing, change daily
Monitor for signs of infection: pus, increasing redness, odor
D. Fluid Management (for moderate to large burns):
Rule of 9s to estimate body surface area burned
Parkland formula: 4 mL × %TBSA × body weight (kg)
Half in first 8 hours, remaining over 16 hours
Monitor urine output: target 0.5–1 mL/kg/hr (adults)
E. Tetanus Prophylaxis:
Tetanus toxoid 0.5 mL IM if vaccination incomplete
Add TIG 250 IU IM for high-risk or deep burns
Expected Side Effects:
Topical agents: mild skin irritation, delayed healing if hypersensitive
NSAIDs: GI upset, renal effects
Fluid therapy: overhydration, electrolyte imbalance if not monitored
Monitoring / Follow-Up:
Daily wound assessment for infection or necrosis
Dressing changes as prescribed
Pain assessment and adjustment
Evaluate for functional limitation or contracture risk
Referral Criteria:
Burns involving >10% TBSA (adults) or >5% (children)
Full-thickness burns, electrical burns, chemical burns
Burns to face, hands, feet, perineum, joints
Inhalation injury, systemic infection, or unstable vitals
Patient Instructions:
Keep burn clean and dry
Avoid home remedies (butter, toothpaste, oils)
Take analgesics as prescribed
Monitor for fever, increasing redness, swelling, or pus
Seek immediate care if worsening or systemic symptoms appear
Legal / Ethical Justification:
Family physicians provide initial burn care and stabilization
Timely first aid and fluid management reduce morbidity and mortality
Documentation of burn assessment, treatment, and referral protects medicolegal interests
Case 16d – Foreign Body Removal (Ear, Nose, Skin, Soft Tissue)
Diagnosis:
Superficial or embedded foreign body in ear, nose, skin, or soft tissue
Patient Presentation / Wordings:
Ear: “My child put a small bead in the ear; it hurts and they can’t hear well.”
Nose: “There is a tiny piece of plastic stuck in my nostril.”
Skin/Soft tissue: “I stepped on a thorn; it’s painful and red.”
Examination / Assessment:
Inspect site: visible object, size, type (organic vs inorganic)
Assess for local infection: redness, swelling, pus
Check surrounding structures: tympanic membrane (ear), septum (nose), tendon/nerve (skin)
Assess tetanus vaccination status
Evaluate for signs of systemic infection
Treatment / Prescription / Management:
A. Ear / Nose Foreign Body Removal:
Preparation:
Position patient comfortably
Use proper lighting and magnification
Removal Techniques:
Ear: alligator forceps, irrigation with warm water (if non-cerumen and not organic)
Nose: suction, forceps, or positive-pressure technique
Avoid deep probing to prevent trauma
Post-Removal Care:
Examine for injury or perforation
Apply topical antibiotic drops if local trauma present
B. Skin / Soft Tissue Foreign Body Removal:
Anesthesia: Local infiltration with lidocaine 1–2% if needed
Technique:
Clean skin with antiseptic
Use sterile forceps or needle to remove object
Irrigate wound with saline
Dressing: Sterile gauze with light compression
C. Pain Relief:
Paracetamol 500–1000 mg PO every 6 hours as needed
Ibuprofen 400 mg PO every 8 hours with food if inflammation present
D. Antibiotic Therapy (if indicated):
Amoxicillin-clavulanate 625 mg PO every 8 hours × 5 days
Indications: contaminated wound, delayed removal, immunocompromised
E. Tetanus Prophylaxis:
Tetanus toxoid 0.5 mL IM if vaccination incomplete
TIG 250 IU IM for high-risk puncture wounds
Expected Side Effects:
Mild local pain or bleeding
NSAIDs: GI upset, renal effects
Antibiotics: diarrhea, rash, hypersensitivity
Monitoring / Follow-Up:
Watch for infection: redness, swelling, pus, fever
Dressing changes daily until healed
Re-evaluate if persistent pain, drainage, or foreign body remains
Referral Criteria:
Deep or large foreign bodies not safely removable in clinic
Organic material with high infection risk (wood splinters, plant material)
Foreign bodies near vital structures (tympanic membrane, nasal septum, tendons)
Signs of systemic infection
Patient Instructions:
Keep site clean and dry
Complete prescribed antibiotics if given
Avoid inserting objects into ears or nose in future
Seek immediate care if fever, worsening pain, or discharge
Legal / Ethical Justification:
Family physicians are trained to remove superficial foreign bodies safely
Prompt removal reduces infection, pain, and functional impairment
Documentation of site, method, anesthesia, and follow-up ensures medico-legal protection
Case 16e – Epistaxis Control and Temporary Dental Pain Management
Diagnosis:
Epistaxis (anterior or posterior nosebleed)
Acute dental pain (toothache) pending definitive dental care
Patient Presentation / Wordings:
Epistaxis: “My nose is bleeding and won’t stop.”
Dental pain: “I have severe tooth pain, especially when chewing or drinking cold water.”
Examination / Assessment:
Epistaxis:
Identify bleeding site: anterior (Kiesselbach’s plexus) vs posterior
Check for trauma, anticoagulant use, hypertension, coagulopathy
Dental pain:
Inspect for caries, abscess, gum swelling, or trauma
Assess for systemic signs of infection (fever, lymphadenopathy)
Treatment / Prescription / Management:
A. Epistaxis Control:
Immediate Measures:
Sit upright, lean forward
Apply firm pressure on anterior nose for 10–15 minutes
Cold compress on nose/cheeks
Local Measures:
Topical vasoconstrictor: Oxymetazoline 0.05% spray, 1–2 sprays per nostril
Anterior nasal packing if bleeding persists
Investigations / Labs if recurrent: CBC, PT/INR, platelets
B. Temporary Dental Pain Relief:
Analgesia:
Paracetamol 500–1000 mg PO every 6 hours as needed
Ibuprofen 400 mg PO every 8 hours with food if inflammation present
Topical Relief:
Oral gel with benzocaine 10–20% for temporary numbness
Antibiotics (if signs of bacterial infection):
Amoxicillin 500 mg PO every 8 hours × 5–7 days for localized abscess or cellulitis
Expected Side Effects:
Vasoconstrictors: mild burning, dryness, rebound congestion if overused
NSAIDs: GI upset, renal effects
Topical anesthetics: mild oral irritation, rare allergic reaction
Antibiotics: diarrhea, rash, hypersensitivity
Monitoring / Follow-Up:
Epistaxis: monitor for recurrent or persistent bleeding
Dental: follow-up with dentist within 24–48 hours
Monitor for fever, swelling, or spreading infection
Referral Criteria:
Posterior epistaxis or uncontrolled anterior bleeding
Recurrent nosebleeds, suspected coagulopathy
Dental abscess with systemic signs (fever, facial swelling)
Severe trauma or persistent pain
Patient Instructions:
Epistaxis: avoid nose picking, heavy lifting, and NSAIDs if bleeding risk
Dental pain: maintain oral hygiene, avoid very hot/cold foods
Take prescribed analgesics and antibiotics as directed
Seek urgent care for persistent bleeding, worsening dental pain, or fever
Legal / Ethical Justification:
Family physicians provide first-line stabilization for epistaxis and temporary dental pain
Early intervention prevents complications and patient discomfort
Documentation of assessment, interventions, and referrals ensures medicolegal safety
Case 16f – Shock, Dehydration, and Hypoglycemia Treatment
Diagnosis:
Hypovolemic, septic, or anaphylactic shock
Dehydration (mild, moderate, severe)
Hypoglycemia (blood glucose <70 mg/dL)
Patient Presentation / Wordings:
Shock: “I feel dizzy, weak, and my heart is racing.”
Dehydration: “I haven’t been able to keep fluids down; I feel very thirsty and weak.”
Hypoglycemia: “I feel sweaty, shaky, and confused; I’m hungry.”
Examination / Assessment:
Shock:
Vital signs: hypotension, tachycardia, tachypnea, low SpO₂
Skin: cold, clammy, pale
Mental status: confusion, agitation
Dehydration:
Assess mucous membranes, skin turgor, capillary refill
Measure urine output
Hypoglycemia:
Measure blood glucose
Assess for neuroglycopenic symptoms (confusion, weakness, seizures)
Identify underlying cause: bleeding, infection, fluid loss, insulin/medication error
Treatment / Prescription / Management:
A. Shock Management:
Airway, Breathing, Circulation (ABC)
IV Access: Large-bore cannula
Fluid Resuscitation:
Hypovolemic: 0.9% Normal saline 20 mL/kg bolus, repeat as needed
Monitor vitals, urine output
Treat underlying cause:
Hemorrhage: control bleeding
Sepsis: IV antibiotics
Anaphylaxis: IM epinephrine 0.3–0.5 mg, repeat every 5–15 min if needed
B. Dehydration Management:
Mild–Moderate: Oral rehydration solution (ORS) 50–100 mL/kg over 4 hours
Severe: IV fluids 0.9% Normal saline or Ringer’s lactate, 20 mL/kg bolus, monitor for correction of electrolytes
C. Hypoglycemia Management:
Conscious Patient: Oral glucose 15–20 g (glucose tabs, juice), repeat if needed
Unconscious Patient:
IV dextrose 25–50 mL of 50% solution (D50) slowly
Repeat blood glucose check in 15 min, then continue IV infusion as needed
Glucagon 1 mg IM/SC if IV access unavailable
D. Supportive Care:
Oxygen if SpO₂ <94%
Monitor vitals continuously
Correct electrolytes if indicated
Expected Side Effects:
Rapid fluid infusion: pulmonary edema in cardiac patients
IV dextrose: local irritation, hyperglycemia if overcorrected
Epinephrine: palpitations, tremor, hypertension
Monitoring / Follow-Up:
Vital signs every 5–15 minutes initially
Urine output: 0.5–1 mL/kg/hr in adults
Serial blood glucose checks in hypoglycemia
Watch for recurrence of shock or fluid imbalance
Referral Criteria:
Persistent hypotension despite fluids
Severe sepsis or multi-organ dysfunction
Recurrent or unexplained hypoglycemia
Patients with comorbidities requiring ICU care
Patient Instructions:
Recognize early signs of dehydration or low blood sugar
Maintain adequate oral fluids
Follow prescribed medication and dietary recommendations
Seek urgent care for dizziness, confusion, or fainting
Legal / Ethical Justification:
Family physicians provide initial stabilization of shock, dehydration, and hypoglycemia
Timely recognition and management prevent morbidity and mortality
Documentation of assessment, interventions, and monitoring ensures medicolegal safety
Case 16g – Anaphylaxis and Asthma Attack Stabilization
Diagnosis:
Anaphylaxis (systemic allergic reaction)
Acute asthma exacerbation
Patient Presentation / Wordings:
Anaphylaxis: “I ate something and now my lips are swelling, I’m having trouble breathing, and I feel dizzy.”
Asthma Attack: “I have severe shortness of breath with wheezing and chest tightness; inhaler is not helping.”
Examination / Assessment:
Anaphylaxis:
Vital signs: hypotension, tachycardia
Skin: urticaria, flushing, angioedema
Respiratory: wheezing, stridor, cyanosis
Gastrointestinal: nausea, vomiting, abdominal pain
Asthma:
Respiratory rate: tachypnea
Wheezing on auscultation, accessory muscle use
Oxygen saturation <94%
Identify triggers or prior history
Treatment / Prescription / Management:
A. Anaphylaxis Management:
Immediate Actions:
Call emergency services
Lay patient supine, elevate legs
Ensure airway patency
Medications:
Epinephrine 0.3–0.5 mg IM (adult) into mid-outer thigh; repeat every 5–15 min as needed
Antihistamines:
Diphenhydramine 25–50 mg IV/IM/PO
Corticosteroids:
Hydrocortisone 100–200 mg IV to prevent biphasic reaction
Oxygen: 8–10 L/min via mask if hypoxic
IV Fluids: 0.9% saline 20 mL/kg if hypotensive
B. Acute Asthma Attack Management:
Short-Acting Beta-Agonist (SABA):
Salbutamol 2.5 mg nebulized every 20 min for first hour
Systemic Corticosteroid:
Prednisolone 40–60 mg PO once daily × 5 days (or IV if unable to take orally)
Oxygen Therapy: Maintain SpO₂ >94%
Monitor for severe attack: Signs include silent chest, exhaustion, cyanosis
Expected Side Effects:
Epinephrine: palpitations, tremor, anxiety
Corticosteroids: hyperglycemia, fluid retention
SABA: tachycardia, tremor
Monitoring / Follow-Up:
Continuous monitoring of airway, breathing, circulation
Repeat epinephrine if symptoms persist
Observe for at least 4–6 hours for biphasic reaction (anaphylaxis)
Follow-up with allergist/asthma specialist
Referral Criteria:
Persistent hypotension or respiratory distress after initial management
Severe asthma attack requiring oxygen or ICU admission
Anaphylaxis with multi-system involvement
Patient Instructions:
Carry an epinephrine auto-injector if history of anaphylaxis
Avoid known triggers
Use inhaler as prescribed and recognize early asthma symptoms
Seek immediate emergency care if symptoms recur
Legal / Ethical Justification:
Family physicians are expected to provide rapid stabilization of life-threatening allergic and respiratory events
Timely intervention prevents morbidity and mortality
Documentation of assessment, medications, response, and referral ensures medicolegal safety
Case 16h – CPR, BLS, and First Aid Certification Practice
Diagnosis:
Cardiac arrest (adult, child, or infant)
Life-threatening emergencies requiring basic life support (BLS)
Patient Presentation / Wordings:
“The patient is unresponsive and not breathing.”
“The child suddenly collapsed and is not moving.”
Examination / Assessment:
Assess responsiveness: shake gently, call patient’s name
Check airway: open and inspect for obstruction
Check breathing: look, listen, feel
Check circulation: carotid pulse (adult/child) or brachial pulse (infant)
Rapid identification of life-threatening conditions
Treatment / Prescription / Management:
A. Adult CPR (Unresponsive, No Breathing, No Pulse):
Call for Help / Activate EMS
Chest Compressions:
30 compressions at 100–120/min, depth 5–6 cm
Allow full chest recoil
Rescue Breaths:
2 breaths after 30 compressions
Each breath ~1 second, chest rise visible
Defibrillation:
Apply AED as soon as available
Follow prompts for shock delivery
B. Child and Infant CPR:
Child: compress 5 cm depth, 30:2 ratio (single rescuer)
Infant: compress 4 cm depth, 30:2 ratio (single rescuer)
Two-rescuer ratio: 15:2
Use gentle jaw-thrust if spinal injury suspected
C. BLS Principles:
Early recognition of cardiac arrest
Activation of EMS
High-quality chest compressions
Defibrillation when indicated
Minimize interruptions in compressions
D. First Aid Basics:
Control bleeding: direct pressure, elevation
Immobilize fractures and sprains
Manage burns, wounds, and foreign bodies
Recognize and manage choking, shock, and hypoglycemia
Expected Side Effects:
Chest compressions: rib fractures, bruising (acceptable risk in life-saving situations)
Rescue breaths: gastric inflation if too forceful
Monitoring / Follow-Up:
Continuous reassessment of airway, breathing, and circulation
Monitor vital signs post-resuscitation
Transfer to hospital for definitive care
Referral / Escalation Criteria:
All cardiac arrests require hospital transfer and advanced life support
Any patient stabilized after first aid should have follow-up for underlying causes
Patient / Bystander Instructions:
Call emergency services immediately
Perform hands-only CPR if untrained in rescue breaths
Use AED if available
Do not delay compressions for minor concerns
Legal / Ethical Justification:
Family physicians must be proficient in CPR and BLS as first responders
Early and correct application saves lives
Documentation of training, interventions, and outcomes ensures medicolegal compliance
Case 16i – Snake Bite and Dog Bite First Aid, Anti-Serum Initiation
Diagnosis:
Snake bite (venomous or non-venomous)
Dog bite (potential rabies exposure)
Patient Presentation / Wordings:
Snake bite: “I was bitten on the foot by a snake; the area is swollen and painful.”
Dog bite: “A dog bit my hand; it’s bleeding and I’m worried about infection.”
Examination / Assessment:
Snake Bite:
Inspect bite site: fang marks, swelling, redness, bruising
Assess neurotoxic or hemotoxic signs: ptosis, difficulty swallowing, bleeding, hematuria
Vital signs: hypotension, tachycardia
Identify type of snake if possible
Dog Bite:
Wound assessment: depth, contamination, puncture vs laceration
Check tetanus vaccination status
Assess risk for rabies exposure
Treatment / Prescription / Management:
A. Snake Bite First Aid:
Keep patient calm and immobile
Immobilize affected limb with splint
Remove constrictive clothing/jewelry
Do NOT: cut, suck, or apply tourniquet
Anti-Venom (if indicated):
Administer as per local protocol after hospital assessment
Monitor for systemic envenomation:
Neurotoxic: ptosis, drooling, muscle weakness
Hemotoxic: bleeding, hematuria, hypotension
B. Dog Bite First Aid:
Immediate wound care:
Wash wound thoroughly with soap and running water for 15 minutes
Irrigate with saline
Apply antiseptic: povidone-iodine 10%
Cover with sterile dressing
Rabies Post-Exposure Prophylaxis (PEP):
Human rabies vaccine per local schedule
Rabies immunoglobulin (RIG) for high-risk bites
Antibiotic prophylaxis:
Amoxicillin-clavulanate 625 mg PO every 8 hours × 5 days (for high-risk bites)
C. Pain Relief:
Paracetamol 500–1000 mg PO every 6 hours as needed
Ibuprofen 400 mg PO every 8 hours with food if inflammation present
D. Tetanus Prophylaxis:
Tetanus toxoid 0.5 mL IM if vaccination incomplete
TIG 250 IU IM for high-risk wounds
Expected Side Effects:
Anti-venom: hypersensitivity, anaphylaxis (administer under supervision)
NSAIDs: GI upset, renal effects
Antibiotics: diarrhea, rash, hypersensitivity
Monitoring / Follow-Up:
Monitor vital signs, bleeding, and neuro status (snake bite)
Check wound daily for infection (dog bite)
Complete rabies vaccine schedule and follow-up at 3, 7, 14 days
Referral Criteria:
Severe envenomation or systemic toxicity (snake bite)
Deep, puncture, or heavily contaminated bites
Signs of infection, abscess, or necrosis
Patients needing anti-venom administration under hospital supervision
Patient Instructions:
Keep the affected area immobilized
Avoid traditional remedies or cutting the wound
Complete prescribed antibiotics and vaccines
Seek immediate care for swelling, bleeding, numbness, or difficulty breathing
Legal / Ethical Justification:
Family physicians are expected to provide initial stabilization and first aid for bites
Timely care reduces morbidity, risk of rabies, and life-threatening complications
Documentation of wound assessment, interventions, and referrals protects medicolegal interests
XVII. INFECTIOUS DISEASES
Case 17a – Fever of Unknown Origin (FUO)
Diagnosis:
Fever ≥38.3°C (101°F) for ≥3 weeks without an identifiable cause after initial evaluation
Common considerations: infections, autoimmune diseases, malignancy, drug fever
Patient Presentation / Wordings:
“I have had a persistent fever for the last three weeks; no specific symptoms.”
“I feel weak and tired; the fever comes and goes.”
“No cough, urinary symptoms, or rash, but the fever persists.”
Examination / Assessment:
Vital signs: temperature pattern, heart rate, blood pressure
General: pallor, lymphadenopathy, hepatosplenomegaly, weight loss
Systemic exam: skin rashes, joint swelling, neurological signs, abdominal tenderness
Review medications, travel, animal exposure, and past infections
Investigations:
CBC with differential
ESR/CRP
Blood cultures (multiple sets)
Urine analysis and culture
Chest X-ray
Liver and renal function tests
Further imaging (USG, CT) as indicated
Serology for malaria, dengue, typhoid, HIV, hepatitis if epidemiologically relevant
Treatment / Prescription / Management:
Symptomatic Management:
Paracetamol 500–1000 mg PO every 6 hours as needed for fever
Maintain hydration and nutrition
Empiric Therapy: Only if patient is unstable or high risk:
Broad-spectrum antibiotics (e.g., ceftriaxone 1–2 g IV daily) may be started while cultures are pending
Investigational Management:
Targeted therapy based on lab/imaging results
Referral: To infectious disease, hematology, or rheumatology for persistent or unexplained cases
Expected Side Effects:
Paracetamol: rare hepatotoxicity if overdosed
Antibiotics: diarrhea, rash, hypersensitivity
Monitoring / Follow-Up:
Daily or frequent temperature monitoring
Monitor for new symptoms (rash, cough, organ-specific signs)
Repeat investigations if fever persists or clinical status worsens
Referral Criteria:
Persistent fever >3–4 weeks with negative initial workup
Hemodynamic instability, organ dysfunction
Suspicion of malignancy, autoimmune disease, or rare infection
Patient Instructions:
Record daily temperature and symptoms
Maintain hydration and nutrition
Report new symptoms: rash, bleeding, jaundice, shortness of breath
Adhere to follow-up appointments and lab investigations
Legal / Ethical Justification:
Family physicians provide initial evaluation, stabilization, and empiric management of FUO
Early identification and referral prevent delayed diagnosis of serious underlying disease
Proper documentation of assessment, investigations, and management ensures medicolegal protection
Case 17b(i) – Dengue Fever
Diagnosis:
Acute viral infection caused by dengue virus (Aedes mosquito-borne)
Classic dengue: high fever, myalgia, retro-orbital pain, rash
Warning signs: abdominal pain, persistent vomiting, bleeding, lethargy, fluid accumulation
Patient Presentation / Wordings:
“I have a sudden high fever with severe body aches.”
“My eyes hurt, and I feel very tired.”
“I noticed a red rash on my skin and mild nose bleeding.”
Examination / Assessment:
Vital signs: fever, pulse, BP (watch for hypotension/shock)
General: pallor, dehydration, rash, mucosal bleeding
Abdominal exam: tenderness, hepatomegaly, ascites
Warning signs: persistent vomiting, severe abdominal pain, bleeding, lethargy
Investigations:
CBC: leukopenia, thrombocytopenia, hemoconcentration
Dengue NS1 antigen (early) or IgM/IgG serology
Liver function tests
Ultrasound: fluid accumulation in severe cases
Hematocrit monitoring
Treatment / Prescription / Management:
A. Supportive Care:
Oral hydration: 50–100 mL/kg/day (children), maintain adequate fluid intake in adults
Paracetamol 500–1000 mg PO every 6 hours as needed for fever and pain
Avoid NSAIDs (ibuprofen, aspirin) due to bleeding risk
B. Monitoring:
Daily CBC and hematocrit in hospitalized patients
Monitor for warning signs: hypotension, persistent vomiting, mucosal bleeding
C. Severe Dengue / Dengue Hemorrhagic Fever:
Hospitalization for IV fluid therapy:
Ringer’s lactate or 0.9% saline 5–10 mL/kg/hr initially
Adjust according to vital signs, urine output, and hematocrit
Blood transfusion if significant bleeding
Expected Side Effects:
Paracetamol: rare hepatotoxicity if overdosed
IV fluids: overhydration if not monitored carefully
Monitoring / Follow-Up:
Daily assessment for fever, bleeding, abdominal pain
CBC and hematocrit until recovery
Patient may recover within 7–10 days in mild cases
Referral Criteria:
Persistent vomiting, shock, severe bleeding, or organ involvement
Rapid drop in platelets with signs of plasma leakage
Patient Instructions:
Rest, maintain oral hydration
Avoid NSAIDs and aspirin
Report any bleeding, severe abdominal pain, or lethargy immediately
Follow up daily if outpatient management
Legal / Ethical Justification:
Family physicians provide early recognition, monitoring, and stabilization of dengue
Proper documentation of warning signs, hydration, and follow-up prevents complications and medicolegal issues
Case 17b(ii) – Malaria
Diagnosis:
Acute febrile illness caused by Plasmodium species (P. falciparum, P. vivax, P. ovale, P. malariae)
Classic presentation: fever with chills, rigors, headache, malaise, and myalgia
Patient Presentation / Wordings:
“I have recurrent high fevers with chills and sweating.”
“I feel very weak, and my head aches.”
“Sometimes the fever comes in waves every 48–72 hours.”
Examination / Assessment:
Vital signs: fever, tachycardia
General: pallor, dehydration, jaundice
Splenomegaly or hepatomegaly on abdominal exam
Assess for complications: altered consciousness, seizures, hypotension, respiratory distress
Investigations:
Peripheral blood smear (thick and thin) for parasite identification
Rapid diagnostic test (RDT) for malaria antigen
CBC: anemia, thrombocytopenia
Renal and liver function tests if severe
Treatment / Prescription / Management:
A. Uncomplicated Malaria:
P. falciparum:
Artemisinin-based combination therapy (ACT), e.g., Artemether-Lumefantrine 20/120 mg: 4 tablets orally twice daily × 3 days
P. vivax, P. ovale:
Chloroquine 600 mg base (10 mg/kg) orally, then 300 mg at 6, 24, 48 hours
Followed by primaquine 0.25 mg/kg daily × 14 days for liver hypnozoites (after G6PD testing)
B. Severe Malaria:
Hospitalization for IV Artesunate or Quinidine
Supportive care: fluids, blood transfusion if severe anemia, oxygen if hypoxic
C. Symptomatic Care:
Paracetamol 500–1000 mg PO every 6 hours as needed for fever
Maintain hydration
Expected Side Effects:
ACT: nausea, headache, mild dizziness
Chloroquine: GI upset, pruritus
Primaquine: hemolysis in G6PD deficiency
Monitoring / Follow-Up:
Repeat blood smear after treatment to ensure parasite clearance
Monitor for recurrent fever or complications
Assess hemoglobin and platelet count if initially low
Referral Criteria:
Severe malaria with organ dysfunction (cerebral, renal, respiratory)
Pregnant women with malaria
Children <5 years with high parasitemia or complications
Patient Instructions:
Take full course of prescribed medications
Stay hydrated and rest
Seek immediate care if fever persists, jaundice develops, or neurological symptoms appear
Use mosquito protection to prevent reinfection
Legal / Ethical Justification:
Family physicians are responsible for early recognition, treatment, and referral for malaria
Timely treatment reduces morbidity, mortality, and transmission risk
Documentation of diagnosis, treatment, and follow-up ensures medicolegal safety
Case 17b(iii) – Typhoid Fever
Diagnosis:
Systemic infection caused by Salmonella enterica serovar Typhi or Paratyphi
Classic presentation: prolonged fever, abdominal pain, malaise, and sometimes rash (“rose spots”)
Patient Presentation / Wordings:
“I have had a continuous high fever for the past week.”
“I feel weak, with headaches and abdominal discomfort.”
“Sometimes I notice small red spots on my chest and abdomen.”
Examination / Assessment:
Vital signs: persistent fever, relative bradycardia
General: pallor, dehydration
Abdominal exam: tenderness in right lower quadrant, hepatosplenomegaly
Examine for complications: intestinal bleeding or perforation, confusion
Investigations:
Blood culture: gold standard for diagnosis (especially first week)
Widal test: supportive in endemic areas
CBC: leukopenia, mild anemia
Liver function tests if prolonged illness
Treatment / Prescription / Management:
A. Uncomplicated Typhoid Fever:
Adults:
Ceftriaxone 1–2 g IV/IM daily × 10–14 days
Oral alternatives (if sensitive):
Ciprofloxacin 500 mg PO twice daily × 7–14 days (check local resistance)
Children: weight-based dosing
Ceftriaxone 50 mg/kg IV daily
Ciprofloxacin 15 mg/kg PO twice daily
B. Supportive Care:
Paracetamol 500–1000 mg PO every 6 hours for fever and discomfort
Maintain hydration
Soft, easily digestible diet
C. Monitoring / Complications:
Watch for persistent fever after 5–7 days of therapy
Monitor for intestinal bleeding, perforation, or encephalopathy
Repeat blood cultures if fever persists
Expected Side Effects:
Antibiotics: diarrhea, rash, hypersensitivity
Paracetamol: rare hepatotoxicity if overdosed
Referral Criteria:
Severe typhoid with complications (intestinal perforation, encephalopathy)
Persistent fever despite appropriate therapy
Pregnant women with complicated typhoid
Patient Instructions:
Complete full course of antibiotics
Maintain hydration and rest
Monitor for new abdominal pain, bleeding, or neurological symptoms
Seek urgent care if fever persists or complications arise
Legal / Ethical Justification:
Family physicians provide early recognition, treatment, and monitoring of typhoid
Timely antibiotic therapy reduces morbidity and prevents complications
Proper documentation ensures medicolegal protection
Case 17b(iv) – Hepatitis (A, B, C)
Diagnosis:
Acute or chronic liver infection caused by hepatitis viruses (HAV, HBV, HCV)
Clinical features vary by type: jaundice, fatigue, anorexia, nausea, dark urine
Patient Presentation / Wordings:
“I feel very tired and my eyes look yellow.”
“I have nausea, loss of appetite, and my urine is dark.”
“I recently had unprotected sex/traveled to an endemic area/received a blood transfusion.”
Examination / Assessment:
Vital signs: fever in acute infection
General: jaundice, pallor, dehydration
Abdominal exam: hepatomegaly, tenderness
Assess for complications: ascites, encephalopathy, coagulopathy
Investigations:
Liver function tests: ALT, AST, ALP, bilirubin
Hepatitis serology:
HAV IgM
HBsAg, anti-HBs, anti-HBc IgM (HBV)
Anti-HCV, HCV RNA
CBC and coagulation profile
Treatment / Prescription / Management:
A. Hepatitis A:
Supportive care: hydration, rest, balanced diet
Avoid hepatotoxic drugs (NSAIDs in severe liver injury)
No specific antiviral therapy required
B. Hepatitis B:
Acute HBV: supportive care; monitor liver function
Chronic HBV with active replication: antiviral therapy (Tenofovir 300 mg PO daily or Entecavir 0.5 mg PO daily)
Monitor liver function, viral load, and serology
C. Hepatitis C:
Direct-acting antivirals (DAAs) based on genotype (e.g., Sofosbuvir + Velpatasvir PO daily × 12 weeks)
Monitor liver function, viral load, and fibrosis markers
D. Symptomatic Management:
Paracetamol 500–1000 mg PO every 6 hours as needed for mild fever or discomfort
Avoid alcohol, hepatotoxic drugs, and high-fat diets
Expected Side Effects:
DAAs/antivirals: fatigue, headache, mild GI upset
Paracetamol: hepatotoxicity if overdosed
Tenofovir: renal impairment or decreased bone mineral density
Monitoring / Follow-Up:
Liver function tests every 2–4 weeks initially
Viral load for HBV/HCV every 3–6 months during therapy
Monitor for jaundice, ascites, confusion (hepatic encephalopathy)
Referral Criteria:
Acute liver failure
Severe jaundice, coagulopathy, encephalopathy
Chronic HBV/HCV requiring specialist antiviral therapy
Patient Instructions:
Rest and maintain hydration
Avoid alcohol and hepatotoxic medications
Take antiviral therapy exactly as prescribed
Report new symptoms: confusion, bleeding, or abdominal swelling
Legal / Ethical Justification:
Family physicians provide early recognition, counseling, and referral for viral hepatitis
Proper management reduces complications, transmission risk, and chronic liver disease
Documentation of assessment, counseling, and antiviral therapy ensures medicolegal protection
Case 17b(v) – Influenza
Diagnosis:
Acute viral respiratory infection caused by influenza A or B virus
Typical features: sudden onset fever, myalgia, headache, cough, sore throat, fatigue
Patient Presentation / Wordings:
“I have a sudden high fever, chills, and body aches.”
“I feel extremely tired and have a sore throat and dry cough.”
“My symptoms started suddenly two days ago.”
Examination / Assessment:
Vital signs: fever, tachycardia, possible hypotension in severe cases
General: malaise, myalgia
Respiratory: mild congestion, dry cough, sometimes rhonchi
Assess for complications: pneumonia, hypoxia, exacerbation of chronic illnesses
Investigations:
Rapid influenza diagnostic test (RIDT) or PCR if available
CBC: usually mild leukopenia
Chest X-ray if pneumonia suspected
Treatment / Prescription / Management:
A. Symptomatic Care:
Paracetamol 500–1000 mg PO every 6 hours for fever and body aches
Maintain hydration and rest
Humidified air and saline nasal drops if nasal congestion
B. Antiviral Therapy (for high-risk or severe cases):
Oseltamivir 75 mg PO twice daily × 5 days (initiate within 48 hours of symptom onset)
Alternative: Zanamivir inhalation 10 mg twice daily × 5 days
C. Monitoring / Complications:
Watch for shortness of breath, persistent high fever, worsening cough
Monitor elderly, pregnant, or immunocompromised patients closely
Expected Side Effects:
Oseltamivir: nausea, vomiting, headache
Paracetamol: rare hepatotoxicity if overdosed
Referral Criteria:
Severe respiratory distress, hypoxia, or pneumonia
Pregnant women with influenza symptoms
Elderly or immunocompromised with severe symptoms
Patient Instructions:
Rest, maintain fluids, avoid spreading infection
Take antiviral therapy as prescribed
Seek urgent care if difficulty breathing, persistent high fever, or confusion develops
Vaccination for influenza is recommended annually for prevention
Legal / Ethical Justification:
Family physicians provide early recognition, supportive care, and antiviral therapy for influenza
Timely intervention reduces complications and hospitalizations
Documentation of symptoms, treatment, and counseling ensures medicolegal protection
Case 17b(vi) – COVID-19
Diagnosis:
Acute respiratory illness caused by SARS-CoV-2 virus
Presentation ranges from mild flu-like symptoms to severe pneumonia and multi-organ involvement
Patient Presentation / Wordings:
“I have a fever, cough, and body aches.”
“I feel short of breath and very fatigued.”
“I lost my sense of taste and smell.”
Examination / Assessment:
Vital signs: fever, tachypnea, oxygen saturation (SpO₂), blood pressure, pulse
General: malaise, myalgia
Respiratory: cough, tachypnea, crackles if pneumonia develops
Assess for warning signs: persistent hypoxia, confusion, chest pain, inability to eat or drink
Investigations:
COVID-19 RT-PCR or rapid antigen test
CBC, CRP, D-dimer if severe
Chest X-ray or CT if respiratory compromise
Oxygen saturation monitoring
Treatment / Prescription / Management:
A. Mild COVID-19 (Home Isolation):
Symptomatic care:
Paracetamol 500–1000 mg PO every 6 hours for fever or pain
Adequate hydration and rest
Isolation for at least 5–7 days or per local guidelines
Monitor SpO₂ at home with pulse oximeter
B. Moderate to Severe COVID-19 (Hospitalization if needed):
Oxygen therapy: maintain SpO₂ >92%
Antiviral therapy (if indicated and within recommended window):
Remdesivir 200 mg IV loading dose, then 100 mg IV daily × 5 days
Corticosteroids for hypoxic patients:
Dexamethasone 6 mg PO/IV daily × 10 days
Anticoagulation prophylaxis in hospitalized patients: LMWH per weight
C. Monitoring / Complications:
Monitor respiratory rate, SpO₂, heart rate, blood pressure
Watch for ARDS, secondary bacterial infections, thromboembolic events
Expected Side Effects:
Antivirals: nausea, elevated liver enzymes
Corticosteroids: hyperglycemia, immunosuppression
Paracetamol: hepatotoxicity if overdosed
Referral Criteria:
SpO₂ <90%, respiratory distress
Persistent fever, confusion, or chest pain
Comorbid patients (cardiac, renal, immunocompromised)
Patient Instructions:
Follow home isolation and hygiene measures
Maintain hydration and nutrition
Monitor SpO₂, temperature, and new symptoms
Seek urgent care for worsening shortness of breath, confusion, or persistent high fever
Legal / Ethical Justification:
Family physicians provide initial assessment, home monitoring, and early treatment of COVID-19
Timely recognition and referral reduce morbidity, mortality, and transmission
Proper documentation ensures medicolegal protection and compliance with public health guidelines
Case 17c – Sexually Transmitted Diseases (STDs)
Diagnosis:
Common STDs include chlamydia, gonorrhea, syphilis, herpes simplex virus (HSV), and human papillomavirus (HPV)
Diagnosis based on history, symptoms, and laboratory tests
Patient Presentation / Wordings:
“I have painful urination and unusual discharge from my penis/vagina.”
“I noticed sores or ulcers on my genitals.”
“I want to get tested for a new sexual partner.”
Examination / Assessment:
Genital examination: discharge, ulcers, warts, rash
Lymph nodes: inguinal lymphadenopathy
Skin and mucous membranes for rashes or lesions
Evaluate for systemic symptoms: fever, malaise, joint pain
Investigations:
Urine or swab PCR for chlamydia and gonorrhea
Rapid plasma reagin (RPR)/VDRL for syphilis
HIV test
Hepatitis B and C serology
HSV PCR or culture if lesions present
Treatment / Prescription / Management:
A. Chlamydia:
Azithromycin 1 g PO single dose
Alternative: Doxycycline 100 mg PO twice daily × 7 days
B. Gonorrhea:
Ceftriaxone 500 mg IM single dose
If co-infection with chlamydia is suspected, add azithromycin 1 g PO
C. Syphilis:
Benzathine penicillin G 2.4 million units IM single dose (for primary/secondary)
Monitor for Jarisch-Herxheimer reaction
D. Herpes Simplex Virus (HSV):
Acyclovir 400 mg PO three times daily × 7–10 days for primary infection
Symptomatic relief: analgesics, topical antiseptics
E. Counseling:
Safe sexual practices: condom use, limiting multiple partners
Partner notification and treatment
Regular screening if at risk
Expected Side Effects:
Antibiotics: diarrhea, rash, hypersensitivity
Acyclovir: headache, nausea
Benzathine penicillin: mild injection site reaction, Jarisch-Herxheimer reaction
Monitoring / Follow-Up:
Re-evaluate symptoms after 1–2 weeks
Repeat testing for chlamydia/gonorrhea in 3 months if high-risk
Monitor for treatment adherence and adverse reactions
Referral Criteria:
Complicated infections (PID, epididymitis, disseminated infection)
HIV-positive patients requiring specialized care
Suspected congenital infection in newborns
Patient Instructions:
Complete full course of medication
Abstain from sexual activity until treatment completed and partner treated
Practice safe sex to prevent reinfection
Seek care for worsening symptoms or allergic reactions
Legal / Ethical Justification:
Family physicians are responsible for initial screening, counseling, and treatment of STDs
Early intervention prevents transmission, complications, and legal issues
Documentation of counseling, treatment, and partner notification ensures medicolegal protection
Case 17d – HIV Counseling, Testing, and Post-Exposure Prophylaxis (PEP)
Diagnosis:
Risk of HIV exposure from sexual contact, needle-stick injury, blood transfusion, or other potential exposures
Confirmed HIV diagnosis requires serologic testing
Patient Presentation / Wordings:
“I had unprotected sex with a new partner and I’m worried about HIV.”
“I was accidentally pricked by a used needle at work.”
“I want to get tested for HIV before starting a new relationship.”
Examination / Assessment:
Assess exposure risk: type, timing (<72 hours for PEP), severity
Review medical history: liver/renal disease, medications
Vital signs and general assessment
Baseline labs: HIV rapid test, CBC, renal and liver function, hepatitis B/C status
Investigations:
HIV rapid test (screening)
Confirmatory test if rapid test positive (ELISA/Western blot or PCR)
Additional STI screening as indicated
Treatment / Prescription / Management:
A. HIV Testing and Counseling:
Pre-test counseling: explain purpose, confidentiality, window period, and implications of results
Post-test counseling:
Negative: discuss prevention strategies
Positive: referral to HIV care and initiation of antiretroviral therapy (ART)
B. Post-Exposure Prophylaxis (PEP):
Indication: Exposure within past 72 hours
Regimen (Adults):
Tenofovir 300 mg + Emtricitabine 200 mg PO once daily
Dolutegravir 50 mg PO once daily
Duration: 28 days
Children: weight-based dosing of same regimen
C. Monitoring During PEP:
Baseline renal and liver function
Monitor for drug side effects: nausea, fatigue, headache, diarrhea
Follow-up HIV testing at 6 weeks, 12 weeks, and 6 months post-exposure
Expected Side Effects:
Tenofovir/Emtricitabine: nausea, mild renal effects
Dolutegravir: headache, insomnia, GI upset
Referral Criteria:
Confirmed HIV infection
Severe drug intolerance or pre-existing renal/hepatic disease
Recurrent high-risk exposures requiring long-term prophylaxis guidance
Patient Instructions:
Start PEP as soon as possible (within 72 hours of exposure)
Take medications daily and complete full 28-day course
Avoid high-risk behaviors during PEP and until confirmatory testing
Report adverse effects promptly
Legal / Ethical Justification:
Family physicians are responsible for timely PEP initiation to prevent HIV infection
Confidential counseling, testing, and follow-up are critical for patient safety and legal protection
Documentation of exposure, counseling, PEP initiation, and follow-up testing is mandatory
Case 17e – Traveler’s Health: Vaccination and Malaria Prophylaxis
Diagnosis / Purpose:
Preventive care for travelers to endemic regions
Protection against vaccine-preventable diseases and malaria
Patient Presentation / Wordings:
“I’m traveling to Africa/Asia and want to know which vaccines I need.”
“I need advice for malaria prevention before my trip.”
“Are there any medications I should take to avoid illness while traveling?”
Examination / Assessment:
Review travel itinerary and duration
Assess medical history: allergies, chronic diseases, pregnancy, immunosuppression
Review vaccination history: Hepatitis A/B, Tetanus, Typhoid, Yellow Fever, MMR, Influenza
Check contraindications to vaccines or prophylactic medications
Investigations / Pre-Travel Labs:
Baseline CBC, renal and liver function if starting prophylactic medications
Screen for immunity to specific vaccines if indicated
Treatment / Prescription / Management:
A. Vaccinations:
Hepatitis A: 0.5 mL IM at 0 and 6 months
Hepatitis B: 0.5 mL IM at 0, 1, 6 months
Typhoid: Injectable 0.5 mL IM single dose or oral capsule series
Yellow Fever: 0.5 mL SC single dose (if endemic country; check contraindications)
Influenza: annual dose if traveling during flu season
Other vaccines as indicated: MMR, meningococcal, rabies pre-exposure
B. Malaria Prophylaxis:
Drug selection based on region and resistance patterns:
Atovaquone-Proguanil 250/100 mg PO once daily, start 1–2 days before travel, continue 7 days after leaving endemic area
Doxycycline 100 mg PO once daily, start 1–2 days before travel, continue 4 weeks after leaving
Mefloquine 250 mg PO weekly, start 2 weeks before travel, continue 4 weeks after leaving
Advise mosquito bite prevention: nets, repellents, long sleeves, indoor accommodation
C. Travel Health Counseling:
Safe food and water practices
Hand hygiene
Avoid insect bites and animal exposure
Emergency contacts for local healthcare facilities
Expected Side Effects:
Vaccines: mild fever, injection site pain, rare allergic reactions
Malaria prophylaxis: nausea, GI upset, vivid dreams (mefloquine), photosensitivity (doxycycline)
Monitoring / Follow-Up:
Monitor for vaccine reactions
Ensure completion of prophylaxis course
Post-travel evaluation if febrile illness develops
Referral Criteria:
Travelers with immunodeficiency, pregnancy, or chronic illness needing special vaccination schedule
Adverse reaction to vaccine or prophylaxis
Fever within 1 year after travel to endemic area
Patient Instructions:
Complete vaccination schedule and keep record
Take malaria prophylaxis exactly as prescribed
Follow preventive measures during travel
Seek medical attention promptly if fever, jaundice, diarrhea, or other illness occurs during or after travel
Legal / Ethical Justification:
Family physicians provide pre-travel preventive care to reduce morbidity and mortality
Proper counseling, prescription, and documentation protect patient health and ensure medicolegal safety
Awareness of local regulations (e.g., Yellow Fever certificate) is part of ethical care
XVIII. PREVENTIVE & COMMUNITY HEALTH
Case 18a – Screening: BP, Diabetes, Cholesterol, BMI, Cancer, Anemia
Diagnosis / Purpose:
Early detection of common chronic diseases and risk factors to prevent complications
Target population: adults ≥18 years, high-risk individuals, and age-appropriate cancer screening
Patient Presentation / Wordings:
“I want a general health check-up.”
“I have a family history of diabetes and high blood pressure.”
“I’m overweight and concerned about my health.”
“I haven’t had any blood tests in a while and want to know my risk.”
Examination / Assessment:
Vital signs: BP measurement (sitting and standing if indicated)
Anthropometry: height, weight, BMI calculation, waist circumference
General: pallor, jaundice, skin changes
Abdominal exam: hepatosplenomegaly
Breast exam (women) and testicular exam (men) if indicated
Other focused exams based on age and risk factors
Investigations / Screening Tests:
BP: ≥140/90 mmHg = hypertension; consider home BP monitoring
Diabetes: Fasting blood glucose, HbA1c
Cholesterol / Lipid profile: Total cholesterol, LDL, HDL, triglycerides
BMI / Obesity: BMI ≥25 = overweight, ≥30 = obese
Cancer screening:
Breast: mammography every 2 years (women ≥40)
Cervical: Pap smear every 3 years (women ≥21)
Colorectal: FOBT annually or colonoscopy every 10 years (≥50)
Anemia: CBC (especially in at-risk groups: women of reproductive age, elderly)
Treatment / Prescription / Management:
A. Lifestyle & Risk Factor Management:
Diet: balanced diet, reduce saturated fats, sugar, salt
Exercise: 30 min moderate activity ≥5 days/week
Smoking cessation: behavioral therapy ± pharmacotherapy (nicotine replacement, varenicline)
Weight management: goal-oriented BMI reduction
B. Pharmacologic Intervention (if indicated):
Hypertension: ACE inhibitors, ARBs, calcium channel blockers, or diuretics based on comorbidities
Diabetes: Metformin 500 mg PO twice daily initially, titrate as needed
Hyperlipidemia: Statins (e.g., Atorvastatin 10–20 mg PO nightly) if LDL above target
C. Follow-Up / Monitoring:
BP: every 3–6 months if elevated
Blood glucose / HbA1c: every 3–6 months if abnormal
Lipid profile: annually if normal, more often if elevated
BMI: monitor monthly if lifestyle intervention ongoing
Cancer screening: per recommended intervals
CBC: repeat if anemia detected or symptomatic
Expected Side Effects:
Antihypertensives: dizziness, hypotension, cough (ACE inhibitors)
Metformin: GI upset
Statins: myalgia, elevated liver enzymes
Referral Criteria:
Persistent BP ≥180/120 mmHg or hypertensive crisis
Uncontrolled diabetes or HbA1c >9%
Abnormal screening suggesting malignancy
Severe or symptomatic anemia
Patient Instructions:
Maintain lifestyle modifications consistently
Take medications exactly as prescribed
Report new symptoms: chest pain, persistent fatigue, unexplained bleeding, weight loss
Adhere to follow-up schedule and repeat screening tests
Legal / Ethical Justification:
Family physicians are responsible for preventive screening to reduce morbidity and mortality
Early detection of chronic diseases and cancer improves outcomes and reduces healthcare costs
Documentation of screening results, counseling, and follow-up ensures medicolegal protection
Case 18b – Immunization: Child, Adult, Travel, Occupational
Diagnosis / Purpose:
Prevention of vaccine-preventable diseases in children, adults, travelers, and occupational risk groups
Patient Presentation / Wordings:
“I want my child to be fully vaccinated.”
“I’m traveling abroad and need advice on vaccines.”
“I work in a hospital and want occupational vaccines.”
“I haven’t had my tetanus booster in years.”
Examination / Assessment:
Review immunization history (childhood and adult vaccines)
Assess age, comorbidities, pregnancy status, allergies
Identify contraindications (e.g., immunosuppression, previous severe reaction)
Evaluate risk factors: travel destination, occupation, lifestyle
Vaccination / Prescription / Management:
A. Childhood Immunization:
BCG: birth (TB prevention)
DTP / DTaP: 6, 10, 14 weeks, booster 4–6 years
Polio (IPV/OPV): same schedule as DTP
Hepatitis B: birth, 6, 14 weeks
MMR: 9 months, 15 months
Pneumococcal: 6, 10, 14 weeks
Rotavirus: 6, 10 weeks
Hib: 6, 10, 14 weeks
B. Adult Immunization:
Td/Tdap booster: every 10 years
Influenza: annually
Hepatitis B: for high-risk adults (healthcare workers, diabetics)
Pneumococcal: adults ≥65 or high-risk adults
C. Travel Vaccination:
Yellow Fever: 0.5 mL SC, single dose
Hepatitis A: 0.5 mL IM × 2 doses
Typhoid: injectable 0.5 mL IM or oral capsules
Meningococcal ACWY: 0.5 mL IM single dose
D. Occupational Vaccination:
Hepatitis B: healthcare workers
Tetanus: construction, lab personnel
Influenza: annual for healthcare workers
Rabies pre-exposure: veterinarians, animal handlers
Expected Side Effects:
Mild: pain, redness at injection site, low-grade fever
Rare: allergic reactions, anaphylaxis (observe 15 minutes post-vaccine)
Monitoring / Follow-Up:
Observe for immediate reactions 15–30 minutes post-vaccination
Schedule boosters and complete multi-dose series
Maintain accurate immunization record
Referral Criteria:
Severe allergic history or prior anaphylaxis
Immunocompromised patients needing specialized vaccination schedule
Pregnancy: consult obstetrics for live vaccines
Patient Instructions:
Report fever, swelling, or rash after vaccination
Follow booster schedule for full protection
Maintain vaccination card for personal and occupational record
Legal / Ethical Justification:
Family physicians are responsible for preventive vaccination and counseling
Ensures protection against serious infectious diseases and reduces community outbreaks
Proper documentation protects against medicolegal liability and supports public health compliance
Case 18c – Health Education: Smoking Cessation & Weight Management
Diagnosis / Purpose:
Lifestyle-related risk factors for chronic diseases such as cardiovascular disease, diabetes, COPD, and cancer
Goal: promote healthy behaviors and reduce preventable morbidity
Patient Presentation / Wordings:
“I want to quit smoking but have tried several times.”
“I’m overweight and want to lose weight safely.”
“I want advice on improving my diet and exercise habits.”
Examination / Assessment:
Vital signs: BP, HR, BMI, waist circumference
General: obesity, central adiposity, signs of nicotine use (yellowing fingers, oral mucosa changes)
Assess readiness to change behavior and previous attempts
Screen for comorbidities: diabetes, hypertension, dyslipidemia
Investigations (if indicated):
Fasting blood glucose / HbA1c
Lipid profile
Liver and renal function tests (if considering pharmacotherapy for weight loss or nicotine cessation)
Treatment / Prescription / Management:
A. Smoking Cessation:
Behavioral counseling: motivational interviewing, triggers, coping strategies
Pharmacotherapy (if needed):
Nicotine replacement therapy: patches, gum, lozenges
Varenicline: 0.5 mg PO once daily × 3 days, then 0.5 mg twice daily × 4 days, then 1 mg PO twice daily × 11 weeks
Bupropion SR: 150 mg PO daily × 3 days, then 150 mg PO twice daily × 7–12 weeks
Monitor for mood changes, insomnia, or side effects
B. Weight Management:
Lifestyle modification:
Balanced diet: calorie deficit of 500–750 kcal/day
Exercise: 150 min/week moderate-intensity aerobic activity + resistance training
Behavioral strategies: food diary, portion control
Pharmacotherapy (if indicated and BMI ≥30 or ≥27 with comorbidities):
Orlistat 120 mg PO TID with meals containing fat
Monitor for GI side effects and fat-soluble vitamin supplementation
Expected Side Effects:
Nicotine replacement: local irritation, mild nausea
Varenicline: nausea, insomnia, vivid dreams, mood changes
Bupropion: insomnia, dry mouth, seizure risk (rare)
Orlistat: steatorrhea, flatulence, fat-soluble vitamin deficiency
Monitoring / Follow-Up:
Smoking cessation: weekly to monthly follow-up during initial quit phase
Weight management: monthly weight check, review diet/exercise logs
Lab tests: monitor liver/kidney function if using pharmacotherapy
Referral Criteria:
Severe psychiatric comorbidity interfering with smoking cessation
Obesity with complications needing bariatric referral
Unsuccessful lifestyle interventions after 6–12 months
Patient Instructions:
Set realistic, measurable goals (quit dates, weight targets)
Avoid triggers for smoking and maintain adherence to pharmacotherapy
Keep a food and exercise diary
Report any adverse effects promptly
Legal / Ethical Justification:
Family physicians are responsible for lifestyle counseling and early intervention for risk factors
Reduces risk of chronic diseases and healthcare costs
Documentation of counseling, pharmacotherapy, and follow-up ensures medicolegal protection
Case 18d – Occupational Health & Ergonomic Counseling
Diagnosis / Purpose:
Prevention and early detection of work-related illnesses and injuries
Promote safe workplace practices and ergonomics to reduce musculoskeletal and occupational risks
Patient Presentation / Wordings:
“I work long hours at a desk and have back and neck pain.”
“I’m exposed to chemicals at work and want advice on safety.”
“I want to know how to prevent injuries in my job.”
Examination / Assessment:
Vital signs: BP, HR
Musculoskeletal: posture, range of motion, pain points
Neurological: reflexes, sensory deficits if nerve compression suspected
Respiratory: for chemical or dust exposure
Skin: dermatitis or occupational rashes
Work environment: repetitive tasks, lifting, ergonomics
Investigations (if indicated):
CBC and metabolic panel (chemical exposure)
Pulmonary function tests for respiratory hazards
Imaging (X-ray, MRI) for musculoskeletal complaints
Audiometry for noise exposure
Treatment / Prescription / Management:
A. Ergonomic Counseling:
Correct workstation setup: chair height, monitor level, keyboard/mouse position
Proper lifting techniques and use of assistive devices
Frequent breaks: micro-breaks every 30–60 minutes
Stretching exercises to prevent musculoskeletal strain
B. Occupational Health Measures:
Personal protective equipment (PPE): masks, gloves, goggles as appropriate
Vaccinations for at-risk occupations (Hepatitis B, tetanus, influenza)
Education on chemical safety and hand hygiene
Noise reduction strategies and hearing protection
C. Symptomatic Management:
NSAIDs (e.g., Ibuprofen 400 mg PO TID with food) for musculoskeletal pain if not contraindicated
Physiotherapy referral for chronic back/neck pain or repetitive strain injuries
Expected Side Effects:
NSAIDs: GI upset, renal effects
Prolonged PPE use: skin irritation
Monitoring / Follow-Up:
Reassess musculoskeletal pain monthly or as needed
Monitor for skin or respiratory issues from occupational exposure
Track adherence to ergonomic recommendations and PPE usage
Referral Criteria:
Persistent musculoskeletal pain or nerve compression
Work-related respiratory disease or chemical exposure complications
Severe or complex injuries requiring specialist intervention
Patient Instructions:
Maintain proper posture and ergonomics consistently
Use PPE correctly and follow workplace safety protocols
Perform recommended exercises and stretching regularly
Report new symptoms related to work exposures promptly
Legal / Ethical Justification:
Family physicians are responsible for occupational health assessment and preventive counseling
Reduces risk of chronic musculoskeletal, respiratory, and dermatologic conditions
Proper documentation protects against legal liability and supports workplace safety compliance
Case 18e – Environmental & Vector-Borne Disease Awareness
Diagnosis / Purpose:
Prevention of diseases caused by environmental exposures and vectors (mosquitoes, ticks, rodents)
Promote public and individual health through awareness and preventive measures
Patient Presentation / Wordings:
“I live in a mosquito-prone area and want to avoid dengue or malaria.”
“I want advice on safe water and sanitation at home.”
“I’m concerned about ticks and Lyme disease while hiking.”
Examination / Assessment:
Assess living environment: water stagnation, sanitation, waste disposal
Occupation and recreational exposures: farming, gardening, hiking
Personal protective habits: insect repellent use, bed nets, clothing coverage
Review vaccination history for preventable vector-borne diseases (Yellow Fever, Japanese Encephalitis)
Investigations (if indicated):
No routine labs for awareness/prevention
Symptomatic individuals: test for dengue, malaria, chikungunya, leptospirosis, or tick-borne infections
Treatment / Prescription / Management:
A. Mosquito-Borne Disease Prevention:
Eliminate stagnant water and mosquito breeding sites
Use insect repellents (DEET 20–30%) on exposed skin
Use bed nets treated with permethrin
Wear long-sleeved clothing during peak mosquito activity
B. Tick and Rodent-Borne Disease Prevention:
Wear protective clothing when hiking/working outdoors
Use tick repellents (permethrin on clothing)
Avoid contact with rodent droppings; maintain clean storage and surroundings
Prompt removal of attached ticks to prevent Lyme disease and other infections
C. Safe Water & Environmental Hygiene:
Boil or filter drinking water
Proper waste disposal and hand hygiene
Avoid swimming in contaminated water sources
D. Vaccinations (if indicated):
Yellow Fever for travelers to endemic regions
Japanese Encephalitis for travelers in high-risk areas
Expected Side Effects:
Insect repellents: mild skin irritation
Bed nets: rare allergic reactions to permethrin
Vaccines: mild fever, injection site pain
Monitoring / Follow-Up:
Routine check-ins for individuals in high-risk environments
Observe for early symptoms of vector-borne diseases (fever, rash, myalgia)
Educate households/community on preventive measures
Referral Criteria:
Symptomatic individuals with suspected vector-borne infection
Outbreak situations requiring public health intervention
Complications of environmental exposures (severe dehydration, toxin exposure)
Patient Instructions:
Maintain environmental cleanliness and remove mosquito breeding sites
Use repellents, protective clothing, and bed nets consistently
Drink safe water and follow hygiene measures
Seek care promptly if fever, rash, or unusual symptoms develop
Legal / Ethical Justification:
Family physicians are responsible for preventive counseling on environmental and vector-borne risks
Reduces morbidity and mortality from preventable infections
Proper documentation of education, counseling, and preventive measures protects against medicolegal liability
XIX. REHABILITATION & CHRONIC CARE
Case 19a – Post-Stroke Rehabilitation
Diagnosis:
Cerebrovascular accident (ischemic or hemorrhagic stroke)
Residual motor, sensory, cognitive, or speech deficits
Patient Presentation / Wordings:
“I have weakness on one side of my body.”
“I have trouble speaking or understanding words.”
“I feel unsteady and fall easily.”
“I get frustrated and feel low since my stroke.”
Examination / Assessment:
Neurological: muscle strength (0–5 scale), tone, reflexes, coordination
Speech and swallowing assessment (dysarthria, dysphagia)
Cognitive evaluation: memory, attention, orientation
Functional assessment: ADLs (dressing, feeding, mobility)
Emotional status: depression, anxiety
Investigations / Monitoring:
Imaging review (CT/MRI) to assess stroke type and residual damage
Blood pressure, blood glucose, lipid profile
Swallowing study of dysphagia suspected
Treatment / Prescription / Management:
A. Physical Rehabilitation:
Physiotherapy: passive and active range-of-motion exercises, balance and gait training
Occupational therapy: ADL training, fine motor skill improvement, adaptive devices
B. Speech and Cognitive Therapy:
Speech therapy: articulation exercises, language comprehension practice
Cognitive rehabilitation: memory exercises, attention and problem-solving tasks
C. Medication Management:
Antiplatelets: Aspirin 75–100 mg PO daily or Clopidogrel 75 mg PO daily
Statins: Atorvastatin 20–40 mg PO daily
Blood pressure control: ACE inhibitors, beta-blockers, or ARBs as indicated
Diabetes management: Metformin or other anti-diabetics if needed
D. Pain Management:
Paracetamol 500–1000 mg PO every 6 hours as needed
NSAIDs cautiously if musculoskeletal pain present
E. Lifestyle & Risk Factor Modification:
Balanced diet, low-salt, low-fat, high-fiber
Gradual, supervised physical activity
Smoking and alcohol cessation
Psychological support and counseling
F. Home Care & Caregiver Training:
Assistance with mobility, toileting, and feeding
Safe home environment to prevent falls
Monitoring for warning signs: sudden weakness, speech changes, chest pain, infection
Encourage social interaction and emotional support
Expected Side Effects:
Antiplatelets: bleeding risk, GI upset
Statins: myalgia, liver enzyme elevation
NSAIDs: GI irritation, renal effects
Monitoring / Follow-Up:
Regular physiotherapy and occupational therapy sessions
Neurological and functional assessment every 4–6 weeks
Blood pressure, lipid profile, and glucose monitoring
Referral Criteria:
Recurrent stroke or TIA
Severe functional impairment requiring inpatient rehabilitation
Uncontrolled comorbidities
Patient Instructions:
Adhere to prescribed exercises and medications
Maintain healthy lifestyle and nutrition
Report new neurological symptoms immediately
Support caregivers in ensuring safety and adherence
Legal / Ethical Justification:
Family physicians coordinate long-term rehabilitation to reduce disability
Proper documentation of therapy, medications, and caregiver instructions ensures medicolegal protection
Early intervention improves functional recovery and quality of life
Case 19b – Post-Myocardial Infarction (Post-MI) Rehabilitation
Diagnosis:
Recovery phase after acute myocardial infarction
Goal: improve cardiac function, prevent complications, and reduce risk of recurrent events
Patient Presentation / Wordings:
“I get tired easily and have mild shortness of breath.”
“I want to start exercising safely after my heart attack.”
“I’m worried about taking my medications and returning to work.”
Examination / Assessment:
Vital signs: BP, HR, respiratory rate
Cardiovascular: heart sounds, murmurs, signs of heart failure (edema, JVP)
Functional assessment: exercise tolerance, ADLs
Emotional assessment: anxiety, depression, fear of exertion
Investigations / Monitoring:
ECG and echocardiography to assess cardiac function
Lipid profile, fasting glucose, HbA1c
Blood pressure and weight monitoring
Cardiac biomarkers if new symptoms arise
Treatment / Prescription / Management:
A. Cardiac Rehabilitation:
Phase I: inpatient mobilization and education
Phase II: supervised outpatient exercise program (walking, cycling, low-intensity aerobic activity)
Phase III: home-based or community program for long-term fitness
Monitor for angina, dyspnea, or arrhythmias during exercise
B. Medications:
Antiplatelets: Aspirin 75–100 mg PO daily ± Clopidogrel 75 mg PO daily
Beta-blockers: Metoprolol 25–50 mg PO twice daily
ACE inhibitors / ARBs: Lisinopril 10–20 mg PO daily
Statins: Atorvastatin 20–40 mg PO nightly
Diuretics: if heart failure symptoms present
Nitrates: for angina relief if indicated
C. Lifestyle Modification:
Heart-healthy diet: low-salt, low-fat, high-fiber
Gradual increase in physical activity as tolerated
Smoking cessation and alcohol moderation
Stress management: mindfulness, counseling, social support
D. Pain & Symptom Management:
Paracetamol 500–1000 mg PO every 6 hours for musculoskeletal or mild chest discomfort
Avoid NSAIDs unless approved by cardiologist
Expected Side Effects:
Beta-blockers: bradycardia, fatigue, dizziness
ACE inhibitors: cough, hyperkalemia
Statins: myalgia, liver enzyme elevation
Antiplatelets: GI irritation, bleeding risk
Monitoring / Follow-Up:
Cardiology review 2–4 weeks after discharge
BP, heart rate, and weight monitoring weekly initially
Lipid profile and blood glucose every 3–6 months
Monitor adherence to medications and lifestyle changes
Referral Criteria:
Persistent chest pain or new angina
Shortness of breath at rest, orthopnea, or edema (possible heart failure)
Arrhythmias or syncope
Patient Instructions:
Take medications as prescribed without skipping doses
Gradually resume physical activity under guidance
Maintain follow-up appointments with primary care and cardiology
Report any warning symptoms immediately (chest pain, severe dyspnea, palpitations)
Legal / Ethical Justification:
Family physicians coordinate post-MI rehabilitation to reduce morbidity and recurrent cardiac events
Documentation of medications, exercise program, and counseling ensures medicolegal protection
Early intervention improves survival, functional capacity, and quality of life
Case 19c – Post-Fracture / Musculoskeletal Rehabilitation
Diagnosis:
Recovery phase following fracture (upper/lower limb, vertebral, or pelvic)
Goal: restore mobility, strength, function, and prevent complications
Patient Presentation / Wordings:
“I had a broken arm/leg and I feel weak and stiff.”
“I have pain when moving my joint after my fracture heals.”
“I’m worried about falling again or not regaining full function.”
Examination / Assessment:
Inspect for deformity, swelling, redness, or muscle wasting
Assess joint range of motion and muscle strength
Check neurovascular status distal to fracture
Functional assessment: ability to perform ADLs, gait, balance
Investigations / Monitoring:
X-ray to confirm fracture healing
Bone density test if osteoporosis suspected
CBC, calcium, vitamin D levels if healing is delayed
Treatment / Prescription / Management:
A. Physical & Occupational Therapy:
Early mobilization: passive range-of-motion exercises as tolerated
Progressive strengthening: resistance exercises for affected limb
Gait training: walking aids if lower limb involved
ADL training: adaptive strategies for dressing, bathing, and household tasks
B. Pain Management (Non-Opioid, Non-Invasive):
Paracetamol 500–1000 mg PO every 6 hours as needed
NSAIDs (e.g., Ibuprofen 400 mg PO every 8 hours with food) if not contraindicated
Topical analgesics: Diclofenac gel for localized pain
C. Lifestyle & Nutritional Support:
Adequate protein and calcium intake, vitamin D supplementation
Weight-bearing exercises as tolerated to improve bone strength
Fall prevention strategies: safe home environment, handrails, non-slip mats
D. Home Care & Caregiver Training:
Safe handling of affected limb or assistive devices
Guidance on dressing changes or cast care if applicable
Monitoring for signs of infection or complications
Expected Side Effects:
NSAIDs: GI upset, renal effects
Topical agents: mild skin irritation
Overuse during rehabilitation: fatigue, soreness
Monitoring / Follow-Up:
Weekly to monthly physiotherapy sessions until functional recovery
Periodic X-rays to monitor fracture union
Assessment of pain, range of motion, and ADL independence
Referral Criteria:
Persistent pain or restricted motion beyond expected healing period
Non-union or malunion on imaging
Neurological deficits or vascular compromise
Patient Instructions:
Adhere strictly to physiotherapy and rehabilitation exercises
Avoid high-impact activities until cleared
Report new swelling, redness, numbness, or severe pain
Encourage caregiver support for safe mobility
Legal / Ethical Justification:
Family physicians coordinate rehabilitation to reduce long-term disability and improve quality of life
Proper documentation of therapy, home care instructions, and follow-up protects against legal liability
Early intervention prevents chronic pain, deformity, and secondary injuries
Case 19d – Lifestyle Modification Plans
Diagnosis / Purpose:
Prevention and management of chronic diseases through sustainable lifestyle changes
Target conditions: cardiovascular disease, diabetes, obesity, hypertension, dyslipidemia
Patient Presentation / Wordings:
“I want to reduce my risk of heart disease.”
“I want to lose weight and manage my blood sugar better.”
“I struggle to maintain a healthy diet and exercise routine.”
Examination / Assessment:
Vital signs: BP, HR
Anthropometry: weight, height, BMI, waist circumference
Cardiovascular and musculoskeletal examination
Assess current diet, physical activity, smoking, and alcohol use
Evaluate readiness to change behavior
Investigations / Screening:
Fasting blood glucose / HbA1c
Lipid profile
Blood pressure monitoring
Optional: liver and renal function, ECG
Treatment / Prescription / Management:
A. Diet & Nutrition:
Balanced diet: fruits, vegetables, whole grains, lean proteins
Reduce saturated fats, trans fats, added sugars, and salt
Portion control and regular meal timing
Consider referral to dietitian for personalized plan
B. Physical Activity:
At least 150 minutes/week moderate-intensity aerobic activity
Resistance training 2–3 times per week
Gradual progression tailored to fitness level and comorbidities
C. Smoking & Alcohol:
Smoking cessation: behavioral counseling ± pharmacotherapy (nicotine replacement, bupropion, varenicline)
Limit alcohol: ≤1 drink/day women, ≤2 drinks/day men
D. Stress Management & Sleep Hygiene:
Relaxation techniques: meditation, deep breathing, yoga
Adequate sleep: 7–9 hours/night
Cognitive-behavioral strategies for stress reduction
E. Monitoring & Follow-Up:
Monthly or quarterly follow-up to track weight, BP, glucose, lipid profile
Adjust lifestyle plan based on progress and adherence
Reinforce motivation and provide support
Expected Side Effects / Challenges:
Initial fatigue with exercise
Hunger or cravings with dietary changes
Mood fluctuations during behavior modification
Referral Criteria:
Persistent obesity (BMI ≥40) or obesity with complications
Uncontrolled diabetes, hypertension, or dyslipidemia despite lifestyle interventions
Mental health concerns affecting adherence
Patient Instructions:
Set realistic and measurable goals
Keep a food and activity diary
Incorporate lifestyle changes gradually for sustainability
Seek support from family, community programs, or health coaches
Legal / Ethical Justification:
Family physicians are responsible for preventive counseling to reduce chronic disease risk
Documentation of counseling, lifestyle plan, and follow-up ensures medicolegal protection
Early intervention improves long-term health outcomes and reduces healthcare costs
Case 19e – Pain Management (Non-Opioid, Non-Invasive) & Home Care Advice
Diagnosis / Purpose:
Management of chronic or post-rehabilitation pain without opioids
Support for functional recovery and quality of life
Home care strategies to optimize safety and independence
Patient Presentation / Wordings:
“I have persistent joint/back pain after my surgery/stroke/fracture.”
“I want pain relief but I don’t want strong painkillers.”
“I need guidance for taking care of myself at home safely.”
Examination / Assessment:
Pain assessment: intensity (0–10 scale), quality, triggers, timing
Musculoskeletal: range of motion, tenderness, joint stability
Neurological: sensation, reflexes, motor function
Functional assessment: ability to perform ADLs and mobility
Environmental assessment for fall or injury risks at home
Investigations (if indicated):
X-rays, MRI, or ultrasound for musculoskeletal pain
CBC, ESR/CRP for inflammatory conditions
Renal and liver function if prolonged NSAID use anticipated
Treatment / Prescription / Management:
A. Pain Management (Non-Opioid, Non-Invasive):
Paracetamol: 500–1000 mg PO every 6 hours as needed (max 4 g/day)
NSAIDs: Ibuprofen 400 mg PO every 8 hours with food; monitor renal function and GI tolerance
Topical analgesics: Diclofenac gel or lidocaine patches for localized pain
Physical modalities: heat/cold therapy, TENS, physiotherapy exercises
Behavioral strategies: relaxation techniques, cognitive-behavioral therapy for chronic pain
B. Home Care Advice & Caregiver Training:
Safe mobility: use of walking aids, grab bars, and non-slip mats
Assistance with ADLs as needed (dressing, bathing, feeding)
Medication administration and adherence monitoring
Early recognition of complications: swelling, redness, new pain, fever
Nutrition: adequate protein and hydration to support recovery
Encourage social interaction and mental stimulation
Expected Side Effects:
NSAIDs: GI upset, renal effects
Topical agents: mild skin irritation
Overuse of physical modalities: temporary soreness
Monitoring / Follow-Up:
Weekly to monthly reassessment of pain intensity and function
Monitor adherence to exercises and home safety measures
Adjust therapy based on patient progress and tolerance
Referral Criteria:
Severe or uncontrolled pain
Neurological deficits, worsening function, or signs of infection
Complications requiring specialist intervention (orthopedics, neurology, pain clinic)
Patient Instructions:
Follow prescribed exercise and therapy routines consistently
Take medications as directed and report side effects
Ensure safe home environment to prevent falls and injuries
Encourage caregiver involvement in monitoring and support
Legal / Ethical Justification:
Family physicians provide non-opioid pain management and home care guidance to enhance recovery and prevent complications
Documentation of treatment, home care instructions, and follow-up protects against medicolegal liability
Promotes safe, evidence-based, patient-centered care
XX. LEGAL & ETHICAL RESPONSIBILITIES
Case 20a – Documentation & Record Retention
Diagnosis / Purpose:
Accurate record-keeping to ensure continuity of care, legal protection, and quality assurance
Patient Presentation / Wordings:
“I want a copy of my previous consultations.”
“My doctor didn’t write down my treatment plan.”
“Can you provide documentation for insurance or work?”
Examination / Assessment:
Review current documentation practices in clinic
Evaluate completeness: patient demographics, history, examination, investigations, treatment plan, follow-up
Assess legibility, date/time stamps, signatures, and professional identifiers
Treatment / Prescription / Management (Documentation Workflow):
A. Essential Components of Medical Records:
Patient identifiers: name, age, sex, ID number, contact information
Clinical notes: history, examination, differential diagnosis
Investigations: ordered tests, results, interpretation
Treatment: medications, dosages, procedures
Follow-up: appointments, referrals, counseling
Consent: procedural and therapeutic consents
B. Record Retention Guidelines:
Maintain adult patient records ≥5–10 years (varies by jurisdiction)
Pediatric records until at least age 21 or as per local regulations
Digital records: secure access, password-protected, regular backups
Paper records: organized filing, secure storage
C. Legal & Ethical Considerations:
Legible, complete, and timely documentation prevents malpractice claims
Avoid abbreviations that may cause confusion or misinterpretation
Maintain confidentiality at all times
Record any patient refusals, missed appointments, or deviations from recommended care
Expected Risks / Pitfalls:
Incomplete or illegible records can lead to mismanagement or legal liability
Unauthorized access or disclosure of patient data
Loss of records due to poor storage or inadequate backup
Monitoring / Follow-Up:
Periodic internal audits of documentation practices
Update templates and electronic records to reflect current standards
Continuous staff training on record-keeping, confidentiality, and legal compliance
Referral / Escalation Criteria:
Requests for records exceeding scope (legal subpoenas, insurance fraud investigations) should be referred to hospital/legal department
Complex cases requiring forensic documentation should involve a senior or certified medical officer
Patient Instructions:
Patients may request copies of records or summaries as per local regulations
Encourage patients to review their records for accuracy and report discrepancies
Legal / Ethical Justification:
Accurate documentation ensures continuity of care, patient safety, and legal protection
Provides evidence of professional practice in case of disputes
Upholds ethical standards for transparency and patient rights
Case 20b – Informed Consent & Confidentiality
Diagnosis / Purpose:
Ensuring that patients understand procedures, treatments, and investigations
Protecting patient autonomy, privacy, and legal rights
Patient Presentation / Wordings:
“I want to understand the risks of this procedure before agreeing.”
“Will my medical information remain private?”
“Do I need to sign a consent form for this test?”
Examination / Assessment:
Assess patient capacity to give consent: age, mental status, comprehension
Evaluate understanding of the proposed intervention, alternatives, and risks
Identify vulnerable populations: minors, cognitively impaired, incapacitated patients
Treatment / Prescription / Management (Consent & Confidentiality Workflow):
A. Informed Consent Process:
Explanation: Provide clear verbal explanation of procedure, purpose, benefits, risks, alternatives, and expected outcomes
Understanding: Confirm patient comprehension through teach-back or discussion
Voluntariness: Ensure the patient is not coerced or pressured
Documentation: Record discussion, signed consent form, date, and witness if required
B. Confidentiality:
Maintain privacy of all patient information: verbal, written, and electronic
Limit access to authorized personnel only
Disclose information only with patient consent or when legally mandated (e.g., public health reporting, court orders)
Educate staff and caregivers about confidentiality obligations
C. Special Considerations:
Minors: parental or guardian consent required; assent from capable minors
Incapacitated adults: consent from legal guardian or next of kin
Emergencies: treatment may proceed if delay poses risk to life; document justification
Expected Risks / Pitfalls:
Proceeding without proper consent may result in legal action or professional sanctions
Breach of confidentiality can lead to loss of trust, legal liability, and regulatory penalties
Monitoring / Follow-Up:
Regular review of consent forms and documentation procedures
Audit staff adherence to confidentiality protocols
Update consent forms to reflect changes in procedures, laws, or guidelines
Referral / Escalation Criteria:
Complex or high-risk procedures may require legal or ethical consultation
Breach or suspected breach of confidentiality should be reported to compliance or legal department
Patient Instructions:
Ask questions until fully understood
Review consent forms carefully before signing
Expect that their personal and medical information will be kept private
Report any concerns regarding privacy violations
Legal / Ethical Justification:
Family physicians are ethically and legally obligated to ensure informed consent and maintain confidentiality
Proper documentation of consent and privacy safeguards protects both patient and physician
Upholds patient autonomy, trust, and professional integrity
Case 20c – Medico-Legal Cases (MLCs: Injury, Assault, Poisoning) Documentation & Referral
Diagnosis / Purpose:
Proper identification, documentation, and referral of cases with legal implications
Ensures compliance with law, evidence preservation, and patient safety
Patient Presentation / Wordings:
“I was injured in an accident and need a medical report.”
“I was assaulted and want treatment documented for legal purposes.”
“I ingested a poisonous substance; what should I do?”
Examination / Assessment:
Detailed history: time, location, mechanism of injury or exposure, witnesses
Thorough physical examination: wounds, bruises, burns, fractures, signs of assault
Assess vital signs and general condition: airway, breathing, circulation
Neurological and mental status assessment if trauma or poisoning involved
Identify potential life-threatening issues first
Investigations (if indicated):
Blood tests, urine toxicology, imaging (X-ray, CT)
Forensic samples: swabs from wounds, clothing, or vomitus as required
Treatment / Prescription / Management:
A. Immediate Medical Care:
Stabilize airway, breathing, circulation
Treat injuries or poisoning according to standard protocols
Pain management and wound care as needed
B. Documentation for MLC:
Record detailed history in patient’s words
Document date, time, and place of incident
Describe injuries in detail: size, color, pattern, location
Include photographs if permitted by law and patient consent
Record treatment given and follow-up instructions
Avoid assumptions or subjective statements; report only factual findings
C. Referral & Reporting:
Report to police or legal authorities as mandated by law
Refer to forensic specialists if required
Notify poison control centers for toxic exposures
Coordinate with hospital/legal department for proper chain of evidence
Expected Risks / Pitfalls:
Inadequate documentation may compromise legal proceedings
Mishandling evidence may invalidate forensic claims
Delay in reporting may have legal consequences
Monitoring / Follow-Up:
Monitor patient for complications of injury, poisoning, or assault
Ensure follow-up appointments and continued documentation
Track legal reporting deadlines and submission of required forms
Referral / Escalation Criteria:
Severe injuries requiring surgical or specialized care
Life-threatening poisoning
Complex forensic cases requiring certified MLC officer or medicolegal specialist
Patient Instructions:
Cooperate with examination and provide accurate history
Follow prescribed treatment and attend follow-up
Understand their rights regarding legal reporting and documentation
Legal / Ethical Justification:
Family physicians are legally obligated to identify, document, and report MLCs appropriately
Proper documentation preserves evidence and protects both patient and physician
Timely medical care combined with legal compliance ensures justice and patient safety
Case 20d – Disability & Fitness Certification
Diagnosis / Purpose:
Assessment and certification of physical or mental fitness for work, driving, education, or other activities
Objective documentation of disability or limitations in accordance with legal and professional standards
Patient Presentation / Wordings:
“I need a fitness certificate for my job/sports license.”
“I require a disability certificate for government benefits.”
“My employer asked for medical clearance before returning to work.”
Examination / Assessment:
Comprehensive history relevant to functional capacity, comorbidities, and limitations
Physical examination: vital signs, musculoskeletal, neurological, cardiovascular, respiratory, sensory, and cognitive evaluation
Assessment of activities of daily living (ADLs) and occupational requirements
Review previous investigations, imaging, and specialist reports if available
Investigations (if indicated):
Blood tests, imaging, or specialist evaluations relevant to the disability or fitness requirement
Functional tests: exercise tolerance, mobility, vision/hearing tests
Treatment / Prescription / Management (Certification Workflow):
A. Assessment & Documentation:
Evaluate medical condition objectively against criteria for disability or fitness
Clearly state limitations, restrictions, or accommodations needed
Include duration of fitness/disability if temporary or periodic review required
Use standardized forms or templates where applicable
B. Communication & Counseling:
Explain findings and implications to patient
Advise on workplace or activity modifications if required
Clarify legal and administrative responsibilities associated with certification
Expected Risks / Pitfalls:
Issuing inaccurate or fraudulent certification may result in legal and professional consequences
Failure to document objective findings or rationale may compromise credibility
Overlooking relevant medical conditions can endanger patient or public safety
Monitoring / Follow-Up:
Reassessment for temporary disabilities or conditions likely to improve
Monitor compliance with recommended accommodations or restrictions
Referral / Escalation Criteria:
Complex or contested disability cases requiring specialist evaluation
High-risk activities (e.g., driving, aviation, heavy machinery) requiring additional clearance
Legal disputes regarding fitness or disability claims
Patient Instructions:
Provide complete and accurate medical history
Attend required follow-up or reassessment
Comply with recommended restrictions and workplace accommodations
Legal / Ethical Justification:
Family physicians must objectively assess and document fitness/disability to protect patient safety and public welfare
Certification must comply with local laws and professional guidelines
Accurate documentation protects physician from legal liability and ensures ethical practice
Case 20e – Professional Boundaries, Referral Ethics & Prescribing Legally Registered Medicines
Diagnosis / Purpose:
Maintain ethical professional conduct, appropriate referral practices, and legal prescribing standards
Protect patient safety, trust, and physician integrity
Patient Presentation / Wordings:
“Can you prescribe this medicine that is not available locally?”
“I want you to treat me even though a specialist suggested a referral.”
“Is it okay to share my health info with my family/employer?”
Examination / Assessment:
Review patient’s medical condition and complexity
Determine if care is within family physician scope
Identify potential conflicts of interest, coercion, or inappropriate requests
Treatment / Prescription / Management (Workflow):
A. Professional Boundaries:
Maintain appropriate physician-patient relationships
Avoid dual relationships that may impair objectivity (financial, social, familial)
Establish clear limits regarding availability, communication, and scope of practice
B. Referral Ethics:
Refer patients to specialists when condition exceeds primary care capabilities
Explain reasons for referral and expected benefits to the patient
Avoid unnecessary referrals that may increase costs or inconvenience
Coordinate care and share relevant information with the specialist, maintaining confidentiality
C. Prescribing Legally Registered Medicines:
Prescribe only medications approved and registered by local regulatory authorities
Document indication, dosage, duration, and monitoring requirements
Avoid unapproved or off-label drugs unless supported by strong evidence and informed consent
Monitor for adverse effects, interactions, and patient adherence
Expected Risks / Pitfalls:
Prescribing unregistered or unapproved medicines may lead to legal action or professional sanctions
Breach of professional boundaries can compromise patient trust and safety
Inappropriate or delayed referrals may result in suboptimal patient outcomes
Monitoring / Follow-Up:
Regularly review prescribing patterns and patient response
Maintain documentation of referrals and communication with specialists
Update knowledge of legally approved medications and ethical guidelines
Referral / Escalation Criteria:
Complex cases requiring specialist intervention
Ethical dilemmas or conflicts of interest requiring institutional guidance
Requests for unapproved or high-risk medications
Patient Instructions:
Follow prescribed medication and monitoring plan
Understand the reasons for referral and follow specialist recommendations
Respect physician’s professional boundaries and scope of practice
Legal / Ethical Justification:
Family physicians must uphold professional boundaries, ethical referral practices, and legal prescribing standards
Protects patients from harm, ensures care quality, and maintains physician integrity
Proper documentation safeguards against legal liability and reinforces ethical practice
The End
“The Family Medicine Casebook: Practical Clinical Scenarios for Everyday Practice”
By
Dr. Syed Aamir Ali Naqvi
Family Physician (Gold Medalist)
Credentialed (PM&DC, MMC, DHA)
Member – Pakistan Academy of Family Physicians (PAFP)
M.D. (SSMU, KZ)
ECFMG Regd. (USA)
MCC Certified (Canada)
PGD-FM (SCM, STMU, PK)
PGCert-MHR (GIHD, STMU, PK)
© 2026 Dr. Syed Aamir Ali Naqvi – All Rights Reserved